<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Gen Physiol</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Gen. Physiol</journal-id>
<journal-id journal-id-type="publisher-id">jgp</journal-id>
<journal-id journal-id-type="hwp">jgp</journal-id>
<journal-title-group>
<journal-title>The Journal of General Physiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-1295</issn>
<issn pub-type="epub">1540-7748</issn>
<publisher>
<publisher-name>Rockefeller University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31427379</article-id>
<article-id pub-id-type="pmc">6785733</article-id>
<article-id pub-id-type="publisher-id">201912457</article-id>
<article-id pub-id-type="doi">10.1085/jgp.201912457</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Reviews</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>510</subject>
</subj-group>
</article-categories>
<title-group>
<article-title><italic>KCNMA1</italic>-linked channelopathy</article-title>
<alt-title alt-title-type="short"><italic>KCNMA1</italic>-linked channelopathy</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Bailey</surname>
<given-names>Cole S.</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9206-1366</contrib-id>
<name>
<surname>Moldenhauer</surname>
<given-names>Hans J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Park</surname>
<given-names>Su Mi</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0001-9264-9824</contrib-id>
<name>
<surname>Keros</surname>
<given-names>Sotirios</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1061-2302</contrib-id>
<name>
<surname>Meredith</surname>
<given-names>Andrea L.</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="corresp" rid="cor3"></xref>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1</label>
<institution>Dept. of Physiology, University of Maryland School of Medicine, Baltimore, MD</institution>
</aff>
<aff id="aff2">
<label>2</label>
<institution>Department of Pediatrics, University of South Dakota Sanford School of Medicine, Sioux Falls, SD</institution>
</aff>
<author-notes>
<corresp id="cor3">Correspondence to Andrea L. Meredith: <email>ameredith@som.umaryland.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>07</day>
<month>10</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>19</day>
<month>8</month>
<year>2019</year>
</pub-date>
<volume>151</volume>
<issue>10</issue>
<fpage>1173</fpage>
<lpage>1189</lpage>
<history>
<date date-type="received">
<day>29</day>
<month>7</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>8</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 Bailey et al.</copyright-statement>
<copyright-year>2019</copyright-year>
<ali:free_to_read start_date="2020-04-06" xmlns:ali="http://www.niso.org/schemas/ali/1.0/"></ali:free_to_read>
<license>
<ali:license_ref specific-use="vor" xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://www.rupress.org/terms/</ali:license_ref>
<ali:license_ref specific-use="vor" start_date="2020-04-06" xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see <ext-link ext-link-type="uri" xlink:href="http://www.rupress.org/terms/">http://www.rupress.org/terms/</ext-link>). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/">https://creativecommons.org/licenses/by-nc-sa/4.0/</ext-link>).</license-p>
</license>
</permissions>
<self-uri xlink:href="JGP_201912457_thumb.gif" xlink:role="icon"></self-uri>
<abstract abstract-type="precis">
<p>Bailey et al. review a new neurological channelopathy associated with <italic>KCNMA1</italic>, encoding the BK voltage- and Ca<sup>2+</sup>-activated K<sup>+</sup> channel.</p>
</abstract>
<abstract>
<p><italic>KCNMA1</italic> encodes the pore-forming α subunit of the “Big K<sup>+</sup>” (BK) large conductance calcium and voltage-activated K<sup>+</sup> channel. BK channels are widely distributed across tissues, including both excitable and nonexcitable cells. Expression levels are highest in brain and muscle, where BK channels are critical regulators of neuronal excitability and muscle contractility. A global deletion in mouse (<italic>KCNMA1<sup>−/−</sup></italic>) is viable but exhibits pathophysiology in many organ systems. Yet despite the important roles in animal models, the consequences of dysfunctional BK channels in humans are not well characterized. Here, we summarize 16 rare <italic>KCNMA1</italic> mutations identified in 37 patients dating back to 2005, with an array of clinically defined pathological phenotypes collectively referred to as “<italic>KCNMA1</italic>-linked channelopathy.” These mutations encompass gain-of-function (GOF) and loss-of-function (LOF) alterations in BK channel activity, as well as several variants of unknown significance (VUS). Human <italic>KCNMA1</italic> mutations are primarily associated with neurological conditions, including seizures, movement disorders, developmental delay, and intellectual disability. Due to the recent identification of additional patients, the spectrum of symptoms associated with <italic>KCNMA1</italic> mutations has expanded but remains primarily defined by brain and muscle dysfunction. Emerging evidence suggests the functional BK channel alterations produced by different <italic>KCNMA1</italic> alleles may associate with semi-distinct patient symptoms, such as paroxysmal nonkinesigenic dyskinesia (PNKD) with GOF and ataxia with LOF. However, due to the de novo origins for the majority of <italic>KCNMA1</italic> mutations identified to date and the phenotypic variability exhibited by patients, additional evidence is required to establish causality in most cases. The symptomatic picture developing from patients with <italic>KCNMA1</italic>-linked channelopathy highlights the importance of better understanding the roles BK channels play in regulating cell excitability. Establishing causality between <italic>KCNMA1</italic>-linked BK channel dysfunction and specific patient symptoms may reveal new treatment approaches with the potential to increase therapeutic efficacy over current standard regimens.</p>
</abstract>
<funding-group>
<award-group id="sp1">
<funding-source>
<institution-wrap>
<institution>National Heart, Lung, and Blood Institute</institution>
<institution-id institution-id-type="DOI">http://dx.doi.org/10.13039/100000050</institution-id>
</institution-wrap>
</funding-source>
<award-id rid="sp1">R01-HL102758</award-id>
<award-id rid="sp1">T32-GM008181</award-id>
</award-group>
<award-group id="sp2">
<funding-source>
<institution-wrap>
<institution>American Physiological Society</institution>
<institution-id institution-id-type="DOI">http://dx.doi.org/10.13039/100005384</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group id="sp3">
<funding-source>
<institution-wrap>
<institution>University of Maryland School of Medicine</institution>
</institution-wrap>
</funding-source>
</award-group>
</funding-group>
<counts>
<page-count count="17"></page-count>
</counts>
</article-meta>
</front>
<body><sec disp-level="2" id="s02"><title>Introduction</title><sec id="s03"><title>Ion channelopathies</title><p>Ion channels are ubiquitously expressed throughout the body and perform key membrane transport processes crucial to normal physiological function. Pathogenic alterations to ion channel activity can disrupt homeostatic and physiological functions leading to disorders such as hemiplegic migraines, epilepsy, or cardiac arrhythmias, collectively referred to as "channelopathies” (<xref ref-type="bibr" rid="bib11">Brenner and Wilcox, 2012</xref>; <xref ref-type="bibr" rid="bib76">Kim, 2014</xref>; <xref ref-type="bibr" rid="bib105">Meredith, 2015</xref>). Channelopathies are rare monogenetic disorders stemming from inherited or de novo mutations in genes encoding the functional components of ion channels. Advancements in whole exome sequencing (WES) have contributed to a growing list of diagnosable monogenetic channelopathies (<xref ref-type="bibr" rid="bib76">Kim, 2014</xref>), yet the molecular basis for these genetic mutations and how they produce clinical phenotypes are not fully established in many cases. Current understandings of channelopathies are limited by several factors, such as deficiencies in (a) the direct evidence for causality due to a very limited number of patients and lack of genetic pedigree analysis, (b) the functional data for the classification of mutant channel properties, and (c) the tissue loci and nature of aberrant excitability linked to abnormal patient phenotypes. This review will focus on one channelopathy involving the large conductance Ca<sup>2+</sup> and voltage-activated K<sup>+</sup> (BK, K<sub>Ca</sub>1.1) channel, encoded by <italic>KCNMA1</italic>. The hallmark clinical presentation of <italic>KCNMA1</italic>-linked channelopathy is neurological dysfunction, including seizures, movement disorders, developmental delay, and intellectual disability.</p></sec><sec id="s04"><title>BK channel structure</title><p>The <italic>KCNMA1</italic> gene, located on human chromosome 10q22.3, produces the pore-forming α-subunit of the BK channel (<xref ref-type="bibr" rid="bib30">Dworetzky et al., 1994</xref>; <xref ref-type="bibr" rid="bib122">Pallanck and Ganetzky, 1994</xref>; <xref ref-type="bibr" rid="bib98">McCobb et al., 1995</xref>). BK channels, named for their “Big K<sup>+</sup>” conductance (&gt;100 pS), are members of the voltage-gated K<sup>+</sup> channel family and mediate K<sup>+</sup> efflux from excitable and non-excitable cells (<xref ref-type="bibr" rid="bib82">Latorre and Miller, 1983</xref>; <xref ref-type="bibr" rid="bib117">Neyton and Miller, 1988</xref>). BK channels assemble as homotetramers of the <italic>KCNMA1</italic> gene product. Each α-subunit consists of seven transmembrane domains (S0–S6), and a large intracellular C-terminus (<xref ref-type="fig" rid="fig1">Fig. 1</xref>). The extracellular N-terminus and presence of the S0 transmembrane segment differs between BK and other voltage-gated K<sup>+</sup> channels and confers interactions with accessory proteins (β and γ subunits; <xref ref-type="bibr" rid="bib175">Wallner et al., 1996</xref>; <xref ref-type="bibr" rid="bib111">Morrow et al., 2006</xref>; <xref ref-type="bibr" rid="bib192">Yan and Aldrich, 2010</xref>, <xref ref-type="bibr" rid="bib193">2012</xref>). The S1–S4 segments contain positively charged residues and constitute the voltage sensing domain, while the S5–S6 segments form the pore domain, which houses the highly K<sup>+</sup>-selective conduction pathway (<xref ref-type="bibr" rid="bib101">Meera et al., 1997</xref>; <xref ref-type="bibr" rid="bib154">Stefani et al., 1997</xref>; <xref ref-type="bibr" rid="bib61">Horrigan et al., 1999</xref>; <xref ref-type="bibr" rid="bib60">Horrigan and Aldrich, 2002</xref>; <xref ref-type="bibr" rid="bib194">Yang et al., 2015</xref>). The intracellular C-terminus of the BK channel encompasses the gating ring, a structure comprised of two regulators of K<sup>+</sup> conductance (RCK) domains. RCK1 and RCK2 each contain two distinct high-affinity Ca<sup>2+</sup> binding sites, mediating the allosteric gating of BK channels (<xref ref-type="bibr" rid="bib191">Xia et al., 2002</xref>; <xref ref-type="bibr" rid="bib176">Wang and Sigworth, 2009</xref>; <xref ref-type="bibr" rid="bib85">Lee and Cui, 2010</xref>; <xref ref-type="bibr" rid="bib198">Yuan et al., 2010</xref>, <xref ref-type="bibr" rid="bib199">2011</xref>; <xref ref-type="bibr" rid="bib202">Zhang et al., 2010</xref>). The human BK channel structure was determined in 2010 (<xref ref-type="bibr" rid="bib198">Yuan et al., 2010</xref>), providing a basis for understanding the location of specific residues, such as mutations, with respect to functional domains.</p><fig fig-type="figure" id="fig1" orientation="portrait" position="float"><label>Figure 1.</label><caption><p><bold>Human <italic>KCNMA1</italic> mutations.</bold> Schematic of the <italic>KCNMA1</italic> gene product, the α-subunit of the BK channel (GenBank accession no. <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="NM_002247.3">NM_002247.3</ext-link>). The voltage-sensitive pore-forming region of the BK channel is comprised of transmembrane domains S0–S6, while the intracellular gating ring contains the two Ca<sup>2+</sup> binding sites in the RCK1 and RCK2 domains. Red indicates GOF mutations (<italic>n</italic> = 2), blue indicates LOF or putative LOF mutations (<italic>n</italic> = 11), and black indicates putative benign mutations (<italic>n</italic> = 3) or VUS (<italic>n</italic> = 1). *C413Y/N499fs is a double mutation harbored by a single patient. Numbers to the right or left of each mutation indicate the total number of patients carrying each mutation reported in published studies. N995S, N999S, and N1053S are the same amino acid substitution, but are reported in the literature using three different reference sequencing number schemes.</p></caption><graphic xlink:href="JGP_201912457_Fig1"></graphic></fig></sec><sec id="s05"><title>Voltage and calcium regulation of BK channel activity</title><p>Multiple activation mechanisms are involved in opening the channels in vivo (<xref ref-type="bibr" rid="bib66">Hou et al., 2009</xref>). Under physiological conditions in excitable cells, the BK channel activation requires both membrane depolarization and an increase in intracellular Ca<sup>2+</sup> to micromolar levels for activation (<xref ref-type="bibr" rid="bib194">Yang et al., 2015</xref>). These high concentrations of Ca<sup>2+</sup> are attained in local microdomains through tight functional coupling with voltage-gated Ca<sup>2+</sup> channels or channels that release Ca<sup>2+</sup> from intracellular stores (<xref ref-type="bibr" rid="bib37">Fakler and Adelman, 2008</xref>). Different tissues exhibit BK currents of varying voltage and Ca<sup>2+</sup>-dependent activation properties, underlying the complex roles for BK channels in regulating excitability. This cell and tissue-specific regulation is achieved via extensive alternative splicing of <italic>KCNMA1</italic> transcripts, assembly with modulatory β- and γ-regulatory subunits, and a variety of post-translational modifications (<xref ref-type="bibr" rid="bib79">Kyle and Braun, 2014</xref>; <xref ref-type="bibr" rid="bib83">Latorre et al., 2017</xref>; <xref ref-type="bibr" rid="bib45">Gonzalez-Perez and Lingle, 2019</xref>). These mechanisms work together to tailor the voltage and Ca<sup>2+</sup> dependence of channel activation, as well as the kinetics of activation and deactivation gating, for the cell-specific function of BK channels in excitability or K<sup>+</sup> transport.</p></sec><sec id="s06"><title>Tissue distribution and links to human pathophysiology</title><p>In humans, BK channels are widely expressed in the body including nervous, muscular, skeletal, endocrine, cardiovascular, digestive, urinary, and reproductive systems (<xref ref-type="fig" rid="fig2">Fig. 2</xref>; <xref ref-type="bibr" rid="bib123">Pallotta et al., 1981</xref>; <xref ref-type="bibr" rid="bib3">Adams et al., 1982</xref>; <xref ref-type="bibr" rid="bib4">Becker et al., 1995</xref>; <xref ref-type="bibr" rid="bib98">McCobb et al., 1995</xref>; <xref ref-type="bibr" rid="bib59">Hirukawa et al., 2008</xref>; <xref ref-type="bibr" rid="bib22">Cui et al., 2009</xref>; <xref ref-type="bibr" rid="bib35">Fagerberg et al., 2014</xref>; <xref ref-type="bibr" rid="bib21">Contet et al., 2016</xref>; <xref ref-type="bibr" rid="bib83">Latorre et al., 2017</xref>; <xref ref-type="bibr" rid="bib45">Gonzalez-Perez and Lingle, 2019</xref>). Prior to the identification of <italic>KCNMA1</italic>-linked channelopathy patients, changes in BK channel expression or activity had been implicated in human studies of erectile dysfunction, overactive bladder, hypertension, and premature uterine contraction during pregnancy (<xref ref-type="bibr" rid="bib17">Christ et al., 2001</xref>, <xref ref-type="bibr" rid="bib18">2009</xref>; <xref ref-type="bibr" rid="bib104">Melman et al., 2007</xref>; <xref ref-type="bibr" rid="bib164">Tomás et al., 2008</xref>; <xref ref-type="bibr" rid="bib49">Grimm and Sansom, 2010</xref>; <xref ref-type="bibr" rid="bib196">Yang et al., 2013</xref>; <xref ref-type="bibr" rid="bib88">Li et al., 2014</xref>). Moreover, several nonsynonymous single nucleotide polymorphisms (SNPs) in <italic>KCNMA1</italic> and genes encoding BK-specific auxiliary β subunits (<italic>KCNMB1-4</italic>) were also linked to human disorders or disease risk, including autism, hypertension and cardiovascular function, and asthma (<xref ref-type="bibr" rid="bib44">Gollasch et al., 2002</xref>; <xref ref-type="bibr" rid="bib143">Schuckit et al., 2005</xref>; <xref ref-type="bibr" rid="bib84">Laumonnier et al., 2006</xref>; <xref ref-type="bibr" rid="bib52">Han et al., 2013</xref>). Despite these studies implicating BK channel function in several pathological conditions, genetic linkage and analysis of human tissues have revealed only a limited picture of what is known about BK channel roles in vivo. Extensive investigations in animal models, which are more accessible to the interrogation of specific cell types and tissues, have provided a more complete assessment of the various roles for BK channels in physiology and pathophysiology. Although neurological and muscle phenotypes are well represented, BK channel function in rodents is more broadly required for a panoply of organ functions that parallels their wide expression across tissues (<xref ref-type="fig" rid="fig3">Fig. 3</xref>). Taken together, these animal studies detail a greater potential for wide-ranging pathophysiological dysfunction in patients carrying mutations in <italic>KCNMA1</italic>.</p><fig fig-type="figure" id="fig2" orientation="portrait" position="float"><label>Figure 2.</label><caption><p><bold>BK channel expression in human tissues and prominent phenotypes reported in patients with <italic>KCNMA1</italic>-linked channelopathy.</bold> Major tissues or systems expressing BK channels are depicted in black (high relative expression), gray (medium), and light gray (low). Organs demonstrating high levels of BK channel expression include the CNS (olfactory system, neocortex, basal ganglia, hippocampus, thalamus, habenula and its tract to the interpeduncular nucleus in the midbrain, cerebellum, vestibular nuclei in the hindbrain, and spinal cord), gastrointestinal tract (stomach, small intestine, and colon), and reproductive organs (corpus cavernosum, prostate, testes, ovaries, and uterus). Organs demonstrating medium BK channel expression include salivary glands, neuroendocrine glands (thyroid, parathyroid, adrenal), heart, urinary bladder, liver and gallbladder, kidneys, and spleen/immune system. Organs demonstrating low levels of BK channel include lungs, lymph nodes, vasculature, skeletal muscle, and bone. Data on expression levels were derived from the Human Protein Atlas v18.1 (<ext-link ext-link-type="uri" xlink:href="https://www.proteinatlas.org">https://www.proteinatlas.org</ext-link>; <xref ref-type="bibr" rid="bib170">Uhlén et al., 2015</xref>), the NCBI Gene Database (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov">https://www.ncbi.nlm.nih.gov</ext-link>), and published reports (<xref ref-type="bibr" rid="bib30">Dworetzky et al., 1994</xref>; <xref ref-type="bibr" rid="bib98">McCobb et al., 1995</xref>; <xref ref-type="bibr" rid="bib12">Brenner et al., 2000</xref>).</p></caption><graphic xlink:href="JGP_201912457_Fig2"></graphic></fig><fig fig-type="figure" id="fig3" orientation="portrait" position="float"><label>Figure 3.</label><caption><p><bold>BK channel dysfunction by organ and functional system in rodent models.</bold> BK channel knockout mice (<italic>KCNMA1<sup>−/−</sup></italic>) show a wider range of pathophysiology compared with human <italic>KCNMA1</italic> patients with LOF mutations. Such findings are consistent with the extensive distribution of BK channels across tissues. Key organ and functional systems disrupted by BK channel dysfunction in mouse models are indicated. BK channel activity was required for several aspects of neurological operations in rodent models, such as regulation of neuronal excitability (<xref ref-type="bibr" rid="bib73">Jin et al., 2000</xref>; <xref ref-type="bibr" rid="bib34">Faber and Sah, 2003</xref>; <xref ref-type="bibr" rid="bib13">Brenner et al., 2005</xref>; <xref ref-type="bibr" rid="bib146">Shruti et al., 2008</xref>; <xref ref-type="bibr" rid="bib145">Sheehan et al., 2009</xref>), ​locomotor function (<xref ref-type="bibr" rid="bib106">Meredith et al., 2004</xref>; <xref ref-type="bibr" rid="bib136">Sausbier et al., 2004</xref>; <xref ref-type="bibr" rid="bib16">Chen et al., 2010</xref>), circadian rhythm (<xref ref-type="bibr" rid="bib107">Meredith et al., 2006</xref>; <xref ref-type="bibr" rid="bib75">Kent and Meredith, 2008</xref>; <xref ref-type="bibr" rid="bib110">Montgomery et al., 2013</xref>; <xref ref-type="bibr" rid="bib185">White et al., 2015</xref>; <xref ref-type="bibr" rid="bib187">Whitt et al., 2016</xref>), learning and memory (<xref ref-type="bibr" rid="bib169">Typlt et al., 2013b</xref>), vision (<xref ref-type="bibr" rid="bib57">Henne and Jeserich, 2004</xref>; <xref ref-type="bibr" rid="bib48">Grimes et al., 2009</xref>; <xref ref-type="bibr" rid="bib160">Tanimoto et al., 2012</xref>), hearing and vestibular reflexes (<xref ref-type="bibr" rid="bib130">Pyott et al., 2007</xref>; <xref ref-type="bibr" rid="bib94">Maison et al., 2013</xref>; <xref ref-type="bibr" rid="bib134">Rohmann et al., 2015</xref>; <xref ref-type="bibr" rid="bib129">Pyott and Duncan, 2016</xref>; <xref ref-type="bibr" rid="bib116">Nelson et al., 2017</xref>), and neurovascular coupling (<xref ref-type="bibr" rid="bib39">Filosa et al., 2006</xref>; <xref ref-type="bibr" rid="bib41">Girouard et al., 2010</xref>). In addition to neurological roles, rodent models further revealed that BK channels are required for regulation of cardiovascular function (<xref ref-type="bibr" rid="bib137">Sausbier et al., 2005</xref>; <xref ref-type="bibr" rid="bib70">Imlach et al., 2010</xref>; <xref ref-type="bibr" rid="bib80">Lai et al., 2014</xref>; <xref ref-type="bibr" rid="bib113">Nagaraj et al., 2016</xref>), airway control (<xref ref-type="bibr" rid="bib139">Sausbier et al., 2007</xref>; <xref ref-type="bibr" rid="bib43">Goldklang et al., 2013</xref>; <xref ref-type="bibr" rid="bib95">Manzanares et al., 2014</xref>)​, urination (<xref ref-type="bibr" rid="bib106">Meredith et al., 2004</xref>; <xref ref-type="bibr" rid="bib163">Thorneloe et al., 2005</xref>; <xref ref-type="bibr" rid="bib14">Brown et al., 2008</xref>; <xref ref-type="bibr" rid="bib152">Sprossmann et al., 2009</xref>)​, glucose homeostasis (<xref ref-type="bibr" rid="bib67">Houamed et al., 2010</xref>; <xref ref-type="bibr" rid="bib29">Düfer et al., 2011</xref>)​, renal K<sup>+</sup> homeostasis (<xref ref-type="bibr" rid="bib92">Liu et al., 2007</xref>; <xref ref-type="bibr" rid="bib132">Rieg et al., 2007</xref>), reproductive function (<xref ref-type="bibr" rid="bib183">Werner et al., 2005</xref>, <xref ref-type="bibr" rid="bib184">2008</xref>; <xref ref-type="bibr" rid="bib88">Li et al., 2014</xref>), ethanol intoxication (<xref ref-type="bibr" rid="bib96">Martin et al., 2004</xref>; <xref ref-type="bibr" rid="bib125">Pietrzykowski et al., 2008</xref>), gastrointestinal function (<xref ref-type="bibr" rid="bib138">Sausbier et al., 2006a</xref>; <xref ref-type="bibr" rid="bib150">Sørensen et al., 2008</xref>), body weight (<xref ref-type="bibr" rid="bib51">Halm et al., 2017</xref>), pain (<xref ref-type="bibr" rid="bib54">Hayashi et al., 2016</xref>), immunity (<xref ref-type="bibr" rid="bib32">Essin et al., 2009</xref>), bone remodeling (<xref ref-type="bibr" rid="bib141">Sausbier et al., 2011</xref>; <xref ref-type="bibr" rid="bib55">Hei et al., 2016</xref>), and salivary secretion (<xref ref-type="bibr" rid="bib97">Maruyama et al., 1983</xref>; <xref ref-type="bibr" rid="bib157">Stummann et al., 2003</xref>).</p></caption><graphic xlink:href="JGP_201912457_Fig3"></graphic></fig></sec><sec id="s07"><title><italic>KCNMA1</italic> patient mutations</title><p>16 <italic>KCNMA1</italic> mutations in 37 symptomatic patients have been reported in the literature to date (<xref ref-type="fig" rid="fig1">Fig. 1</xref>). Functional classifications into GOF and LOF effects on channel properties have been based on expression of BK channel complementary DNAs harboring the patient mutations in nonexcitable heterologous cell lines (<xref ref-type="table" rid="tbl1">Table 1</xref> and Supplemental text). From these studies, two mutations have been shown to confer GOF properties to BK channels: D434G and N995S (also referred to as N999S or N1053S; <xref ref-type="bibr" rid="bib28">Du et al., 2005</xref>; <xref ref-type="bibr" rid="bib203">Zhang et al., 2015</xref>; <xref ref-type="bibr" rid="bib87">Li et al., 2018</xref>; <xref ref-type="bibr" rid="bib126">Plante et al., 2019</xref>). 10 mutations have been classified as LOF (S351Y, G354S, G356R, G375R, C413Y/N449fs, I663V, P805L, and D984N; <xref ref-type="bibr" rid="bib15">Carvalho-de-Souza et al., 2016</xref>; <xref ref-type="bibr" rid="bib89">Liang et al., 2019</xref>) or putative LOF (premature truncation mutations: Y676Lfs*7 and Arg458Ter; <xref ref-type="bibr" rid="bib158">Tabarki et al., 2016</xref>; <xref ref-type="bibr" rid="bib197">Yeşil et al., 2018</xref>). The remaining mutations have not yet been conclusively defined with respect to channel properties (variant of unknown significance, VUS; E884K; <xref ref-type="bibr" rid="bib203">Zhang et al., 2015</xref>) or have not been demonstrated to produce changes in channel function (K518N, E656A, and N1159S; <xref ref-type="bibr" rid="bib87">Li et al., 2018</xref>).</p><table-wrap id="tbl1" orientation="portrait" position="float"><label>Table 1.</label><caption><title><italic>KCNMA1</italic> mutation effects on BK channel function</title></caption><table frame="hsides" rules="groups"><col span="1" width="20%"/><col span="1" width="21%"/><col span="1" width="59%"/><thead><tr><th align="left" colspan="1" rowspan="1" scope="col"><bold>Mutation</bold></th><th align="left" colspan="1" rowspan="1" scope="col"><bold>BK current properties</bold></th><th align="left" colspan="1" rowspan="1" scope="col"><bold>Mechanism</bold></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1" scope="row" style="background-color:rgb(166,166,166)">D434G</td><td align="left" colspan="1" rowspan="1" style="background-color:rgb(166,166,166)">Increased current</td><td align="left" colspan="1" rowspan="1" style="background-color:rgb(166,166,166)">G-V shift to hyperpolarized potentials, increased open probability, faster activation, slower deactivation, increased Ca<sup>2+</sup> sensitivity (<xref ref-type="bibr" rid="bib28">Du et al., 2005</xref>; <xref ref-type="bibr" rid="bib26">Díez-Sampedro et al., 2006</xref>; <xref ref-type="bibr" rid="bib177">Wang et al., 2009</xref>; <xref ref-type="bibr" rid="bib195">Yang et al., 2010</xref>; <xref ref-type="bibr" rid="bib126">Plante et al., 2019</xref>)</td></tr><tr><td align="left" colspan="1" rowspan="1" scope="row" style="background-color:rgb(166,166,166)">N995/999/1053S</td><td align="left" colspan="1" rowspan="1" style="background-color:rgb(166,166,166)">Increased current</td><td align="left" colspan="1" rowspan="1" style="background-color:rgb(166,166,166)">G-V shift to hyperpolarized potentials, increased open probability, faster activation, slower deactivation, Ca<sup>2+</sup>-independent mechanism (<xref ref-type="bibr" rid="bib87">Li et al., 2018</xref>; <xref ref-type="bibr" rid="bib126">Plante et al., 2019</xref>)</td></tr><tr><td align="left" colspan="1" rowspan="1" scope="row" style="background-color:rgb(217,217,217)">S351Y, G356R, G375R, N449fs*, I663V</td><td align="left" colspan="1" rowspan="1" style="background-color:rgb(217,217,217)">No current</td><td align="left" colspan="1" rowspan="1" style="background-color:rgb(217,217,217)">Not determined (<xref ref-type="bibr" rid="bib89">Liang et al., 2019</xref>)</td></tr><tr><td align="left" colspan="1" rowspan="1" scope="row" style="background-color:rgb(217,217,217)">C413Y, P805L</td><td align="left" colspan="1" rowspan="1" style="background-color:rgb(217,217,217)">Reduced current</td><td align="left" colspan="1" rowspan="1" style="background-color:rgb(217,217,217)">G-V shift to depolarized potentials, decreased expression (P805L; <xref ref-type="bibr" rid="bib89">Liang et al., 2019</xref>)</td></tr><tr><td align="left" colspan="1" rowspan="1" scope="row" style="background-color:rgb(217,217,217)">D984N</td><td align="left" colspan="1" rowspan="1" style="background-color:rgb(217,217,217)">Reduced current</td><td align="left" colspan="1" rowspan="1" style="background-color:rgb(217,217,217)">Not determined (<xref ref-type="bibr" rid="bib89">Liang et al., 2019</xref>)</td></tr><tr><td align="left" colspan="1" rowspan="1" scope="row" style="background-color:rgb(217,217,217)">G354S</td><td align="left" colspan="1" rowspan="1" style="background-color:rgb(217,217,217)">Reduced current</td><td align="left" colspan="1" rowspan="1" style="background-color:rgb(217,217,217)">Slower activation (<xref ref-type="bibr" rid="bib15">Carvalho-de-Souza et al., 2016</xref>)</td></tr><tr><td align="left" colspan="1" rowspan="1" scope="row">R458Ter, Y676Lfs*7</td><td align="left" colspan="1" rowspan="1">Not determined</td><td align="left" colspan="1" rowspan="1">Putative truncations (<xref ref-type="bibr" rid="bib158">Tabarki et al., 2016</xref>; <xref ref-type="bibr" rid="bib197">Yeşil et al., 2018</xref>)</td></tr><tr><td align="left" colspan="1" rowspan="1" scope="row">K518N, E656A, N1195S</td><td align="left" colspan="1" rowspan="1">No current difference</td><td align="left" colspan="1" rowspan="1"><xref ref-type="bibr" rid="bib87">Li et al., 2018</xref></td></tr><tr><td align="left" colspan="1" rowspan="1" scope="row">E884K</td><td align="left" colspan="1" rowspan="1">Not determined</td><td align="left" colspan="1" rowspan="1"><xref ref-type="bibr" rid="bib203">Zhang et al., 2015</xref></td></tr></tbody></table><table-wrap-foot><p>Dark gray, GOF mutations; light gray, LOF mutations; no shading, VUS. Full descriptions of experimental investigations for mutant channel properties are contained in Supplemental text. The N995S/N999S/N1053S mutation is reported in the literature using three different reference sequence numbering schemes but constitutes the same residue substitution (Figure 1). In this review, this mutation will be referred to by the numbering scheme in the original publication for the data being discussed.</p></table-wrap-foot></table-wrap><p>The majority of the mutations are de novo variants, and patients are heterozygous (<xref ref-type="fig" rid="fig1">Fig. 1</xref>). Since BK channels are comprised of tetramers of the <italic>KCNMA1</italic> gene product, this presents the potential for mitigation of mutant effects by coassembly with WT subunits in heterozygous patients. However, it is not yet known whether tetramers are actually formed between WT and mutant subunits in patients with one normal and one mutant allele, or how the interaction between these subunits would affect BK channel properties. It is also not well studied how the native regulatory processes that set channel function in vivo would combine with the mutation to affect channel properties. It is also possible that some previously established GOF or LOF classifications could change under different experimental conditions than those initially tested. <italic>KCNMA1</italic> patient mutations that have been characterized in at least one standard condition are presented in <xref ref-type="table" rid="tbl1">Table 1</xref> and further described in the Supplemental text.</p></sec><sec id="s08"><title>Neuronal mechanisms of BK channel dysfunction</title><p>The mechanisms by which <italic>KCNMA1</italic> mutations alter BK channel activity to cause patient symptoms is still an open question. In the central nervous system (CNS), BK channels play an important role in neuronal excitability, passing outward K<sup>+</sup> current upon membrane depolarization and increased intracellular Ca<sup>2+</sup> during the action potential, leading to hyperpolarization of the membrane and decreased excitability (<xref ref-type="bibr" rid="bib58">Hille, 2001</xref>). BK current shapes action potential waveforms by mediating the repolarization and afterhyperpolarization (AHP) phases (<xref ref-type="bibr" rid="bib144">Shao et al., 1999</xref>; <xref ref-type="bibr" rid="bib33">Faber and Sah, 2002</xref>; <xref ref-type="bibr" rid="bib50">Gu et al., 2007</xref>; <xref ref-type="bibr" rid="bib93">Ly et al., 2011</xref>; <xref ref-type="bibr" rid="bib21">Contet et al., 2016</xref>). In the majority of neuronal and muscle contexts where the channels are expressed, activation of BK current reduces neuronal firing rates, presynaptic neurotransmitter release, or muscle contraction or tone (<xref ref-type="bibr" rid="bib72">Jaggar et al., 2000</xref>; <xref ref-type="bibr" rid="bib21">Contet et al., 2016</xref>; <xref ref-type="bibr" rid="bib166">Tricarico and Mele, 2017</xref>). In neurons, this decrease in firing is predominantly due to the contribution of BK current to the AHP phase of the action potential (<xref ref-type="bibr" rid="bib156">Storm, 1987</xref>; <xref ref-type="bibr" rid="bib21">Contet et al., 2016</xref>). In cerebellar Purkinje and dentate gyrus (DG) granule neurons, cell types which have been linked to central neurological phenotypes, the β4 subunit facilitates the suppressive role for BK channels in neuronal firing. β4 subunits slow BK current activation, shifting their activation to the AHP phase (<xref ref-type="bibr" rid="bib13">Brenner et al., 2005</xref>; <xref ref-type="bibr" rid="bib189">Womack et al., 2009</xref>; <xref ref-type="bibr" rid="bib124">Petrik et al., 2011</xref>; <xref ref-type="bibr" rid="bib6">Benton et al., 2013</xref>). BK channel activation also reduces excitatory synaptic activity at neuromuscular junctions and in central neurons (<xref ref-type="bibr" rid="bib133">Robitaille et al., 1993</xref>; <xref ref-type="bibr" rid="bib131">Raffaelli et al., 2004</xref>). In smooth muscle cells, BK channels hyperpolarize the membrane potential, which in turn decreases Ca<sup>2+</sup> influx through voltage-gated Ca<sup>2+</sup> channels and promotes smooth muscle relaxation (<xref ref-type="bibr" rid="bib72">Jaggar et al., 2000</xref>). These studies suggest that LOF in BK channel activity would broadly produce hyperexcitability, such as that resulting in seizure. Consistent with this, at least half of the patients with putative LOF <italic>KCNMA1</italic> mutations have seizures of some type (<xref ref-type="fig" rid="fig4">Fig. 4</xref>).</p><fig fig-type="figure" id="fig4" orientation="portrait" position="float"><label>Figure 4.</label><caption><p><bold>Patient phenotypes for GOF versus LOF <italic>KCNMA1</italic> alleles.</bold> Summary of the main phenotypes exhibited by <italic>KCNMA1</italic>-linked channelopathy patients: seizure, movement disorder, neurodevelopment, and intellectual disability. The denominator is the total number of patients included in each mutation group, and the numerator is the number of patients reported with the particular phenotype. The intersection includes shared symptoms among all patients (<italic>n</italic> = 37) identified with any <italic>KCNMA1</italic> mutation (<italic>n</italic> = 16) reported in this review. Additional subtype descriptors for PNKD, epilepsy, and sensory impairment are annotated. 11/20 of GOF patients had no additional description for their PNKD symptoms in the published reports.</p></caption><graphic xlink:href="JGP_201912457_Fig4"></graphic></fig><p>GOF <italic>KCNMA1</italic> patient mutations are also clearly associated with seizure, raising the possibility that changes in BK channel activity in both directions could alter the balance of excitation and inhibition in the brain. Underlying the potential for bidirectional effects on excitability, BK channels are expressed in both excitatory and inhibitory neurons, and the effects of BK current on firing can vary by neuron type (<xref ref-type="bibr" rid="bib21">Contet et al., 2016</xref>). Activation of BK current can both decrease and increase neuronal firing rates (<xref ref-type="bibr" rid="bib109">Montgomery and Meredith, 2012</xref>), a paradox that can be resolved by understanding the voltage and Ca<sup>2+</sup> dependence and gating kinetics of the channels in a specific membrane and cellular context. Predicting the effect of BK channel activation on action potential frequency, for example, requires knowledge of the activation, inactivation, and deactivation properties for the BK channels, as well as their subcellular localization and interaction with other ionic currents in that cell (<xref ref-type="bibr" rid="bib71">Jaffe et al., 2011</xref>; <xref ref-type="bibr" rid="bib93">Ly et al., 2011</xref>; <xref ref-type="bibr" rid="bib109">Montgomery and Meredith, 2012</xref>; <xref ref-type="bibr" rid="bib10">Bock and Stuart, 2016</xref>; <xref ref-type="bibr" rid="bib21">Contet et al., 2016</xref>). The intrinsic gating properties, in turn, are regulated by the subunit composition of the BK channel complex: the α, β, and γ subunits of the BK channel and its associated Ca<sup>2+</sup> source (<xref ref-type="bibr" rid="bib9">Berkefeld and Fakler, 2008</xref>; <xref ref-type="bibr" rid="bib83">Latorre et al., 2017</xref>). A pro-excitatory effect of BK channel activation is revealed by BK antagonists that decrease neuronal firing or plateau potentials (<xref ref-type="bibr" rid="bib149">Solaro et al., 1995</xref>; <xref ref-type="bibr" rid="bib73">Jin et al., 2000</xref>; <xref ref-type="bibr" rid="bib174">Van Goor et al., 2001</xref>; <xref ref-type="bibr" rid="bib136">Sausbier et al., 2004</xref>; <xref ref-type="bibr" rid="bib50">Gu et al., 2007</xref>; <xref ref-type="bibr" rid="bib5">Bell et al., 2008</xref>) or reduce sinoatrial node firing and heart rate (<xref ref-type="bibr" rid="bib80">Lai et al., 2014</xref>), an opposite effect from the typical result of inhibiting BK channels in most excitable cells. Furthermore, BK channel inhibition has been reported to exert anticonvulsant, rather than epileptogenic, effects in picrotoxin and pentylenetetrazole (PTZ) mouse seizure models (<xref ref-type="bibr" rid="bib145">Sheehan et al., 2009</xref>).</p><p>The mechanisms underlying the pro-excitatory effects could simply stem from the increased BK current produced by GOF channels hyperpolarizing the membrane of inhibitory neurons. On the other hand, one property correlated with pro-excitatory BK currents is fast activation. More rapid BK current activation directly increases neuronal firing rates by leading to faster repolarization of the action potential (<xref ref-type="bibr" rid="bib71">Jaffe et al., 2011</xref>; <xref ref-type="bibr" rid="bib93">Ly et al., 2011</xref>; <xref ref-type="bibr" rid="bib109">Montgomery and Meredith, 2012</xref>; <xref ref-type="bibr" rid="bib21">Contet et al., 2016</xref>), an effect that could link GOF channels to hyperexcitation and increased firing in excitatory neurons. In addition, rapidly activating BK currents contribute to the fast phase of the AHP, facilitating enhanced Na<sub>v</sub> channel recovery from inactivation and decreased activation of other K<sup>+</sup> currents (<xref ref-type="bibr" rid="bib174">Van Goor et al., 2001</xref>; <xref ref-type="bibr" rid="bib50">Gu et al., 2007</xref>; <xref ref-type="bibr" rid="bib42">Gittis et al., 2010</xref>; <xref ref-type="bibr" rid="bib178">Wang et al., 2014</xref>). Thus, rather than strictly hyperpolarizing membranes due to increased BK current, mutations such as D434G and N995S/N999S/N1053S, which activate more rapidly than WT channels (<xref ref-type="bibr" rid="bib28">Du et al., 2005</xref>; <xref ref-type="bibr" rid="bib177">Wang et al., 2009</xref>; <xref ref-type="bibr" rid="bib195">Yang et al., 2010</xref>; <xref ref-type="bibr" rid="bib87">Li et al., 2018</xref>; <xref ref-type="bibr" rid="bib126">Plante et al., 2019</xref>), may be capable of directly increasing action potential firing. Thus, the bidirectional and cell-specific effects of BK channels on neuronal excitability suggests that <italic>KCNMA1</italic> mutation-linked dysfunction could disrupt neuronal circuitry and provoke pathological symptoms via multiple potential mechanisms.</p></sec><sec id="s09"><title>KCNMA1-linked channelopathy and the spectrum of patient phenotypes</title><p>The clinical symptoms of patients with <italic>KCNMA1</italic>-linked channelopathy have not been comprehensively defined but are principally characterized by seizures and movement disorders. Of the 16 <italic>KCNMA1</italic> mutations reported in the literature to date, 4 mutations have been identified in more than one patient (<xref ref-type="fig" rid="fig1">Fig. 1</xref>). Comparison of these cases suggests that patients sharing the same mutation do exhibit similar and/or overlapping neurological and neuromuscular phenotypes, in addition to distinct symptoms. Particularly with the de novo mutations, this provides evidence for the causative nature of the mutations in patient symptoms. The evidence for symptomatic similarities by mutation is summarized in the following.</p><p>The D434G <italic>KCNMA1</italic> mutation was identified in 13 members of a large family with symptoms of a coexistent syndrome of generalized epilepsy and paroxysmal dyskinesia (<xref ref-type="bibr" rid="bib28">Du et al., 2005</xref>). Within this group, seven patients developed PNKD, one patient developed epilepsy, and five patients developed both symptoms (<xref ref-type="bibr" rid="bib28">Du et al., 2005</xref>). These clinical findings were the first to link <italic>KCNMA1</italic> to disease in humans and provided prima facie confirmation of the BK channel’s extensive involvement in CNS function.</p><p>The N1053S mutation (also called N995S or N999S) has been identified in seven unrelated patients from around the world (<xref ref-type="bibr" rid="bib203">Zhang et al., 2015</xref>; <xref ref-type="bibr" rid="bib180">Wang et al., 2017</xref>; <xref ref-type="bibr" rid="bib87">Li et al., 2018</xref>; <xref ref-type="bibr" rid="bib56">Heim et al., 2019</xref>) who share similar symptoms with the D434G patients. Of these patients, four developed early onset PNKD, two developed epileptic seizures, and one patient developed both symptoms. In addition, all seven patients were reported to have developmental delays, three patients had intellectual disability, and one patient had other symptoms involving CNS dysfunction, potentially expanding the neurological phenotypes associated with this channelopathy. The symptoms associated with D434G and N1053S mutations constitute the description of phenotype MIM #609446 (“PKND3”) provided by the Online Mendelian Inheritance in Man (OMIM) database (<ext-link ext-link-type="uri" xlink:href="https://omim.org">https://omim.org</ext-link>).</p><p>The Y676Lfs*7 mutation was identified in two siblings from a consanguineous family (<xref ref-type="bibr" rid="bib158">Tabarki et al., 2016</xref>). Both patients were reported to have the same symptoms starting at a young age which included epileptic seizures, severe developmental delay, and nonprogressive cerebellar atrophy (<xref ref-type="bibr" rid="bib158">Tabarki et al., 2016</xref>). These two patient cases constitute the description of phenotype MIM #617643 provided by the OMIM database. While seizure and developmental delay are shared phenotypes with D434G and N995S/N999S/N1053S, cerebellar atrophy without paroxysmal dyskinesia is a distinct phenotype and adds to the variability of neurological symptoms associated with this channelopathy.</p><p>The final mutation reported in the literature that is shared by multiple patients is G375R (<xref ref-type="bibr" rid="bib89">Liang et al., 2019</xref>). This mutation was identified in three unrelated patients who experienced overlapping and heterogenous symptoms. All three patients were reported to have a multiple malformation syndrome characterized by facial dysmorphisms, visceral malformations, development delay, intellectual disability, and axial hypotonia (<xref ref-type="bibr" rid="bib89">Liang et al., 2019</xref>). Additionally, two of the three patients developed epileptic seizures and one patient had mild cerebral and cerebellar atrophy (<xref ref-type="bibr" rid="bib89">Liang et al., 2019</xref>). This mutation is associated with the most distinct clinical findings relative to the other three mutations but still demonstrates some phenotypic overlap with the previous mutations regarding neurological and neuromuscular dysfunction.</p><p>Of these four <italic>KCNMA1</italic> mutations, D434G exhibited autosomal dominant inheritance and was the only mutation identified in patients from successive generations of a pedigree (<xref ref-type="bibr" rid="bib28">Du et al., 2005</xref>). Y676Lfs*7 demonstrated autosomal recessive inheritance and was identified in a single generation of a pedigree (<xref ref-type="bibr" rid="bib158">Tabarki et al., 2016</xref>). These hereditable mutations produced very similar symptoms in affected family members, suggesting a causal role. The remaining two mutations shared by multiple patients were de novo variants (N995S/N999S/N1053S and G375R). In these cases, clinical similarities between patients sharing the same mutations has suggested causality in the absence of comprehensive pedigrees. As a result of the confidence in the <italic>KCNMA1</italic> linkage to patient symptoms, paroxysmal nonkinesigenic dyskinesia-3 with or without generalized epilepsy (PNKD3; MIM #609446) is now recognized as distinct type of movement disorder linked to at least two mutations in <italic>KCNMA1</italic> (D434G and N995S/N999S/N1053S).</p><p>For mutations where only a single patient defines the clinical presentation, causality must still be investigated. Nine additional de novo <italic>KCNMA1</italic> mutations have been reported in the literature where a single patient represents the known symptomatic information. These mutations include: R458Ter*, G354S, S351Y, G356R, C413Y/N449fs, I6663V, P805L, E884K, and D98N (<xref ref-type="bibr" rid="bib203">Zhang et al., 2015</xref>; <xref ref-type="bibr" rid="bib15">Carvalho-de-Souza et al., 2016</xref>; <xref ref-type="bibr" rid="bib153">Staisch et al., 2016</xref>; <xref ref-type="bibr" rid="bib89">Liang et al., 2019</xref>; <xref ref-type="fig" rid="fig1">Fig. 1</xref>). In these cases, most of the symptoms are similar to those previously described and only a few symptoms do not overlap. For example, seven of the nine patients developed a movement disorder, two developed seizures, all nine were reported to have developmental delay, seven had intellectual disability, and four had abnormal brain imaging indicative of cerebellar atrophy. The new symptoms were mostly related to neurological dysfunction and included autistic like features and areflexia (<xref ref-type="bibr" rid="bib89">Liang et al., 2019</xref>). These clinical findings suggest semi-distinct phenotypes associated with some of these mutations (<xref ref-type="fig" rid="fig4">Fig. 4</xref>), however the single patient sample size makes it difficult to validate this conclusion.</p><p>Lastly, three additional patients with epilepsy were identified to harbor other <italic>KCNMA1</italic> mutations of unknown significance (K518N, E656A, and N1159S). While patch-clamp recordings classified these three variants as benign (<xref ref-type="bibr" rid="bib87">Li et al., 2018</xref>), the shared symptom of epileptic seizure with other pathogenic <italic>KCNMA1</italic> mutations may indicate these mutations interfere with BK activity and regulation of neuronal excitability through a yet-to-be-defined mechanism.</p><p>Across the <italic>KCNMA1</italic>-linked channelopathy patient population, another important outstanding question is whether patient symptoms and phenotypes can be classified with respect to the functional changes in BK channel activity produced by mutations. Patients with both GOF or LOF <italic>KNCMA1</italic> mutations exhibit overlapping symptoms, especially with respect to seizures and neurodevelopment (<xref ref-type="fig" rid="fig4">Fig. 4</xref>). Thus, combined with the small patient sample size for each mutation, definitive categorization of specific symptoms with increases or decreases in BK channel activity is not yet possible. Moreover, published reports lack detailed clinical description, further limiting the ability to determine if particular symptoms are specific to GOF versus LOF channel mutations. Nevertheless, a few symptoms, primarily movement disorders and muscle dysfunction, appear to be somewhat distinct for GOF versus LOF mutations (<xref ref-type="fig" rid="fig4">Fig. 4</xref>). Below, we summarize the variability of symptoms pertaining to seizure, movement disorder, and neurodevelopment for all patients, while highlighting certain symptoms that may segregate with GOF or LOF mutations.</p></sec><sec id="s10"><title>Movement disorder</title><p>A predominant phenotype of <italic>KCNMA1</italic>-linked channelopathy, regardless of the functional classification of the mutation (GOF, LOF, or VUS), is movement disorder. 24 of the 37 patients were reported to have symptoms related to a movement disorder with variability of the symptomatic presentation among patients. However, there seems to be more apparent segregation by channel functional classification for movement disorder compared with other predominant symptoms like seizures. These symptoms include PNKD (GOF) versus ataxia, axial hypotonia, and tremor (LOF; <xref ref-type="fig" rid="fig4">Fig. 4</xref>).</p><p>PNKD was reported in 17 of 20 GOF patients and only 2 of 13 LOF patients (<xref ref-type="bibr" rid="bib28">Du et al., 2005</xref>; <xref ref-type="bibr" rid="bib203">Zhang et al., 2015</xref>; <xref ref-type="bibr" rid="bib153">Staisch et al., 2016</xref>; <xref ref-type="bibr" rid="bib180">Wang et al., 2017</xref>; <xref ref-type="bibr" rid="bib197">Yeşil et al., 2018</xref>; <xref ref-type="bibr" rid="bib56">Heim et al., 2019</xref>). A patient with the VUS E884K mutation was also reported to have paroxysmal dyskinesia (<xref ref-type="bibr" rid="bib203">Zhang et al., 2015</xref>). The paroxysmal dyskinesia symptoms were described as “nonkinesigenic” due to the lack of a movement trigger, in contrast to the more common paroxysmal kinesigenic dyskinesia, which is induced by various movements, and other forms of dyskinesia such as exertion-induced dyskinesia. Although the patients were diagnosed with PNKD, the specific types of movements and body parts involved during PNKD attacks were not stereotypical between patients. For example, the patients with D434G GOF mutation experienced episodes of involuntary mouth movements and hand stiffness during attacks (<xref ref-type="bibr" rid="bib28">Du et al., 2005</xref>). Another patient harboring the G354S LOF mutation was reported to have perioral dyskinesia diagnosed at 18 mo (<xref ref-type="bibr" rid="bib153">Staisch et al., 2016</xref>). One patient with the N1053S mutation was diagnosed with PNKD at 7 mo after having paroxysmal dystonic postures (<xref ref-type="bibr" rid="bib203">Zhang et al., 2015</xref>). The three patients with N999S mutations were all diagnosed at different ages with alike paroxysmal drop attacks characterized by behavioral arrest and generalized dystonic posture or stiffening (<xref ref-type="bibr" rid="bib56">Heim et al., 2019</xref>; A.L. Meredith and S. Keros, personal observations). The frequency and duration of theses movement attacks were variable, ranging from few to many dozens of attacks every day, and lasting a few seconds to minutes. OMIM defines this movement disorder phenotype as “PNKD type 3” or “PNKD3” (MIM #609446), because <italic>KCNMA1</italic> was the third gene linked to a PNKD phenotype. The other two genes include MR1 located on chromosome 2q35 and PNKD2 on chromosome 2q31, and they correspond to PNKD1 (phenotype MIM #118800) and PNKD2 (phenotype MIM #611147), respectively. However, the specific term PKND3 is not systematically used for patients with PNKD and <italic>KCNMA1</italic> mutations in the literature, suggesting existing and new patients expressing similar symptoms should be reevaluated for this diagnosis.</p><p>A movement disorder distinct from PNKD, and noted only in LOF patients, was ataxia (<xref ref-type="fig" rid="fig4">Fig. 4</xref>; <xref ref-type="bibr" rid="bib15">Carvalho-de-Souza et al., 2016</xref>; <xref ref-type="bibr" rid="bib89">Liang et al., 2019</xref>), a phenotype also well described in BK channel “knockout” mice harboring a LOF deletion in the <italic>KCNMA1</italic> gene (<xref ref-type="bibr" rid="bib106">Meredith et al., 2004</xref>; <xref ref-type="bibr" rid="bib136">Sausbier et al., 2004</xref>; <xref ref-type="bibr" rid="bib16">Chen et al., 2010</xref>). In patients, the ataxic symptoms included lack of coordination, unbalanced gait, and spasticity of lower extremities. Three of the five ataxic patients also had cerebellar atrophy diagnosed by brain MRI (<xref ref-type="bibr" rid="bib15">Carvalho-de-Souza et al., 2016</xref>; <xref ref-type="bibr" rid="bib89">Liang et al., 2019</xref>), which was another clinical finding distinct for LOF patients. Studies of <italic>KCNMA1<sup>−/−</sup></italic> mouse models showed reduced basal firing from cerebellar Purkinje neurons and impaired cerebellar signaling and motor coordination, which may offer a possible mechanism for the ataxic symptoms in these patients (<xref ref-type="bibr" rid="bib136">Sausbier et al., 2004</xref>). In addition, BK channel inhibitors produce ataxia when ingested or injected (<xref ref-type="bibr" rid="bib69">Imlach et al., 2008</xref>; <xref ref-type="bibr" rid="bib99">McManus and Rothberg, 2014</xref>; <xref ref-type="bibr" rid="bib63">Hoshi and Heinemann, 2016</xref>; <xref ref-type="bibr" rid="bib74">Kaczorowski and Garcia, 2016</xref>), supporting association between BK channel LOF and ataxic movement disorder.</p><p>Baseline axial hypotonia is another motor dysfunction symptom most prominent with LOF mutations (<xref ref-type="fig" rid="fig4">Fig. 4</xref>). The axial hypotonia reported in 8 of 13 LOF patients ranged from mild to severe and was independent from PNKD-associated symptoms noted in GOF patients (<xref ref-type="bibr" rid="bib158">Tabarki et al., 2016</xref>;<xref ref-type="bibr" rid="bib89">Liang et al., 2019</xref>). Additionally, tremor was noted in two LOF patients, and is a phenotype shared with BK channel KO mice (<xref ref-type="bibr" rid="bib136">Sausbier et al., 2004</xref>; <xref ref-type="bibr" rid="bib69">Imlach et al., 2008</xref>), but specific details describing this symptom were not provided (<xref ref-type="bibr" rid="bib197">Yeşil et al., 2018</xref>; <xref ref-type="bibr" rid="bib89">Liang et al., 2019</xref>). Further diagnostic studies are required to determine if these movement disorder attacks are due to mutant BK channel activity within the affected muscle groups, or whether they are secondary to CNS dysfunction, as both mechanisms are seen in a variety of channelopathies associated with movement disorders (<xref ref-type="bibr" rid="bib46">Graves and Hanna, 2005</xref>).</p></sec><sec id="s11"><title>Seizure disorder</title><p>Seizure is another predominant symptom associated with both GOF and LOF <italic>KCNMA1</italic> mutations. 18 of the 37 patients described in this review developed epileptic seizures. However, there was considerable variability among the characteristics of the seizures such as age of onset, type, EEG pattern, frequency and duration, and response to medications. None of these characteristics are clearly delineated by the mutation type. Both GOF and LOF mutations are associated with overlapping seizure phenotypes including myoclonic (<xref ref-type="bibr" rid="bib158">Tabarki et al., 2016</xref>; <xref ref-type="bibr" rid="bib87">Li et al., 2018</xref>), generalized tonic-clonic (GTCS; <xref ref-type="bibr" rid="bib28">Du et al., 2005</xref>; <xref ref-type="bibr" rid="bib158">Tabarki et al., 2016</xref>; <xref ref-type="bibr" rid="bib197">Yeşil et al., 2018</xref>), and absence seizures (<xref ref-type="bibr" rid="bib28">Du et al., 2005</xref>; <xref ref-type="bibr" rid="bib87">Li et al., 2018</xref>; <xref ref-type="bibr" rid="bib197">Yeşil et al., 2018</xref>; <xref ref-type="bibr" rid="bib89">Liang et al., 2019</xref>; <xref ref-type="fig" rid="fig4">Fig. 4</xref>). Interestingly, all nine GOF patients experienced absence seizures whereas only three of six LOF patients experienced them. Atonic seizures and status epilepticus were only reported in two different patients expressing LOF mutations (<xref ref-type="bibr" rid="bib197">Yeşil et al., 2018</xref>; <xref ref-type="bibr" rid="bib89">Liang et al., 2019</xref>). 10 of the 18 patients were reported to have abnormal inter-ictal EEG findings ranging from mild background slowing to generalized spike wave complexes to Lennox-Gastaut patterning (<xref ref-type="bibr" rid="bib28">Du et al., 2005</xref>; <xref ref-type="bibr" rid="bib158">Tabarki et al., 2016</xref>; <xref ref-type="bibr" rid="bib87">Li et al., 2018</xref>; <xref ref-type="bibr" rid="bib197">Yeşil et al., 2018</xref>). Age of onset for seizure also varied between patients regardless of the mutation type. Of the 13 family members expressing a D434G GOF mutation, 6 were diagnosed with epilepsy at ages ranging from 6 mo and 9 yr (<xref ref-type="bibr" rid="bib28">Du et al., 2005</xref>). Three of the seven patients expressing a N995S or N999S GOF mutation began experiencing seizures at 20 mo, 6 yr, and 9 yr of age (<xref ref-type="bibr" rid="bib87">Li et al., 2018</xref>; <xref ref-type="bibr" rid="bib56">Heim et al., 2019</xref>; A.L. Meredith and S. Keros, personal observations), and the two siblings with the same Y676Lfs*7 putative LOF mutation had seizures beginning at one year of age (<xref ref-type="bibr" rid="bib158">Tabarki et al., 2016</xref>). As in the general population, it is likely that seizure heterogeneity with this subset of patients is heavily influenced by additional factors (<xref ref-type="bibr" rid="bib155">Steinlein, 2008</xref>).</p></sec><sec id="s12"><title>Neurodevelopmental and cognitive phenotypes</title><p>Patients with both GOF and LOF <italic>KCNMA1</italic> alleles showed developmental delay and intellectual disability (<xref ref-type="fig" rid="fig4">Fig. 4</xref>). Of the 37 patients reported in the literature, 21 were described as having developmental delay (<xref ref-type="bibr" rid="bib203">Zhang et al., 2015</xref>; <xref ref-type="bibr" rid="bib15">Carvalho-de-Souza et al., 2016</xref>; <xref ref-type="bibr" rid="bib180">Wang et al., 2017</xref>; <xref ref-type="bibr" rid="bib87">Li et al., 2018</xref>; <xref ref-type="bibr" rid="bib197">Yeşil et al., 2018</xref>; <xref ref-type="bibr" rid="bib56">Heim et al., 2019</xref>; <xref ref-type="bibr" rid="bib89">Liang et al., 2019</xref>) and 12 were noted to have intellectual disability (<xref ref-type="bibr" rid="bib203">Zhang et al., 2015</xref>; <xref ref-type="bibr" rid="bib15">Carvalho-de-Souza et al., 2016</xref>; <xref ref-type="bibr" rid="bib180">Wang et al., 2017</xref>; <xref ref-type="bibr" rid="bib56">Heim et al., 2019</xref>; <xref ref-type="bibr" rid="bib89">Liang et al., 2019</xref>). The developmental delays ranged from mild to severe and included psychomotor symptoms such as delayed/unstable sitting, inability to support head or walk unassisted, speech delay, and global developmental delay (<xref ref-type="bibr" rid="bib203">Zhang et al., 2015</xref>; <xref ref-type="bibr" rid="bib158">Tabarki et al., 2016</xref>; <xref ref-type="bibr" rid="bib56">Heim et al., 2019</xref>; <xref ref-type="bibr" rid="bib89">Liang et al., 2019</xref>). A subset of neurodevelopmental symptoms has only been described in patients with LOF <italic>KCNMA1</italic> alleles (<xref ref-type="fig" rid="fig4">Fig. 4</xref>). One patient had hearing impairment (<xref ref-type="bibr" rid="bib89">Liang et al., 2019</xref>), and multiple patients demonstrated visual impairment due to nystagmus, strabismus, and macular coloboma (<xref ref-type="bibr" rid="bib15">Carvalho-de-Souza et al., 2016</xref>; <xref ref-type="bibr" rid="bib89">Liang et al., 2019</xref>). Two patients had autism disorder or features (<xref ref-type="bibr" rid="bib56">Heim et al., 2019</xref>; A.L. Meredith and S. Keros, personal observations), which together with mental retardation was previously associated with a potential LOF SNP in <italic>KCNMA1</italic> (<xref ref-type="bibr" rid="bib84">Laumonnier et al., 2006</xref>).</p></sec><sec id="s13"><title>Lessons from animal studies linking changes in BK channel function to neurological phenotypes</title><p>Within the rodent brain, high levels of BK channel expression are detected in the neocortex, basal ganglia, hippocampus, thalamus, habenula and its tract to the interpeduncular nucleus in the midbrain, cerebellum, vestibular nuclei in the hindbrain, and olfactory system (<xref ref-type="bibr" rid="bib77">Knaus et al., 1996</xref>; <xref ref-type="bibr" rid="bib182">Wanner et al., 1999</xref>; <xref ref-type="bibr" rid="bib108">Misonou et al., 2006</xref>; <xref ref-type="bibr" rid="bib140">Sausbier et al., 2006b</xref>; <xref ref-type="bibr" rid="bib200">Yue et al., 2014</xref>). Animals with functional deficiency of BK channels displayed behaviors that can recapitulate some of the movement symptoms in patients with putative LOF <italic>KCNMA1</italic> mutations. Pharmacological inhibition of BK channels with lolitrem B or paxilline induced tremor and ataxia in mice and livestock (<xref ref-type="bibr" rid="bib69">Imlach et al., 2008</xref>), and constitutive deletion of <italic>KCNMA1</italic> (<italic>KCNMA1<sup>−/−</sup></italic>) produced several types of motor impairments such as ataxia, tremor, impaired motor coordination, reduced muscle strength, and abnormal eye blink reflex in mice (<xref ref-type="bibr" rid="bib106">Meredith et al., 2004</xref>; <xref ref-type="bibr" rid="bib136">Sausbier et al., 2004</xref>; <xref ref-type="bibr" rid="bib69">Imlach et al., 2008</xref>; <xref ref-type="bibr" rid="bib168">Typlt et al., 2013a</xref>). The motor impairments exhibited by <italic>KCNMA1<sup>−/−</sup></italic> mice suggested cerebellar dysfunction. Consistent with this, <italic>KCNMA1<sup>−/−</sup></italic> Purkinje neurons showed significantly reduced basal firing activity and increased short term transmission depression at synapses on deep cerebellar nuclei and disrupted olivo-cerebellar feedback (<xref ref-type="bibr" rid="bib136">Sausbier et al., 2004</xref>; <xref ref-type="bibr" rid="bib16">Chen et al., 2010</xref>). The direct influence of GOF mutations in BK channel function on motor control has not yet been investigated, but mice harboring a strong (nonpatient-derived) GOF mutation that increases voltage-dependent gating of the BK channel (R207Q) have grossly normal locomotor behavior (<xref ref-type="bibr" rid="bib109">Montgomery and Meredith, 2012</xref>). Taken together, the results from animal models demonstrate that BK channel LOF is associated with movement disorder phenotypes that are also observed in human patients, and further suggest the potential for segregation of distinct motor dysfunction with LOF versus GOF BK channel alterations.</p><p>Unlike motor dysfunction, both LOF and GOF alterations in BK channel activity have been linked with the seizure pathophysiology in animal studies. In a chronic temporal lobe epileptic rat model, expression of the BK channel α-subunit encoded by <italic>KCNMA1</italic> was down-regulated in hippocampus and cortex (<xref ref-type="bibr" rid="bib31">Ermolinsky et al., 2008</xref>; <xref ref-type="bibr" rid="bib121">Pacheco Otalora et al., 2008</xref>), suggesting a link between seizure and LOF in BK channel activity. BK channel expression and BK current levels were also reduced in the inferior colliculus during alcohol withdrawal periods in a rat model of alcohol withdrawal seizures (<xref ref-type="bibr" rid="bib112">N’Gouemo et al., 2009</xref>). However, a direct causal relationship between LOF alterations in BK channel activity and epileptogenesis has not yet been reported.</p><p>There is a more solid correlation between GOF alterations in BK channel activity and seizure. Deletion of regulatory β4 subunit (<italic>KCNMB4<sup>−/−</sup></italic>), which slows BK channel activation, produced temporal lobe seizures cortex in mice, associated with hyperactive firing in dentate granule (DG) cells in the hippocampus (<xref ref-type="bibr" rid="bib13">Brenner et al., 2005</xref>). In addition, kainic acid–induced seizure susceptibility was increased in β4 heterozygous mice (<xref ref-type="bibr" rid="bib186">Whitmire et al., 2017</xref>). Furthermore, in a model of fragile X syndrome, enhancement of BK channel activity in <italic>KCNMB4<sup>−/−</sup></italic> mice was associated with alterations in epileptiform activity in hippocampal slices (<xref ref-type="bibr" rid="bib25">Deng and Klyachko, 2016</xref>). Several other studies also show situations where increased BK channel expression was associated with hyperexcitability and seizure activity. Elevated cell surface expression and activity of BK channels via mutation of CRL4A<sup>CRBN</sup> ubiquitin ligase increased susceptibility to spontaneous and PTZ-induced seizures in mice, an effect that can be reduced by pretreatment of the mice with the BK channel inhibitor paxilline (<xref ref-type="bibr" rid="bib90">Liu et al., 2014</xref>). Up-regulation of BK α and down-regulation of β4 protein were reported after seizure induction in rats (<xref ref-type="bibr" rid="bib142">Savina et al., 2014</xref>), and β4 mRNA was down-regulated in DG cells in the hippocampus following pilocarpine-induced seizure (<xref ref-type="bibr" rid="bib186">Whitmire et al., 2017</xref>). BK currents in somatosensory cortex were significantly increased after picrotoxin-induced seizure in mice, and the increased neuronal firing activity was normalized with BK channel inhibitors (<xref ref-type="bibr" rid="bib146">Shruti et al., 2008</xref>). Similarly, BK blockers normalized DG cell firing rates that were increased during pilocarpine-induced seizure episodes in rats (<xref ref-type="bibr" rid="bib102">Mehranfardet al., 2014</xref>, <xref ref-type="bibr" rid="bib103">2015</xref>). These animal studies show that GOF alterations in BK channel activity, either via increased expression or due to loss of the slow gating imparted by the β4 subunit, alters the balance of neuronal activity in the brain. GOF <italic>KCNMA1</italic> mutations affecting BK channel activity in mechanistically similar ways could be causative in <italic>KCNMA1</italic>-linked patient seizures.</p></sec><sec id="s14"><title>Inheritance and prevalence of <italic>KCNMA1</italic>-linked channelopathy</title><p>The majority of the pathogenic <italic>KCNMA1</italic> mutations reported in the literature occurred de novo, however few mutations exhibit autosomal recessive or autosomal dominant inheritance patterns (<xref ref-type="fig" rid="fig1">Fig. 1</xref>). To date, the literature reports a total of 16 mutations identified in 37 symptomatic patients (<xref ref-type="bibr" rid="bib28">Du et al., 2005</xref>; <xref ref-type="bibr" rid="bib203">Zhang et al., 2015</xref>; <xref ref-type="bibr" rid="bib15">Carvalho-de-Souza et al., 2016</xref>; <xref ref-type="bibr" rid="bib158">Tabarki et al., 2016</xref>; <xref ref-type="bibr" rid="bib180">Wang et al., 2017</xref>; <xref ref-type="bibr" rid="bib87">Li et al., 2018</xref>; <xref ref-type="bibr" rid="bib197">Yeşil et al., 2018</xref>; <xref ref-type="bibr" rid="bib56">Heim et al., 2019</xref>; <xref ref-type="bibr" rid="bib89">Liang et al., 2019</xref>). 17 patients have de novo mutations, which constitute 9/16 <italic>KCNMA1</italic> mutations. 4 patients inherited an autosomal recessive mutation, constituting 3/16 mutations. 13 patients (one family) inherited a single (1/16) autosomal dominant mutation. Additionally, there are three benign <italic>KCNMA1</italic> genetic variants (3/16) identified in three patients with epilepsy (<xref ref-type="bibr" rid="bib87">Li et al., 2018</xref>). One of these three variants exhibited an autosomal recessive inheritance pattern, but the inheritance patterns for the other two variants were not determined.</p><p><italic>KCNMA1</italic>-linked channelopathy is a very rare syndrome. The allele frequency of certain pathogenic <italic>KCNMA1</italic> mutations in larger populations is estimated to be less than 1:100,000 in the Genome Aggregation Database (D434G = 3 × 10<sup>−5</sup> and Y676Lfs*7 = 4 × 10<sup>−6</sup>; <xref ref-type="bibr" rid="bib86">Lek et al., 2016</xref>). However, the allele frequency in larger populations is unknown for majority of the pathogenic <italic>KCNMA1</italic> mutations owing to the rarity of this syndrome. Table S1 provides information regarding the number of missense SNPs present in <italic>KCNMA1</italic> and putative pathogenic mutations reported by different large-scale sequencing databases.</p></sec><sec id="s15"><title>Diagnosis and treatment of <italic>KCNMA1</italic>-linked channelopathy</title><p>Epilepsy and movement disorders are known to be caused by several different medical conditions, a subset of which are the result of monogenetic channelopathies (<xref ref-type="bibr" rid="bib11">Brenner and Wilcox, 2012</xref>; <xref ref-type="bibr" rid="bib76">Kim, 2014</xref>). Traditionally, if a patient presents with epileptic seizures and movement attacks with otherwise unremarkable brain imaging and normal neurological function between episodes, then a genetic channelopathy is a leading consideration and genetic testing is recommended to search for causative genetic mutations. The D434G mutation was initially mapped via microsatellite linkage analysis (<xref ref-type="bibr" rid="bib28">Du et al., 2005</xref>); however, causative genetic findings in neurological disorders are more routinely established now by single gene analysis, panels of multiple gene tests for disorders which share a specific phenotype, or by high-powered WES or whole genome sequencing (WGS; <xref ref-type="bibr" rid="bib128">Pulst, 1999</xref>). When patient symptoms are extensive and a test for multiple pathogenic genetic mutations is desired, WES is typically used instead of WGS (<xref ref-type="bibr" rid="bib78">Kong et al., 2018</xref>). WES is less costly than WGS, and the majority of pathogenic variants are found within the coding regions or splice sites of proteins. However, WES is prone to incomplete coverage of certain loci, variability in coverage from person to person, and has susceptibility to false positives and negatives. Of the 37 patients described in the literature, 21 were identified to have a <italic>KCNMA1</italic> mutation using WES (<xref ref-type="bibr" rid="bib153">Staisch et al., 2016</xref>; <xref ref-type="bibr" rid="bib158">Tabarki et al., 2016</xref>; <xref ref-type="bibr" rid="bib87">Li et al., 2018</xref>; <xref ref-type="bibr" rid="bib197">Yeşil et al., 2018</xref>; <xref ref-type="bibr" rid="bib56">Heim et al., 2019</xref>; <xref ref-type="bibr" rid="bib89">Liang et al., 2019</xref>).</p><p>On the other hand, when the clinical symptoms are well defined or stereotypical such as generalized epilepsy and paroxysmal dyskinesia, as is the case with some patients with <italic>KCNMA1</italic>-linked channelopathy, a limited set of specific candidate genes are assayed. At present, 29 commercial gene panels include <italic>KCNMA1</italic> (Table S2). Of note, the genes included with each panel are frequently updated as additional genetic mutations are associated with specific medical conditions. Three of the 37 patients with <italic>KCNMA1</italic> mutations were identified using epilepsy- and paroxysmal dyskinesia–specific gene panels (<xref ref-type="bibr" rid="bib203">Zhang et al., 2015</xref>;<xref ref-type="bibr" rid="bib180">Wang et al., 2017</xref>).</p><p>Development of treatment regimens specific for <italic>KCNMA1</italic>-linked channelopathy (“precision medicine”) is currently limited by several important factors, including (a) lack of FDA-approved selective BK channel pharmacological modulators, (b) lack of stereotypical clinical presentations with respect to core symptoms (movement disorder and seizure), (c) lack of established causality between alterations in channel activity and patient symptoms, and (d) inadequate medical assessment identifying the loci for symptoms in patients. Thus, the majority <italic>KCNMA1</italic>-linked channelopathy patients with seizures have been treated with anti-seizure medications (ASMs) selected with the same general approach as for any nonsyndromic epilepsy. Several <italic>KCNMA1</italic> patient studies commented on the efficacy of various ASMs and demonstrate the range of patient responses may range from positive, to no response, to negative.</p><p>Sodium valproate and/or lamotrigine were effective in treating the absence seizures in the proband with the GOF D434G mutation (<xref ref-type="bibr" rid="bib28">Du et al., 2005</xref>), as well as the absence, GTCS, and atonic seizures in a patient with the LOF R458Ter* mutation (<xref ref-type="bibr" rid="bib197">Yeşil et al., 2018</xref>), and myoclonic seizures in a patient with homozygous LOF Tyr676Leufs*7 mutation (<xref ref-type="bibr" rid="bib158">Tabarki et al., 2016</xref>). These two ASMs were also used to treat absence seizures in two patients with the LOF G375R mutation, but efficacy of the treatments was not reported (<xref ref-type="bibr" rid="bib89">Liang et al., 2019</xref>). The second patient with the homozygous Tyr676Leufs*7 mutation and myoclonic seizures and GTCS was treated effectively with sodium valproate and levetiracetam (<xref ref-type="bibr" rid="bib158">Tabarki et al., 2016</xref>). Levetiracetam alone was effective to treat atypical absence and myoclonic seizures in two patients with the GOF N995S mutation (<xref ref-type="bibr" rid="bib87">Li et al., 2018</xref>). However, one of these patients was trialed on various ASMs before levetiracetam; treatment with oxcarbazepine, and sodium valproate produced negative side effects, sultiame and perampanel did not have any effects, and zonisamide monotherapy reduced the seizure frequency, but failed to stop the myoclonic seizures. Notably, this patient experienced significant worsening of seizures with ethosuxmide, the drug of choice for the absence seizures seen in childhood absence epilepsy. A dramatic worsening of absence seizures at very low doses of ethosuximide also occurred in a GOF N999S patient, reported in <xref ref-type="bibr" rid="bib56">Heim et al. (2019)</xref>, while levetiracetam was not tolerated due to side effects (S. Keros, personal observation). The patient with a LOF D984N mutation was diagnosed with status epilepticus and treated with several ASMs including clobazam, ethosuximide, lamotrigine, zonisamide, sodium valproate, phenobarbital, and lacosamide, but the therapeutic efficacy was not known (<xref ref-type="bibr" rid="bib89">Liang et al., 2019</xref>).</p><p>Paroxysmal dyskinesias are commonly categorized into three main types (kinesigenic or paroxysmal kinesigenic dyskinesia, nonkinesigenic or PNKD, and exercise-induced or PED), and each type has been shown to respond differently to medications (<xref ref-type="bibr" rid="bib171">Unterberger and Trinka, 2008</xref>). PNKD, the dominant type associated with <italic>KCNMA1</italic>-linked channelopathy, is commonly described as refractory to medications. However, benzodiazepines, particularly clonazepam, and some ASMs have been shown to be effective in some PNKD patients (<xref ref-type="bibr" rid="bib171">Unterberger and Trinka, 2008</xref>). Additional therapies used to treat other movement disorders, such as acetazolamide in episodic ataxia, have demonstrated positive effects in some patients with PNKD (<xref ref-type="bibr" rid="bib147">Silveira-Moriyama et al., 2018</xref>). Acetazolamide is a carbonic anhydrase inhibitor and has been suggested as a possible direct agonist of BK channels in rat cerebellar neurons and skeletal muscle (<xref ref-type="bibr" rid="bib167">Tricarico et al., 2004</xref>; <xref ref-type="bibr" rid="bib2">Abbasi et al., 2014</xref>; <xref ref-type="bibr" rid="bib166">Tricarico and Mele, 2017</xref>). However, the potentiating mechanism for acetazolamide on either WT or mutant BK channels is not currently well established.</p><p>There are a limited number of reports assessing PNKD treatment and related symptoms in patients harboring <italic>KCNMA1</italic> mutations. Clonazepam was partially effective for two patients with GOF D434G mutations (<xref ref-type="bibr" rid="bib28">Du et al., 2005</xref>) and reduced the frequency of PNKD attacks in one patient with the N1053S mutation (<xref ref-type="bibr" rid="bib180">Wang et al., 2017</xref>). Clonazepam was also used to treat dyskinetic tremor, dystonia, and spasticity of the lower extremities in a patient with the R458Ter* mutation (<xref ref-type="bibr" rid="bib197">Yeşil et al., 2018</xref>). A second patient with the GOF N1053S mutation and paroxysmal dystonic postures was unresponsive to oxcarbazepine, sodium valproate, and levetiracetam (<xref ref-type="bibr" rid="bib203">Zhang et al., 2015</xref>), whereas a patient with the GOF N999S mutation experiencing paroxysmal drop attacks responded positively to DHA and acetazolamide after not responding to clonazepam, amitriptyline, or levetiracetam (<xref ref-type="bibr" rid="bib56">Heim et al., 2019</xref>). A second patient with the N999S mutation and experiencing the paroxysmal drop attacks did not respond to levetiracetam, carbamazepine, valproic acid, vitamin B complex, CBD oil, DHA, 5-HIAA, or pimozide (<xref ref-type="bibr" rid="bib56">Heim et al., 2019</xref>; A.L. Meredith and S. Keros, personal observations). Overall, within the <italic>KCNMA1</italic>-linked channelopathy population, patient responses to therapies treating seizure and movement disorders are not predictable a priori.</p></sec><sec id="s16"><title>Precision medicine and future directions</title><p>For most genetic channelopathies, pharmacologic treatment does not yet consist of modulating the specific activity of mutant ion channels. For <italic>KCNMA1</italic> and other channelopathies, the first hurdle to precision medicine involves categorizing patient mutations into functional classes, such as GOF or LOF. However, these classes are not trivial to define and can be condition- or cell-type specific, related to the particular splice variants, accessory subunits, post-translational channel modifications, and cellular contexts (intracellular calcium, in particular for the BK channel) in which the mutation is tested. For this reason, it is not yet clear whether strategies using patient-derived stem cells, which can only be differentiated into a limited set of cell types, would result in BK channel pharmacological modulators that are ultimately clinically relevant. In addition, GOF, LOF, and potentially benign mutations in BK channel activity are associated with overlapping symptoms (<xref ref-type="fig" rid="fig4">Fig. 4</xref>), raising the question of whether selective agonists or antagonists that restore the “correct” level of BK channel activity will actually produce the desired outcome on neuronal activity. Without more detailed information about the origination of the changes in excitability underlying the seizure and movement symptoms in <italic>KCNMA1</italic>-linked channelopathy, it is difficult to ascertain which BK channel components to target, and in which neuron or muscle loci.</p><p>Selective BK channel pharmacotherapy has been under development for over two decades, mostly intended to treat smooth muscle dysfunction resulting from LOF in BK channel activity (hypertension, bladder incontinence, stroke, and erectile dysfunction; <xref ref-type="bibr" rid="bib17">Christ et al., 2001</xref>; <xref ref-type="bibr" rid="bib47">Gribkoff et al., 2001</xref>; <xref ref-type="bibr" rid="bib151">Spektor et al., 2002</xref>; <xref ref-type="bibr" rid="bib173">Vang et al., 2010</xref>; <xref ref-type="bibr" rid="bib148">Soder and Petkov, 2011</xref>; <xref ref-type="bibr" rid="bib91">Liu et al., 2013</xref>). Several compounds, including endogenous, naturally occurring, and synthetic, have been identified as BK agonists and trialed as potential therapeutic agents (<xref ref-type="bibr" rid="bib66">Hou et al., 2009</xref>; <xref ref-type="bibr" rid="bib8">Bentzen et al., 2014</xref>; <xref ref-type="bibr" rid="bib63">Hoshi and Heinemann, 2016</xref>). The endogenous class includes heme and heme-breakdown products (<xref ref-type="bibr" rid="bib159">Tang et al., 2003</xref>; <xref ref-type="bibr" rid="bib62">Horrigan et al., 2005</xref>), free long-chain polyunsaturated acids (<xref ref-type="bibr" rid="bib19">Clarke et al., 2002</xref>, <xref ref-type="bibr" rid="bib20">2003</xref>), metabolites of cytochrome P450, epoxygenase and lipoxygenase (<xref ref-type="bibr" rid="bib38">Félétou, 2009</xref>; <xref ref-type="bibr" rid="bib66">Hou et al., 2009</xref>), and 17 β-estradiol (<xref ref-type="bibr" rid="bib172">Valverde et al., 1999</xref>). The natural occurring class includes a variety of entities found in herbs, roots, and leaves used in folk medicines for treating asthma and other disorders stemming from smooth muscle dysfunction such as DHS-I (<xref ref-type="bibr" rid="bib100">McManus et al., 1993</xref>; <xref ref-type="bibr" rid="bib115">Nardi et al., 2003</xref>). The synthetic class includes benzimidazolone compounds NS004 and NS1619 (<xref ref-type="bibr" rid="bib118">Olesen et al., 1994a</xref>,<xref ref-type="bibr" rid="bib119">b</xref>), the more potent and selective NS11021 (<xref ref-type="bibr" rid="bib7">Bentzen et al., 2007</xref>), and a newer family of BK channel activators called the GoSlo-SR family (anthra-quinone analogues; <xref ref-type="bibr" rid="bib135">Roy et al., 2012</xref>). At least one compound, Cym04 (a dehydroabietic acid derivative) has been shown to demonstrate some specificity for a particular BK channel splice variant (<xref ref-type="bibr" rid="bib23">Cui et al., 2008</xref>; <xref ref-type="bibr" rid="bib40">Gessner et al., 2012</xref>). Despite the ability of these chemical agents to activate BK channels in vitro and animal studies, only a single drug with therapeutic action targeting the BK channel is FDA approved (<xref ref-type="bibr" rid="bib24">Cuppoletti et al., 2007</xref>). This drug, Rescula (unoprostone isopropyl ophthalmical solution) is a potent BK channel activator used to reduce ocular pressure in glaucoma (<xref ref-type="bibr" rid="bib162">Thieme et al., 2001</xref>).</p><p>Other potential, but nonselective, neuromodulators that may affect BK channels include docosahexaenoic acid (DHA), an omega-3 fatty acid found in oily fish, acetazolamide, zonisamide, and riluzole. DHA reversibly binds BKα/β1 expressed primarily in smooth muscle and BKα/β4 channels expressed primarily in the nervous system in mice. DHA increases peak BK current by 20- to 30-fold at certain physiological voltages (<xref ref-type="bibr" rid="bib64">Hoshi et al., 2013a</xref>), suggesting potential efficacy for enhancing LOF BK channel activity. While DHA injection in mice lowers blood pressure (<xref ref-type="bibr" rid="bib65">Hoshi et al., 2013b</xref>), the physiological roles of this fatty acid within the nervous system are not well defined. Injection of DHA in rats increased latency of PTZ-induced seizure implicating its neuroprotective effect ((<xref ref-type="bibr" rid="bib165">Trépanier et al., 2014</xref>)); however, a systemic review assessing protective role of omega-3 supplementation in human seizures reported inconclusive evidence of benefit (<xref ref-type="bibr" rid="bib127">Pourmasoumi et al., 2018</xref>). Two patients with <italic>KCNMA1</italic>-linked channelopathy have been trialed on DHA (in combination with acetazolamide; <xref ref-type="bibr" rid="bib56">Heim et al., 2019</xref>). However, the patients harbor a mutation classified as GOF, suggesting any potential therapeutic effect conferred by DHA might not originate from direct modulation of the BK channel. Thus, the data provide no specific indication on the therapeutic potential for DHA in <italic>KCNMA1</italic>-linked channelopathy patients. Similarly, although acetazolamide has been reported to have agonist effects on BK channels in skeletal muscle (<xref ref-type="bibr" rid="bib167">Tricarico et al., 2004</xref>; <xref ref-type="bibr" rid="bib27">Dinardo et al., 2012</xref>), this has not yet been substantiated on BK channels expressed in heterologous cells or neurons. Two other neurological drugs, zonisamide (an ASM) and riluzole, increased K<sup>+</sup> currents in hippocampal and skeletal cell lines respectively, an effect that was blocked by BK channel inhibitors (<xref ref-type="bibr" rid="bib68">Huang et al., 2007</xref>; <xref ref-type="bibr" rid="bib181">Wang et al., 2008</xref>).</p><p>Another potential pharmacotherapy based on FDA-approved drugs to normalize BK channel activity associated with GOF mutations is Ca<sup>2+</sup> channel inhibitors. For GOF mutations, decreasing the Ca<sup>2+</sup>-dependent activation could reduce BK current. While this approach could require knowledge of the specific Ca<sup>2+</sup> source for the channels in tissues where excitability is altered in the patients, one class of inhibitors, dihydropyridines (DHPs), are known to inhibit BK channel activation in a variety of central neurons (<xref ref-type="bibr" rid="bib36">Fagni et al., 1994</xref>; <xref ref-type="bibr" rid="bib201">Zhang and Gold, 2009</xref>; <xref ref-type="bibr" rid="bib179">Wang et al., 2016</xref>; <xref ref-type="bibr" rid="bib188">Whitt et al., 2018</xref>). The DHPs, nifedipine and nimodipine, and the non-DHP verapamil, are used for some types of dyskinesia (<xref ref-type="bibr" rid="bib1">Abad and Ovsiew, 1993</xref>). Verapamil has been used for refractory epilepsy and hyperkinetic movement disorders (<xref ref-type="bibr" rid="bib120">Ovsiew et al., 1998</xref>; <xref ref-type="bibr" rid="bib114">Narayanan et al., 2016</xref>; <xref ref-type="bibr" rid="bib81">Lakshmikanthcharan et al., 2018</xref>). In addition, there is at least one report that Verapamil might block BK channels directly, further contributing to a reduction in channel activity through a selective mechanism (<xref ref-type="bibr" rid="bib53">Harper et al., 2001</xref>). However, it has not yet been investigated whether doses effective at reducing BK channel activity in the brain would have cardiac side effects.</p><p>Beyond pharmacology, some therapeutic approaches tailored for individual patients with other monogenetic disorders may be conceivable in the future for <italic>KCNMA1</italic>-linked channelopathy, such as gene editing, gene therapy, or optogenetic restoration of neuronal activity. Yet, substantial challenges are present for their application to any disease or disorder, including target specificity, delivery optimization, elimination of off-target side effects, timing optimization before or after critical stages of neurological development (<xref ref-type="bibr" rid="bib190">Wykes and Lignani, 2018</xref>), and creating animal models that best replicate the genetic channelopathy from the molecular level to the clinical phenotype to determine initial safety and efficacy of such therapies (<xref ref-type="bibr" rid="bib161">Tanner and Beeton, 2018</xref>). While these precision medicines may hold eventual promise, until the challenges are overcome, development of additional pharmacological approaches remains the major path forward clinically.</p></sec></sec>
<sec sec-type="supplementary-material">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="PMC_1">
<caption>
<title>Supplemental Materials (PDF)</title>
</caption>
<media mime-subtype="pdf" mimetype="application" xlink:href="JGP_201912457_sm.pdf"></media>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>Sharona E. Gordon served as editor.</p>
<p>We thank Jenna Harvey for preliminary review of the human <italic>KCNMA1</italic> mutations. Figure 1 was created with BioRender.com.</p>
<p>This work was supported by grants from the National Heart, Lung, and Blood Institute (R01-HL102758 to A.L. Meredith), the Training Program in Integrative Membrane Biology, National Heart, Lung, and Blood Institute (T32-GM008181 to A.L. Meredith), the American Physiological Society’s Ryuji Ueno award, sponsored by the S &amp; R Foundation (to A.L. Meredith), and a University of Maryland School of Medicine Proposed Research Initiated by Students and Mentors (PRISM) Program Merit Award (to C.S. Bailey).</p>
<p>The authors declare no competing financial interests.</p>
</ack>
<ref-list>
<ref id="bib1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abad</surname><given-names>V.</given-names></name>, and <name name-style="western"><surname>Ovsiew</surname><given-names>F.</given-names></name></person-group>
<year>1993</year>
<article-title>Treatment of persistent myoclonic tardive dystonia with verapamil</article-title>
<source/>Br. J. Psychiatry.
<volume>162</volume>:<fpage>554</fpage>–<lpage>556</lpage>. <pub-id pub-id-type="doi">10.1192/bjp.162.4.554</pub-id><pub-id pub-id-type="pmid">8097657</pub-id></mixed-citation>
</ref>
<ref id="bib2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abbasi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Abbasi</surname><given-names>A.</given-names></name>, and <name name-style="western"><surname>Sarbaz</surname><given-names>Y.</given-names></name></person-group>
<year>2014</year>
<article-title>Introducing treatment strategy for cerebellar ataxia in mutant med mice: combination of acetazolamide and 4-aminopyridine</article-title>. <source/>Comput. Methods Programs Biomed.
<volume>113</volume>:<fpage>697</fpage>–<lpage>704</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmpb.2013.11.008</pub-id><pub-id pub-id-type="pmid">24326337</pub-id></mixed-citation>
</ref>
<ref id="bib3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adams</surname><given-names>P.R.</given-names></name>, <name name-style="western"><surname>Constanti</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>D.A.</given-names></name>, and <name name-style="western"><surname>Clark</surname><given-names>R.B.</given-names></name></person-group>
<year>1982</year>
<article-title>Intracellular Ca<sup>2+</sup> activates a fast voltage-sensitive K<sup>+</sup> current in vertebrate sympathetic neurones</article-title>. <source/>Nature.
<volume>296</volume>:<fpage>746</fpage>–<lpage>749</lpage>. <pub-id pub-id-type="doi">10.1038/296746a0</pub-id><pub-id pub-id-type="pmid">6280066</pub-id></mixed-citation>
</ref>
<ref id="bib4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Becker</surname><given-names>M.N.</given-names></name>, <name name-style="western"><surname>Brenner</surname><given-names>R.</given-names></name>, and <name name-style="western"><surname>Atkinson</surname><given-names>N.S.</given-names></name></person-group>
<year>1995</year>
<article-title>Tissue-specific expression of a Drosophila calcium-activated potassium channel</article-title>. <source/>J. Neurosci.
<volume>15</volume>:<fpage>6250</fpage>–<lpage>6259</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.15-09-06250.1995</pub-id><pub-id pub-id-type="pmid">7666207</pub-id></mixed-citation>
</ref>
<ref id="bib5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bell</surname><given-names>T.J.</given-names></name>, <name name-style="western"><surname>Miyashiro</surname><given-names>K.Y.</given-names></name>, <name name-style="western"><surname>Sul</surname><given-names>J.Y.</given-names></name>, <name name-style="western"><surname>McCullough</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Buckley</surname><given-names>P.T.</given-names></name>, <name name-style="western"><surname>Jochems</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Meaney</surname><given-names>D.F.</given-names></name>, <name name-style="western"><surname>Haydon</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Cantor</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Parsons</surname><given-names>T.D.</given-names></name>, and <name name-style="western"><surname>Eberwine</surname><given-names>J.</given-names></name></person-group>
<year>2008</year>
<article-title>Cytoplasmic BK<sub>Ca</sub> channel intron-containing mRNAs contribute to the intrinsic excitability of hippocampal neurons</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>105</volume>:<fpage>1901</fpage>–<lpage>1906</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0711796105</pub-id><pub-id pub-id-type="pmid">18250327</pub-id></mixed-citation>
</ref>
<ref id="bib6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benton</surname><given-names>M.D.</given-names></name>, <name name-style="western"><surname>Lewis</surname><given-names>A.H.</given-names></name>, <name name-style="western"><surname>Bant</surname><given-names>J.S.</given-names></name>, and <name name-style="western"><surname>Raman</surname><given-names>I.M.</given-names></name></person-group>
<year>2013</year>
<article-title>Iberiotoxin-sensitive and -insensitive BK currents in Purkinje neuron somata</article-title>. <source/>J. Neurophysiol.
<volume>109</volume>:<fpage>2528</fpage>–<lpage>2541</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00127.2012</pub-id><pub-id pub-id-type="pmid">23446695</pub-id></mixed-citation>
</ref>
<ref id="bib7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bentzen</surname><given-names>B.H.</given-names></name>, <name name-style="western"><surname>Nardi</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Calloe</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Madsen</surname><given-names>L.S.</given-names></name>, <name name-style="western"><surname>Olesen</surname><given-names>S.P.</given-names></name>, and <name name-style="western"><surname>Grunnet</surname><given-names>M.</given-names></name></person-group>
<year>2007</year>
<article-title>The small molecule NS11021 is a potent and specific activator of Ca<sup>2+</sup>-activated big-conductance K<sup>+</sup> channels</article-title>. <source/>Mol. Pharmacol.
<volume>72</volume>:<fpage>1033</fpage>–<lpage>1044</lpage>. <pub-id pub-id-type="doi">10.1124/mol.107.038331</pub-id><pub-id pub-id-type="pmid">17636045</pub-id></mixed-citation>
</ref>
<ref id="bib8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bentzen</surname><given-names>B.H.</given-names></name>, <name name-style="western"><surname>Olesen</surname><given-names>S.P.</given-names></name>, <name name-style="western"><surname>Rønn</surname><given-names>L.C.</given-names></name>, and <name name-style="western"><surname>Grunnet</surname><given-names>M.</given-names></name></person-group>
<year>2014</year>
<article-title>BK channel activators and their therapeutic perspectives</article-title>. <source/>Front. Physiol.
<volume>5</volume>:<fpage>389</fpage>
<pub-id pub-id-type="doi">10.3389/fphys.2014.00389</pub-id><pub-id pub-id-type="pmid">25346695</pub-id></mixed-citation>
</ref>
<ref id="bib9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berkefeld</surname><given-names>H.</given-names></name>, and <name name-style="western"><surname>Fakler</surname><given-names>B.</given-names></name></person-group>
<year>2008</year>
<article-title>Repolarizing responses of BK<sub>Ca</sub>-Ca<sub>v</sub> complexes are distinctly shaped by their Ca<sub>v</sub> subunits</article-title>. <source/>J. Neurosci.
<volume>28</volume>:<fpage>8238</fpage>–<lpage>8245</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2274-08.2008</pub-id><pub-id pub-id-type="pmid">18701686</pub-id></mixed-citation>
</ref>
<ref id="bib10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bock</surname><given-names>T.</given-names></name>, and <name name-style="western"><surname>Stuart</surname><given-names>G.J.</given-names></name></person-group>
<year>2016</year>
<article-title>The Impact of BK Channels on Cellular Excitability Depends on their Subcellular Location</article-title>. <source/>Front. Cell. Neurosci.
<volume>10</volume>:<fpage>206</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2016.00206</pub-id><pub-id pub-id-type="pmid">27630543</pub-id></mixed-citation>
</ref>
<ref id="bib11">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Brenner</surname><given-names>R.</given-names></name>, and <name name-style="western"><surname>Wilcox</surname><given-names>K.S.</given-names></name></person-group>
<year>2012</year>
<article-title>Potassium Channelopathies of Epilpesy</article-title>. In <source/>Jasper’s Basic Mechanisms of the Epilepsies.
<person-group person-group-type="editor"><name name-style="western"><surname>Noebels</surname><given-names>J.L.</given-names></name>, <name name-style="western"><surname>Avoli</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Rogawski</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Olsen</surname><given-names>R.W.</given-names></name>, and <name name-style="western"><surname>Delgado-Escueta</surname><given-names>A.V.</given-names></name></person-group>, editors. <fpage>1029</fpage>–<lpage>1048</lpage>.</mixed-citation>
</ref>
<ref id="bib12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brenner</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Jegla</surname><given-names>T.J.</given-names></name>, <name name-style="western"><surname>Wickenden</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name>, and <name name-style="western"><surname>Aldrich</surname><given-names>R.W.</given-names></name></person-group>
<year>2000</year>
<article-title>Cloning and functional characterization of novel large conductance calcium-activated potassium channel beta subunits, hKCNMB3 and hKCNMB4</article-title>. <source/>J. Biol. Chem.
<volume>275</volume>:<fpage>6453</fpage>–<lpage>6461</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.275.9.6453</pub-id><pub-id pub-id-type="pmid">10692449</pub-id></mixed-citation>
</ref>
<ref id="bib13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brenner</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Q.H.</given-names></name>, <name name-style="western"><surname>Vilaythong</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Toney</surname><given-names>G.M.</given-names></name>, <name name-style="western"><surname>Noebels</surname><given-names>J.L.</given-names></name>, and <name name-style="western"><surname>Aldrich</surname><given-names>R.W.</given-names></name></person-group>
<year>2005</year>
<article-title>BK channel beta4 subunit reduces dentate gyrus excitability and protects against temporal lobe seizures</article-title>. <source/>Nat. Neurosci.
<volume>8</volume>:<fpage>1752</fpage>–<lpage>1759</lpage>. <pub-id pub-id-type="doi">10.1038/nn1573</pub-id><pub-id pub-id-type="pmid">16261134</pub-id></mixed-citation>
</ref>
<ref id="bib14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>S.M.</given-names></name>, <name name-style="western"><surname>Bentcheva-Petkova</surname><given-names>L.M.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Hristov</surname><given-names>K.L.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kellett</surname><given-names>W.F.</given-names></name>, <name name-style="western"><surname>Meredith</surname><given-names>A.L.</given-names></name>, <name name-style="western"><surname>Aldrich</surname><given-names>R.W.</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>M.T.</given-names></name>, and <name name-style="western"><surname>Petkov</surname><given-names>G.V.</given-names></name></person-group>
<year>2008</year>
<article-title>Beta-adrenergic relaxation of mouse urinary bladder smooth muscle in the absence of large-conductance Ca<sup>2+</sup>-activated K<sup>+</sup> channel</article-title>. <source/>Am. J. Physiol. Renal Physiol.
<volume>295</volume>:<fpage>F1149</fpage>–<lpage>F1157</lpage>. <pub-id pub-id-type="doi">10.1152/ajprenal.00440.2007</pub-id><pub-id pub-id-type="pmid">18701628</pub-id></mixed-citation>
</ref>
<ref id="bib15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carvalho-de-Souza</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Kubota</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Du</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Latorre</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Gomez</surname><given-names>C.M.</given-names></name>, and <name name-style="western"><surname>Bezanilla</surname><given-names>F.</given-names></name></person-group>
<year>2016</year>
<article-title>A Missense Mutation in the Selectivity Filter of BK Affects the Channel’s Potassium Conductance</article-title>. <source/>Biophys. J.
<volume>110</volume>:<fpage>499a</fpage>
<pub-id pub-id-type="doi">10.1016/j.bpj.2015.11.2412</pub-id></mixed-citation>
</ref>
<ref id="bib16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Kovalchuk</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Adelsberger</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Henning</surname><given-names>H.A.</given-names></name>, <name name-style="western"><surname>Sausbier</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Wietzorrek</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Ruth</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Yarom</surname><given-names>Y.</given-names></name>, and <name name-style="western"><surname>Konnerth</surname><given-names>A.</given-names></name></person-group>
<year>2010</year>
<article-title>Disruption of the olivo-cerebellar circuit by Purkinje neuron-specific ablation of BK channels</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>107</volume>:<fpage>12323</fpage>–<lpage>12328</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1001745107</pub-id><pub-id pub-id-type="pmid">20566869</pub-id></mixed-citation>
</ref>
<ref id="bib17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Christ</surname><given-names>G.J.</given-names></name>, <name name-style="western"><surname>Day</surname><given-names>N.S.</given-names></name>, <name name-style="western"><surname>Day</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Santizo</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Sclafani</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Zinman</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Hsieh</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Venkateswarlu</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Valcic</surname><given-names>M.</given-names></name>, and <name name-style="western"><surname>Melman</surname><given-names>A.</given-names></name></person-group>
<year>2001</year>
<article-title>Bladder injection of “naked” hSlo/pcDNA3 ameliorates detrusor hyperactivity in obstructed rats in vivo</article-title>. <source/>Am. J. Physiol. Regul. Integr. Comp. Physiol.
<volume>281</volume>:<fpage>R1699</fpage>–<lpage>R1709</lpage>. <pub-id pub-id-type="doi">10.1152/ajpregu.2001.281.5.R1699</pub-id><pub-id pub-id-type="pmid">11641143</pub-id></mixed-citation>
</ref>
<ref id="bib18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Christ</surname><given-names>G.J.</given-names></name>, <name name-style="western"><surname>Andersson</surname><given-names>K.E.</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>D’Agostino</surname><given-names>R.</given-names><suffix>Jr</suffix></name>., <name name-style="western"><surname>Kaplan</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Aboushwareb</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Yoo</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Calenda</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Davies</surname><given-names>K.P.</given-names></name>, <etal></etal></person-group>
<year>2009</year>
<article-title>Smooth-muscle-specific gene transfer with the human maxi-k channel improves erectile function and enhances sexual behavior in atherosclerotic cynomolgus monkeys</article-title>. <source/>Eur. Urol.
<volume>56</volume>:<fpage>1055</fpage>–<lpage>1066</lpage>. <pub-id pub-id-type="doi">10.1016/j.eururo.2008.12.016</pub-id><pub-id pub-id-type="pmid">19167152</pub-id></mixed-citation>
</ref>
<ref id="bib19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clarke</surname><given-names>A.L.</given-names></name>, <name name-style="western"><surname>Petrou</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Walsh</surname><given-names>J.V.</given-names><suffix>Jr</suffix></name>, and <name name-style="western"><surname>Singer</surname><given-names>J.J.</given-names></name></person-group>
<year>2002</year>
<article-title>Modulation of BK<sub>Ca</sub> channel activity by fatty acids: structural requirements and mechanism of action</article-title>. <source/>Am. J. Physiol. Cell Physiol.
<volume>283</volume>:<fpage>C1441</fpage>–<lpage>C1453</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00035.2002</pub-id><pub-id pub-id-type="pmid">12372805</pub-id></mixed-citation>
</ref>
<ref id="bib20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clarke</surname><given-names>A.L.</given-names></name>, <name name-style="western"><surname>Petrou</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Walsh</surname><given-names>J.V.</given-names><suffix>Jr</suffix></name>., and <name name-style="western"><surname>Singer</surname><given-names>J.J.</given-names></name></person-group>
<year>2003</year>
<article-title>Site of action of fatty acids and other charged lipids on BK<sub>Ca</sub> channels from arterial smooth muscle cells</article-title>. <source/>Am. J. Physiol. Cell Physiol.
<volume>284</volume>:<fpage>C607</fpage>–<lpage>C619</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00364.2002</pub-id><pub-id pub-id-type="pmid">12409285</pub-id></mixed-citation>
</ref>
<ref id="bib21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Contet</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Goulding</surname><given-names>S.P.</given-names></name>, <name name-style="western"><surname>Kuljis</surname><given-names>D.A.</given-names></name>, and <name name-style="western"><surname>Barth</surname><given-names>A.L.</given-names></name></person-group>
<year>2016</year>
<article-title>BK Channels in the Central Nervous System</article-title>. <source/>Int. Rev. Neurobiol.
<volume>128</volume>:<fpage>281</fpage>–<lpage>342</lpage>. <pub-id pub-id-type="doi">10.1016/bs.irn.2016.04.001</pub-id><pub-id pub-id-type="pmid">27238267</pub-id></mixed-citation>
</ref>
<ref id="bib22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cui</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>H.</given-names></name>, and <name name-style="western"><surname>Lee</surname><given-names>U.S.</given-names></name></person-group>
<year>2009</year>
<article-title>Molecular mechanisms of BK channel activation</article-title>. <source/>Cell. Mol. Life Sci.
<volume>66</volume>:<fpage>852</fpage>–<lpage>875</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-008-8609-x</pub-id><pub-id pub-id-type="pmid">19099186</pub-id></mixed-citation>
</ref>
<ref id="bib23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cui</surname><given-names>Y.M.</given-names></name>, <name name-style="western"><surname>Yasutomi</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Otani</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Yoshinaga</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Ido</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Sawada</surname><given-names>K.</given-names></name>, and <name name-style="western"><surname>Ohwada</surname><given-names>T.</given-names></name></person-group>
<year>2008</year>
<article-title>Novel BK channel openers containing dehydroabietic acid skeleton: structure-activity relationship for peripheral substituents on ring C</article-title>. <source/>Bioorg. Med. Chem. Lett.
<volume>18</volume>:<fpage>5201</fpage>–<lpage>5205</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2008.08.078</pub-id><pub-id pub-id-type="pmid">18789860</pub-id></mixed-citation>
</ref>
<ref id="bib24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cuppoletti</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Malinowska</surname><given-names>D.H.</given-names></name>, <name name-style="western"><surname>Tewari</surname><given-names>K.P.</given-names></name>, <name name-style="western"><surname>Chakrabarti</surname><given-names>J.</given-names></name>, and <name name-style="western"><surname>Ueno</surname><given-names>R.</given-names></name></person-group>
<year>2007</year>
<article-title>Cellular and molecular effects of unoprostone as a BK channel activator</article-title>. <source/>Biochim. Biophys. Acta.
<volume>1768</volume>:<fpage>1083</fpage>–<lpage>1092</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamem.2006.12.015</pub-id><pub-id pub-id-type="pmid">17307133</pub-id></mixed-citation>
</ref>
<ref id="bib25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deng</surname><given-names>P.Y.</given-names></name>, and <name name-style="western"><surname>Klyachko</surname><given-names>V.A.</given-names></name></person-group>
<year>2016</year>
<article-title>Genetic upregulation of BK channel activity normalizes multiple synaptic and circuit defects in a mouse model of fragile X syndrome</article-title>. <source/>J. Physiol.
<volume>594</volume>:<fpage>83</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1113/JP271031</pub-id><pub-id pub-id-type="pmid">26427907</pub-id></mixed-citation>
</ref>
<ref id="bib26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Díez-Sampedro</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Silverman</surname><given-names>W.R.</given-names></name>, <name name-style="western"><surname>Bautista</surname><given-names>J.F.</given-names></name>, and <name name-style="western"><surname>Richerson</surname><given-names>G.B.</given-names></name></person-group>
<year>2006</year>
<article-title>Mechanism of increased open probability by a mutation of the BK channel</article-title>. <source/>J. Neurophysiol.
<volume>96</volume>:<fpage>1507</fpage>–<lpage>1516</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00461.2006</pub-id><pub-id pub-id-type="pmid">16738211</pub-id></mixed-citation>
</ref>
<ref id="bib27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dinardo</surname><given-names>M.M.</given-names></name>, <name name-style="western"><surname>Camerino</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Mele</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Latorre</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Conte Camerino</surname><given-names>D.</given-names></name>, and <name name-style="western"><surname>Tricarico</surname><given-names>D.</given-names></name></person-group>
<year>2012</year>
<article-title>Splicing of the rSlo gene affects the molecular composition and drug response of Ca<sup>2+</sup>-activated K<sup>+</sup> channels in skeletal muscle</article-title>. <source/>PLoS One. <volume>7</volume>:<fpage>e40235</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0040235</pub-id><pub-id pub-id-type="pmid">22808126</pub-id></mixed-citation>
</ref>
<ref id="bib28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Du</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Bautista</surname><given-names>J.F.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Diez-Sampedro</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>You</surname><given-names>S.A.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Kotagal</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Lüders</surname><given-names>H.O.</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Cui</surname><given-names>J.</given-names></name>, <etal></etal></person-group>
<year>2005</year>
<article-title>Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder</article-title>. <source/>Nat. Genet.
<volume>37</volume>:<fpage>733</fpage>–<lpage>738</lpage>. <pub-id pub-id-type="doi">10.1038/ng1585</pub-id><pub-id pub-id-type="pmid">15937479</pub-id></mixed-citation>
</ref>
<ref id="bib29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Düfer</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Neye</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Hörth</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Krippeit-Drews</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Hennige</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Widmer</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>McClafferty</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Shipston</surname><given-names>M.J.</given-names></name>, <name name-style="western"><surname>Häring</surname><given-names>H.U.</given-names></name>, <name name-style="western"><surname>Ruth</surname><given-names>P.</given-names></name>, and <name name-style="western"><surname>Drews</surname><given-names>G.</given-names></name></person-group>
<year>2011</year>
<article-title>BK channels affect glucose homeostasis and cell viability of murine pancreatic beta cells</article-title>. <source/>Diabetologia.
<volume>54</volume>:<fpage>423</fpage>–<lpage>432</lpage>. <pub-id pub-id-type="doi">10.1007/s00125-010-1936-0</pub-id><pub-id pub-id-type="pmid">20981405</pub-id></mixed-citation>
</ref>
<ref id="bib30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dworetzky</surname><given-names>S.I.</given-names></name>, <name name-style="western"><surname>Trojnacki</surname><given-names>J.T.</given-names></name>, and <name name-style="western"><surname>Gribkoff</surname><given-names>V.K.</given-names></name></person-group>
<year>1994</year>
<article-title>Cloning and expression of a human large-conductance calcium-activated potassium channel</article-title>. <source/>Brain Res. Mol. Brain Res.
<volume>27</volume>:<fpage>189</fpage>–<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1016/0169-328X(94)90203-8</pub-id><pub-id pub-id-type="pmid">7877450</pub-id></mixed-citation>
</ref>
<ref id="bib31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ermolinsky</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Arshadmansab</surname><given-names>M.F.</given-names></name>, <name name-style="western"><surname>Pacheco Otalora</surname><given-names>L.F.</given-names></name>, <name name-style="western"><surname>Zarei</surname><given-names>M.M.</given-names></name>, and <name name-style="western"><surname>Garrido-Sanabria</surname><given-names>E.R.</given-names></name></person-group>
<year>2008</year>
<article-title>Deficit of <italic>Kcnma1</italic> mRNA expression in the dentate gyrus of epileptic rats</article-title>. <source/>Neuroreport.
<volume>19</volume>:<fpage>1291</fpage>–<lpage>1294</lpage>. <pub-id pub-id-type="doi">10.1097/WNR.0b013e3283094bb6</pub-id><pub-id pub-id-type="pmid">18695509</pub-id></mixed-citation>
</ref>
<ref id="bib32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Essin</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Gollasch</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Rolle</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Weissgerber</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Sausbier</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Bohn</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Autenrieth</surname><given-names>I.B.</given-names></name>, <name name-style="western"><surname>Ruth</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Luft</surname><given-names>F.C.</given-names></name>, <name name-style="western"><surname>Nauseef</surname><given-names>W.M.</given-names></name>, and <name name-style="western"><surname>Kettritz</surname><given-names>R.</given-names></name></person-group>
<year>2009</year>
<article-title>BK channels in innate immune functions of neutrophils and macrophages</article-title>. <source/>Blood.
<volume>113</volume>:<fpage>1326</fpage>–<lpage>1331</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2008-07-166660</pub-id><pub-id pub-id-type="pmid">19074007</pub-id></mixed-citation>
</ref>
<ref id="bib33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faber</surname><given-names>E.S.</given-names></name>, and <name name-style="western"><surname>Sah</surname><given-names>P.</given-names></name></person-group>
<year>2002</year>
<article-title>Physiological role of calcium-activated potassium currents in the rat lateral amygdala</article-title>. <source/>J. Neurosci.
<volume>22</volume>:<fpage>1618</fpage>–<lpage>1628</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-05-01618.2002</pub-id><pub-id pub-id-type="pmid">11880492</pub-id></mixed-citation>
</ref>
<ref id="bib34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Faber</surname><given-names>E.S.</given-names></name>, and <name name-style="western"><surname>Sah</surname><given-names>P.</given-names></name></person-group>
<year>2003</year>
<article-title>Calcium-activated potassium channels: multiple contributions to neuronal function</article-title>. <source/>Neuroscientist.
<volume>9</volume>:<fpage>181</fpage>–<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1177/1073858403009003011</pub-id><pub-id pub-id-type="pmid">15065814</pub-id></mixed-citation>
</ref>
<ref id="bib35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fagerberg</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Hallström</surname><given-names>B.M.</given-names></name>, <name name-style="western"><surname>Oksvold</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Kampf</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Djureinovic</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Odeberg</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Habuka</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Tahmasebpoor</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Danielsson</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Edlund</surname><given-names>K.</given-names></name>, <etal></etal></person-group>
<year>2014</year>
<article-title>Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics</article-title>. <source/>Mol. Cell. Proteomics.
<volume>13</volume>:<fpage>397</fpage>–<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.M113.035600</pub-id><pub-id pub-id-type="pmid">24309898</pub-id></mixed-citation>
</ref>
<ref id="bib36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fagni</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Bossu</surname><given-names>J.L.</given-names></name>, and <name name-style="western"><surname>Bockaert</surname><given-names>J.</given-names></name></person-group>
<year>1994</year>
<article-title>Inhibitory effects of dihydropyridines on macroscopic K<sup>+</sup> currents and on the large-conductance Ca<sup>2+</sup>-activated K<sup>+</sup> channel in cultured cerebellar granule cells</article-title>. <source/>Pflugers Arch.
<volume>429</volume>:<fpage>176</fpage>–<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1007/BF00374310</pub-id><pub-id pub-id-type="pmid">7892103</pub-id></mixed-citation>
</ref>
<ref id="bib37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fakler</surname><given-names>B.</given-names></name>, and <name name-style="western"><surname>Adelman</surname><given-names>J.P.</given-names></name></person-group>
<year>2008</year>
<article-title>Control of K<sub>Ca</sub> channels by calcium nano/microdomains</article-title>. <source/>Neuron.
<volume>59</volume>:<fpage>873</fpage>–<lpage>881</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2008.09.001</pub-id><pub-id pub-id-type="pmid">18817728</pub-id></mixed-citation>
</ref>
<ref id="bib38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Félétou</surname><given-names>M.</given-names></name></person-group>
<year>2009</year>
<article-title>Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?</article-title>
<source/>Br. J. Pharmacol.
<volume>156</volume>:<fpage>545</fpage>–<lpage>562</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.2009.00052.x</pub-id><pub-id pub-id-type="pmid">19187341</pub-id></mixed-citation>
</ref>
<ref id="bib39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Filosa</surname><given-names>J.A.</given-names></name>, <name name-style="western"><surname>Bonev</surname><given-names>A.D.</given-names></name>, <name name-style="western"><surname>Straub</surname><given-names>S.V.</given-names></name>, <name name-style="western"><surname>Meredith</surname><given-names>A.L.</given-names></name>, <name name-style="western"><surname>Wilkerson</surname><given-names>M.K.</given-names></name>, <name name-style="western"><surname>Aldrich</surname><given-names>R.W.</given-names></name>, and <name name-style="western"><surname>Nelson</surname><given-names>M.T.</given-names></name></person-group>
<year>2006</year>
<article-title>Local potassium signaling couples neuronal activity to vasodilation in the brain</article-title>. <source/>Nat. Neurosci.
<volume>9</volume>:<fpage>1397</fpage>–<lpage>1403</lpage>. <pub-id pub-id-type="doi">10.1038/nn1779</pub-id><pub-id pub-id-type="pmid">17013381</pub-id></mixed-citation>
</ref>
<ref id="bib40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gessner</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Cui</surname><given-names>Y.M.</given-names></name>, <name name-style="western"><surname>Otani</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Ohwada</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Soom</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hoshi</surname><given-names>T.</given-names></name>, and <name name-style="western"><surname>Heinemann</surname><given-names>S.H.</given-names></name></person-group>
<year>2012</year>
<article-title>Molecular mechanism of pharmacological activation of BK channels</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>109</volume>:<fpage>3552</fpage>–<lpage>3557</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1114321109</pub-id><pub-id pub-id-type="pmid">22331907</pub-id></mixed-citation>
</ref>
<ref id="bib41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Girouard</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Bonev</surname><given-names>A.D.</given-names></name>, <name name-style="western"><surname>Hannah</surname><given-names>R.M.</given-names></name>, <name name-style="western"><surname>Meredith</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Aldrich</surname><given-names>R.W.</given-names></name>, and <name name-style="western"><surname>Nelson</surname><given-names>M.T.</given-names></name></person-group>
<year>2010</year>
<article-title>Astrocytic endfoot Ca<sup>2+</sup> and BK channels determine both arteriolar dilation and constriction</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>107</volume>:<fpage>3811</fpage>–<lpage>3816</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0914722107</pub-id><pub-id pub-id-type="pmid">20133576</pub-id></mixed-citation>
</ref>
<ref id="bib42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gittis</surname><given-names>A.H.</given-names></name>, <name name-style="western"><surname>Moghadam</surname><given-names>S.H.</given-names></name>, and <name name-style="western"><surname>du Lac</surname><given-names>S.</given-names></name></person-group>
<year>2010</year>
<article-title>Mechanisms of sustained high firing rates in two classes of vestibular nucleus neurons: differential contributions of resurgent Na, Kv3, and BK currents</article-title>. <source/>J. Neurophysiol.
<volume>104</volume>:<fpage>1625</fpage>–<lpage>1634</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00378.2010</pub-id><pub-id pub-id-type="pmid">20592126</pub-id></mixed-citation>
</ref>
<ref id="bib43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goldklang</surname><given-names>M.P.</given-names></name>, <name name-style="western"><surname>Perez-Zoghbi</surname><given-names>J.F.</given-names></name>, <name name-style="western"><surname>Trischler</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Nkyimbeng</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Zakharov</surname><given-names>S.I.</given-names></name>, <name name-style="western"><surname>Shiomi</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Zelonina</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Marks</surname><given-names>A.R.</given-names></name>, <name name-style="western"><surname>D’Armiento</surname><given-names>J.M.</given-names></name>, and <name name-style="western"><surname>Marx</surname><given-names>S.O.</given-names></name></person-group>
<year>2013</year>
<article-title>Treatment of experimental asthma using a single small molecule with anti-inflammatory and BK channel-activating properties</article-title>. <source/>FASEB J.
<volume>27</volume>:<fpage>4975</fpage>–<lpage>4986</lpage>. <pub-id pub-id-type="doi">10.1096/fj.13-235176</pub-id><pub-id pub-id-type="pmid">23995289</pub-id></mixed-citation>
</ref>
<ref id="bib44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gollasch</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Tank</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Luft</surname><given-names>F.C.</given-names></name>, <name name-style="western"><surname>Jordan</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Maass</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Krasko</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>A.M.</given-names></name>, <name name-style="western"><surname>Busjahn</surname><given-names>A.</given-names></name>, and <name name-style="western"><surname>Bähring</surname><given-names>S.</given-names></name></person-group>
<year>2002</year>
<article-title>The BK channel beta1 subunit gene is associated with human baroreflex and blood pressure regulation</article-title>. <source/>J. Hypertens.
<volume>20</volume>:<fpage>927</fpage>–<lpage>933</lpage>. <pub-id pub-id-type="doi">10.1097/00004872-200205000-00028</pub-id><pub-id pub-id-type="pmid">12011654</pub-id></mixed-citation>
</ref>
<ref id="bib45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonzalez-Perez</surname><given-names>V.</given-names></name>, and <name name-style="western"><surname>Lingle</surname><given-names>C.J.</given-names></name></person-group>
<year>2019</year>
<article-title>Regulation of BK Channels by Beta and Gamma Subunits</article-title>. <source/>Annu. Rev. Physiol.
<volume>81</volume>:<fpage>113</fpage>–<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-physiol-022516-034038</pub-id><pub-id pub-id-type="pmid">30742788</pub-id></mixed-citation>
</ref>
<ref id="bib46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Graves</surname><given-names>T.D.</given-names></name>, and <name name-style="western"><surname>Hanna</surname><given-names>M.G.</given-names></name></person-group>
<year>2005</year>
<article-title>Neurological channelopathies</article-title>. <source/>Postgrad. Med. J.
<volume>81</volume>:<fpage>20</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1136/pgmj.2004.022012</pub-id><pub-id pub-id-type="pmid">15640425</pub-id></mixed-citation>
</ref>
<ref id="bib47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gribkoff</surname><given-names>V.K.</given-names></name>, <name name-style="western"><surname>Starrett</surname><given-names>J.E.</given-names><suffix>Jr</suffix></name>., <name name-style="western"><surname>Dworetzky</surname><given-names>S.I.</given-names></name>, <name name-style="western"><surname>Hewawasam</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Boissard</surname><given-names>C.G.</given-names></name>, <name name-style="western"><surname>Cook</surname><given-names>D.A.</given-names></name>, <name name-style="western"><surname>Frantz</surname><given-names>S.W.</given-names></name>, <name name-style="western"><surname>Heman</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Hibbard</surname><given-names>J.R.</given-names></name>, <name name-style="western"><surname>Huston</surname><given-names>K.</given-names></name>, <etal></etal></person-group>
<year>2001</year>
<article-title>Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels</article-title>. <source/>Nat. Med.
<volume>7</volume>:<fpage>471</fpage>–<lpage>477</lpage>. <pub-id pub-id-type="doi">10.1038/86546</pub-id><pub-id pub-id-type="pmid">11283675</pub-id></mixed-citation>
</ref>
<ref id="bib48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grimes</surname><given-names>W.N.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Chávez</surname><given-names>A.E.</given-names></name>, and <name name-style="western"><surname>Diamond</surname><given-names>J.S.</given-names></name></person-group>
<year>2009</year>
<article-title>BK channels modulate pre- and postsynaptic signaling at reciprocal synapses in retina</article-title>. <source/>Nat. Neurosci.
<volume>12</volume>:<fpage>585</fpage>–<lpage>592</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2302</pub-id><pub-id pub-id-type="pmid">19363492</pub-id></mixed-citation>
</ref>
<ref id="bib49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grimm</surname><given-names>P.R.</given-names></name>, and <name name-style="western"><surname>Sansom</surname><given-names>S.C.</given-names></name></person-group>
<year>2010</year>
<article-title>BK channels and a new form of hypertension</article-title>. <source/>Kidney Int.
<volume>78</volume>:<fpage>956</fpage>–<lpage>962</lpage>. <pub-id pub-id-type="doi">10.1038/ki.2010.272</pub-id><pub-id pub-id-type="pmid">20720523</pub-id></mixed-citation>
</ref>
<ref id="bib50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gu</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Vervaeke</surname><given-names>K.</given-names></name>, and <name name-style="western"><surname>Storm</surname><given-names>J.F.</given-names></name></person-group>
<year>2007</year>
<article-title>BK potassium channels facilitate high-frequency firing and cause early spike frequency adaptation in rat CA1 hippocampal pyramidal cells</article-title>. <source/>J. Physiol.
<volume>580</volume>:<fpage>859</fpage>–<lpage>882</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2006.126367</pub-id><pub-id pub-id-type="pmid">17303637</pub-id></mixed-citation>
</ref>
<ref id="bib51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Halm</surname><given-names>S.T.</given-names></name>, <name name-style="western"><surname>Bottomley</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Almutairi</surname><given-names>M.M.</given-names></name>, <name name-style="western"><surname>Di Fulvio</surname><given-names>M.</given-names></name>, and <name name-style="western"><surname>Halm</surname><given-names>D.R.</given-names></name></person-group>
<year>2017</year>
<article-title>Survival and growth of C57BL/6J mice lacking the BK channel, <italic>Kcnma1</italic>: lower adult body weight occurs together with higher body fat</article-title>. <source/>Physiol. Rep.
<volume>5</volume>:<fpage>5</fpage>
<pub-id pub-id-type="doi">10.14814/phy2.13137</pub-id></mixed-citation>
</ref>
<ref id="bib52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>B.Z.</given-names></name>, <name name-style="western"><surname>Kranzler</surname><given-names>H.R.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Farrer</surname><given-names>L.A.</given-names></name>, <name name-style="western"><surname>Boerwinkle</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Potash</surname><given-names>J.B.</given-names></name>, and <name name-style="western"><surname>Gelernter</surname><given-names>J.</given-names></name></person-group>
<year>2013</year>
<article-title>Integrating GWASs and human protein interaction networks identifies a gene subnetwork underlying alcohol dependence</article-title>. <source/>Am. J. Hum. Genet.
<volume>93</volume>:<fpage>1027</fpage>–<lpage>1034</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2013.10.021</pub-id><pub-id pub-id-type="pmid">24268660</pub-id></mixed-citation>
</ref>
<ref id="bib53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harper</surname><given-names>A.A.</given-names></name>, <name name-style="western"><surname>Catacuzzeno</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Trequattrini</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Petris</surname><given-names>A.</given-names></name>, and <name name-style="western"><surname>Franciolini</surname><given-names>F.</given-names></name></person-group>
<year>2001</year>
<article-title>Verapamil block of large-conductance Ca-activated K channels in rat aortic myocytes</article-title>. <source/>J. Membr. Biol.
<volume>179</volume>:<fpage>103</fpage>–<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1007/s002320010041</pub-id><pub-id pub-id-type="pmid">11220361</pub-id></mixed-citation>
</ref>
<ref id="bib54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hayashi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Morinaga</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Satoh</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Meredith</surname><given-names>A.L.</given-names></name>, <name name-style="western"><surname>Nakata</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Kohsaka</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Inoue</surname><given-names>K.</given-names></name>, and <name name-style="western"><surname>Nakanishi</surname><given-names>H.</given-names></name></person-group>
<year>2016</year>
<article-title>BK channels in microglia are required for morphine-induced hyperalgesia</article-title>. <source/>Nat. Commun.
<volume>7</volume>:<fpage>11697</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms11697</pub-id><pub-id pub-id-type="pmid">27241733</pub-id></mixed-citation>
</ref>
<ref id="bib55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hei</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Dong</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Tao</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Tian</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>H.</given-names></name>, and <name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name></person-group>
<year>2016</year>
<article-title>BK Knockout by TALEN-Mediated Gene Targeting in Osteoblasts: KCNMA1 Determines the Proliferation and Differentiation of Osteoblasts</article-title>. <source/>Mol. Cells.
<volume>39</volume>:<fpage>530</fpage>–<lpage>535</lpage>. <pub-id pub-id-type="doi">10.14348/molcells.2016.0033</pub-id><pub-id pub-id-type="pmid">27329042</pub-id></mixed-citation>
</ref>
<ref id="bib56">
<mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Heim</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Vemuri</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Lewis</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Meredith</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Keros</surname><given-names>S.</given-names></name>, and <name name-style="western"><surname>Kruer</surname><given-names>M.</given-names></name></person-group>
<year>2019</year>
<article-title>Drop attacks in patients with KCNMA1</article-title> p.<fpage>N999S</fpage> heterozygous de novo mutations. <source/>6th International Symposium on Paediatric Movement Disorders.</mixed-citation>
</ref>
<ref id="bib57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henne</surname><given-names>J.</given-names></name>, and <name name-style="western"><surname>Jeserich</surname><given-names>G.</given-names></name></person-group>
<year>2004</year>
<article-title>Maturation of spiking activity in trout retinal ganglion cells coincides with upregulation of Kv3.1- and BK-related potassium channels</article-title>. <source/>J. Neurosci. Res.
<volume>75</volume>:<fpage>44</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.10830</pub-id><pub-id pub-id-type="pmid">14689447</pub-id></mixed-citation>
</ref>
<ref id="bib58">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Hille</surname><given-names>B.</given-names></name></person-group>
<year>2001</year>
<source/>Ion Channels of Excitable Membranes.
<publisher-name>Sinauer Associates</publisher-name>, <publisher-loc>Sunderland, MA</publisher-loc>.</mixed-citation>
</ref>
<ref id="bib59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hirukawa</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Muraki</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Ohya</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Imaizumi</surname><given-names>Y.</given-names></name>, and <name name-style="western"><surname>Togari</surname><given-names>A.</given-names></name></person-group>
<year>2008</year>
<article-title>Electrophysiological properties of a novel Ca<sup>2+</sup>-activated K<sup>+</sup> channel expressed in human osteoblasts</article-title>. <source/>Calcif. Tissue Int.
<volume>83</volume>:<fpage>222</fpage>–<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1007/s00223-008-9167-9</pub-id><pub-id pub-id-type="pmid">18787886</pub-id></mixed-citation>
</ref>
<ref id="bib60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Horrigan</surname><given-names>F.T.</given-names></name>, and <name name-style="western"><surname>Aldrich</surname><given-names>R.W.</given-names></name></person-group>
<year>2002</year>
<article-title>Coupling between voltage sensor activation, Ca<sup>2+</sup> binding and channel opening in large conductance (BK) potassium channels</article-title>. <source/>J. Gen. Physiol.
<volume>120</volume>:<fpage>267</fpage>–<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.20028605</pub-id><pub-id pub-id-type="pmid">12198087</pub-id></mixed-citation>
</ref>
<ref id="bib61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Horrigan</surname><given-names>F.T.</given-names></name>, <name name-style="western"><surname>Cui</surname><given-names>J.</given-names></name>, and <name name-style="western"><surname>Aldrich</surname><given-names>R.W.</given-names></name></person-group>
<year>1999</year>
<article-title>Allosteric voltage gating of potassium channels I. Mslo ionic currents in the absence of Ca<sup>2+</sup></article-title>
<source/>J. Gen. Physiol.
<volume>114</volume>:<fpage>277</fpage>–<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.114.2.277</pub-id><pub-id pub-id-type="pmid">10436003</pub-id></mixed-citation>
</ref>
<ref id="bib62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Horrigan</surname><given-names>F.T.</given-names></name>, <name name-style="western"><surname>Heinemann</surname><given-names>S.H.</given-names></name>, and <name name-style="western"><surname>Hoshi</surname><given-names>T.</given-names></name></person-group>
<year>2005</year>
<article-title>Heme regulates allosteric activation of the Slo1 BK channel</article-title>
<source/>J. Gen. Physiol.
<volume>126</volume>:<fpage>7</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.200509262</pub-id><pub-id pub-id-type="pmid">15955873</pub-id></mixed-citation>
</ref>
<ref id="bib63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoshi</surname><given-names>T.</given-names></name>, and <name name-style="western"><surname>Heinemann</surname><given-names>S.H.</given-names></name></person-group>
<year>2016</year>
<article-title>Modulation of BK Channels by Small Endogenous Molecules and Pharmaceutical Channel Openers</article-title>. <source/>Int. Rev. Neurobiol.
<volume>128</volume>:<fpage>193</fpage>–<lpage>237</lpage>. <pub-id pub-id-type="doi">10.1016/bs.irn.2016.03.020</pub-id><pub-id pub-id-type="pmid">27238265</pub-id></mixed-citation>
</ref>
<ref id="bib64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoshi</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Tian</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Heinemann</surname><given-names>S.H.</given-names></name>, and <name name-style="western"><surname>Hou</surname><given-names>S.</given-names></name></person-group>
<year>2013</year><comment>a</comment>
<article-title>Mechanism of the modulation of BK potassium channel complexes with different auxiliary subunit compositions by the omega-3 fatty acid DHA</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>110</volume>:<fpage>4822</fpage>–<lpage>4827</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1222003110</pub-id><pub-id pub-id-type="pmid">23487786</pub-id></mixed-citation>
</ref>
<ref id="bib65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoshi</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Wissuwa</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Tian</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Tajima</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Bauer</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Heinemann</surname><given-names>S.H.</given-names></name>, and <name name-style="western"><surname>Hou</surname><given-names>S.</given-names></name></person-group>
<year>2013</year><comment>b</comment>
<article-title>Omega-3 fatty acids lower blood pressure by directly activating large-conductance Ca<sup>2+</sup>-dependent K<sup>+</sup> channels</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>110</volume>:<fpage>4816</fpage>–<lpage>4821</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1221997110</pub-id><pub-id pub-id-type="pmid">23487785</pub-id></mixed-citation>
</ref>
<ref id="bib66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hou</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Heinemann</surname><given-names>S.H.</given-names></name>, and <name name-style="western"><surname>Hoshi</surname><given-names>T.</given-names></name></person-group>
<year>2009</year>
<article-title>Modulation of BK<sub>Ca</sub> channel gating by endogenous signaling molecules</article-title>. <source/>Physiology (Bethesda).
<volume>24</volume>:<fpage>26</fpage>–<lpage>35</lpage>.<pub-id pub-id-type="pmid">19196649</pub-id></mixed-citation>
</ref>
<ref id="bib67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Houamed</surname><given-names>K.M.</given-names></name>, <name name-style="western"><surname>Sweet</surname><given-names>I.R.</given-names></name>, and <name name-style="western"><surname>Satin</surname><given-names>L.S.</given-names></name></person-group>
<year>2010</year>
<article-title>BK channels mediate a novel ionic mechanism that regulates glucose-dependent electrical activity and insulin secretion in mouse pancreatic β-cells</article-title>. <source/>J. Physiol.
<volume>588</volume>:<fpage>3511</fpage>–<lpage>3523</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2009.184341</pub-id><pub-id pub-id-type="pmid">20643769</pub-id></mixed-citation>
</ref>
<ref id="bib68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>C.W.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>C.C.</given-names></name>, and <name name-style="western"><surname>Wu</surname><given-names>S.N.</given-names></name></person-group>
<year>2007</year>
<article-title>Activation by zonisamide, a newer antiepileptic drug, of large-conductance calcium-activated potassium channel in differentiated hippocampal neuron-derived H19-7 cells</article-title>. <source/>J. Pharmacol. Exp. Ther.
<volume>321</volume>:<fpage>98</fpage>–<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.106.116954</pub-id><pub-id pub-id-type="pmid">17255467</pub-id></mixed-citation>
</ref>
<ref id="bib69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Imlach</surname><given-names>W.L.</given-names></name>, <name name-style="western"><surname>Finch</surname><given-names>S.C.</given-names></name>, <name name-style="western"><surname>Dunlop</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Meredith</surname><given-names>A.L.</given-names></name>, <name name-style="western"><surname>Aldrich</surname><given-names>R.W.</given-names></name>, and <name name-style="western"><surname>Dalziel</surname><given-names>J.E.</given-names></name></person-group>
<year>2008</year>
<article-title>The molecular mechanism of “ryegrass staggers,” a neurological disorder of K<sup>+</sup> channels</article-title>. <source/>J. Pharmacol. Exp. Ther.
<volume>327</volume>:<fpage>657</fpage>–<lpage>664</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.108.143933</pub-id><pub-id pub-id-type="pmid">18801945</pub-id></mixed-citation>
</ref>
<ref id="bib70">
<mixed-citation publication-type="confproc"><person-group person-group-type="author"><name name-style="western"><surname>Imlach</surname><given-names>W.L.</given-names></name>, <name name-style="western"><surname>Finch</surname><given-names>S.C.</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>J.H.</given-names></name>, <name name-style="western"><surname>Meredith</surname><given-names>A.L.</given-names></name>, and <name name-style="western"><surname>Dalziel</surname><given-names>J.E.</given-names></name></person-group> (<year>2010</year>). A role for BK channels in heart rate regulation in rodents. <italic>PLoS One</italic> 5, e8698.</mixed-citation>
</ref>
<ref id="bib71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jaffe</surname><given-names>D.B.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name>, and <name name-style="western"><surname>Brenner</surname><given-names>R.</given-names></name></person-group>
<year>2011</year>
<article-title>Shaping of action potentials by type I and type II large-conductance Ca<sup>2</sup>+-activated K+ channels</article-title>. <source/>Neuroscience.
<volume>192</volume>:<fpage>205</fpage>–<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2011.06.028</pub-id><pub-id pub-id-type="pmid">21723921</pub-id></mixed-citation>
</ref>
<ref id="bib72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jaggar</surname><given-names>J.H.</given-names></name>, <name name-style="western"><surname>Porter</surname><given-names>V.A.</given-names></name>, <name name-style="western"><surname>Lederer</surname><given-names>W.J.</given-names></name>, and <name name-style="western"><surname>Nelson</surname><given-names>M.T.</given-names></name></person-group>
<year>2000</year>
<article-title>Calcium sparks in smooth muscle</article-title>. <source/>Am. J. Physiol. Cell Physiol.
<volume>278</volume>:<fpage>C235</fpage>–<lpage>C256</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.2000.278.2.C235</pub-id><pub-id pub-id-type="pmid">10666018</pub-id></mixed-citation>
</ref>
<ref id="bib73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Sugaya</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Tsuda</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Ohguchi</surname><given-names>H.</given-names></name>, and <name name-style="western"><surname>Sugaya</surname><given-names>E.</given-names></name></person-group>
<year>2000</year>
<article-title>Relationship between large conductance calcium-activated potassium channel and bursting activity</article-title>. <source/>Brain Res.
<volume>860</volume>:<fpage>21</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-8993(00)01943-0</pub-id><pub-id pub-id-type="pmid">10727620</pub-id></mixed-citation>
</ref>
<ref id="bib74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaczorowski</surname><given-names>G.J.</given-names></name>, and <name name-style="western"><surname>Garcia</surname><given-names>M.L.</given-names></name></person-group>
<year>2016</year>
<article-title>Developing Molecular Pharmacology of BK Channels for Therapeutic Benefit</article-title>. <source/>Int. Rev. Neurobiol.
<volume>128</volume>:<fpage>439</fpage>–<lpage>475</lpage>. <pub-id pub-id-type="doi">10.1016/bs.irn.2016.02.013</pub-id><pub-id pub-id-type="pmid">27238271</pub-id></mixed-citation>
</ref>
<ref id="bib75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kent</surname><given-names>J.</given-names></name>, and <name name-style="western"><surname>Meredith</surname><given-names>A.L.</given-names></name></person-group>
<year>2008</year>
<article-title>BK channels regulate spontaneous action potential rhythmicity in the suprachiasmatic nucleus</article-title>. <source/>PLoS One.
<volume>3</volume>:<elocation-id>e3884</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0003884</pub-id><pub-id pub-id-type="pmid">19060951</pub-id></mixed-citation>
</ref>
<ref id="bib76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>J.B.</given-names></name></person-group>
<year>2014</year>
<article-title>Channelopathies</article-title>. <source/>Korean J. Pediatr.
<volume>57</volume>:<fpage>1</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.3345/kjp.2014.57.1.1</pub-id><pub-id pub-id-type="pmid">24578711</pub-id></mixed-citation>
</ref>
<ref id="bib77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knaus</surname><given-names>H.G.</given-names></name>, <name name-style="western"><surname>Schwarzer</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Koch</surname><given-names>R.O.</given-names></name>, <name name-style="western"><surname>Eberhart</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kaczorowski</surname><given-names>G.J.</given-names></name>, <name name-style="western"><surname>Glossmann</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Wunder</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Pongs</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Garcia</surname><given-names>M.L.</given-names></name>, and <name name-style="western"><surname>Sperk</surname><given-names>G.</given-names></name></person-group>
<year>1996</year>
<article-title>Distribution of high-conductance Ca<sup>2+</sup>-activated K<sup>+</sup> channels in rat brain: targeting to axons and nerve terminals</article-title>. <source/>J. Neurosci.
<volume>16</volume>:<fpage>955</fpage>–<lpage>963</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.16-03-00955.1996</pub-id><pub-id pub-id-type="pmid">8558264</pub-id></mixed-citation>
</ref>
<ref id="bib78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kong</surname><given-names>S.W.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>I.H.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Hirschhorn</surname><given-names>J.N.</given-names></name>, and <name name-style="western"><surname>Mandl</surname><given-names>K.D.</given-names></name></person-group>
<year>2018</year>
<article-title>Measuring coverage and accuracy of whole-exome sequencing in clinical context</article-title>. <source/>Genet. Med.
<volume>20</volume>:<fpage>1617</fpage>–<lpage>1626</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2018.51</pub-id><pub-id pub-id-type="pmid">29789557</pub-id></mixed-citation>
</ref>
<ref id="bib79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kyle</surname><given-names>B.D.</given-names></name>, and <name name-style="western"><surname>Braun</surname><given-names>A.P.</given-names></name></person-group>
<year>2014</year>
<article-title>The regulation of BK channel activity by pre- and post-translational modifications</article-title>. <source/>Front. Physiol.
<volume>5</volume>:<fpage>316</fpage>
<pub-id pub-id-type="doi">10.3389/fphys.2014.00316</pub-id><pub-id pub-id-type="pmid">25202279</pub-id></mixed-citation>
</ref>
<ref id="bib80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>M.H.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>M.E.</given-names></name>, <name name-style="western"><surname>Dalziel</surname><given-names>J.E.</given-names></name>, and <name name-style="western"><surname>Meredith</surname><given-names>A.L.</given-names></name></person-group>
<year>2014</year>
<article-title>BK channels regulate sinoatrial node firing rate and cardiac pacing in vivo</article-title>. <source/>Am. J. Physiol. Heart Circ. Physiol.
<volume>307</volume>:<fpage>H1327</fpage>–<lpage>H1338</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00354.2014</pub-id><pub-id pub-id-type="pmid">25172903</pub-id></mixed-citation>
</ref>
<ref id="bib81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lakshmikanthcharan</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Hisham</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Chaitanya Juluri</surname><given-names>S.K.</given-names></name>, and <name name-style="western"><surname>Nandakumar</surname><given-names>S.M.</given-names></name></person-group>
<year>2018</year>
<article-title>Verapamil as an Adjuvant Treatment for Drug-Resistant Epilepsy</article-title>. <source/>Indian J. Crit. Care Med.
<volume>22</volume>:<fpage>680</fpage>–<lpage>682</lpage>. <pub-id pub-id-type="doi">10.4103/ijccm.IJCCM_250_18</pub-id><pub-id pub-id-type="pmid">30294138</pub-id></mixed-citation>
</ref>
<ref id="bib82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Latorre</surname><given-names>R.</given-names></name>, and <name name-style="western"><surname>Miller</surname><given-names>C.</given-names></name></person-group>
<year>1983</year>
<article-title>Conduction and selectivity in potassium channels</article-title>. <source/>J. Membr. Biol.
<volume>71</volume>:<fpage>11</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1007/BF01870671</pub-id><pub-id pub-id-type="pmid">6300405</pub-id></mixed-citation>
</ref>
<ref id="bib83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Latorre</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Castillo</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Carrasquel-Ursulaez</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Sepulveda</surname><given-names>R.V.</given-names></name>, <name name-style="western"><surname>Gonzalez-Nilo</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Gonzalez</surname><given-names>C.</given-names></name>, and <name name-style="western"><surname>Alvarez</surname><given-names>O.</given-names></name></person-group>
<year>2017</year>
<article-title>Molecular Determinants of BK Channel Functional Diversity and Functioning</article-title>. <source/>Physiol. Rev.
<volume>97</volume>:<fpage>39</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00001.2016</pub-id><pub-id pub-id-type="pmid">27807200</pub-id></mixed-citation>
</ref>
<ref id="bib84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laumonnier</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Roger</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Guérin</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Molinari</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>M’rad</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Cahard</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Belhadj</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Halayem</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Persico</surname><given-names>A.M.</given-names></name>, <name name-style="western"><surname>Elia</surname><given-names>M.</given-names></name>, <etal></etal></person-group>
<year>2006</year>
<article-title>Association of a functional deficit of the BK<sub>Ca</sub> channel, a synaptic regulator of neuronal excitability, with autism and mental retardation</article-title>. <source/>Am. J. Psychiatry.
<volume>163</volume>:<fpage>1622</fpage>–<lpage>1629</lpage>. <pub-id pub-id-type="doi">10.1176/ajp.2006.163.9.1622</pub-id><pub-id pub-id-type="pmid">16946189</pub-id></mixed-citation>
</ref>
<ref id="bib85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>U.S.</given-names></name>, and <name name-style="western"><surname>Cui</surname><given-names>J.</given-names></name></person-group>
<year>2010</year>
<article-title>BK channel activation: structural and functional insights</article-title>. <source/>Trends Neurosci.
<volume>33</volume>:<fpage>415</fpage>–<lpage>423</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2010.06.004</pub-id><pub-id pub-id-type="pmid">20663573</pub-id></mixed-citation>
</ref>
<ref id="bib86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lek</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Karczewski</surname><given-names>K.J.</given-names></name>, <name name-style="western"><surname>Minikel</surname><given-names>E.V.</given-names></name>, <name name-style="western"><surname>Samocha</surname><given-names>K.E.</given-names></name>, <name name-style="western"><surname>Banks</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Fennell</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>O’Donnell-Luria</surname><given-names>A.H.</given-names></name>, <name name-style="western"><surname>Ware</surname><given-names>J.S.</given-names></name>, <name name-style="western"><surname>Hill</surname><given-names>A.J.</given-names></name>, <name name-style="western"><surname>Cummings</surname><given-names>B.B.</given-names></name>, <etal></etal>. <collab>Exome Aggregation Consortium</collab></person-group>
<year>2016</year>
<article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>. <source/>Nature.
<volume>536</volume>:<fpage>285</fpage>–<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1038/nature19057</pub-id><pub-id pub-id-type="pmid">27535533</pub-id></mixed-citation>
</ref>
<ref id="bib87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Poschmann</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Fazeli</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Oundjian</surname><given-names>N.J.</given-names></name>, <name name-style="western"><surname>Snoeijen-Schouwenaars</surname><given-names>F.M.</given-names></name>, <name name-style="western"><surname>Fricke</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Kamsteeg</surname><given-names>E.J.</given-names></name>, <name name-style="western"><surname>Willemsen</surname><given-names>M.</given-names></name>, and <name name-style="western"><surname>Wang</surname><given-names>Q.K.</given-names></name></person-group>
<year>2018</year>
<article-title>De novo BK channel variant causes epilepsy by affecting voltage gating but not Ca<sup>2+</sup> sensitivity</article-title>. <source/>Eur. J. Hum. Genet.
<volume>26</volume>:<fpage>220</fpage>–<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1038/s41431-017-0073-3</pub-id><pub-id pub-id-type="pmid">29330545</pub-id></mixed-citation>
</ref>
<ref id="bib88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Lorca</surname><given-names>R.A.</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Rhodes</surname><given-names>A.</given-names></name>, and <name name-style="western"><surname>England</surname><given-names>S.K.</given-names></name></person-group>
<year>2014</year>
<article-title>BK channels regulate myometrial contraction by modulating nuclear translocation of NF-κB</article-title>. <source/>Endocrinology.
<volume>155</volume>:<fpage>3112</fpage>–<lpage>3122</lpage>. <pub-id pub-id-type="doi">10.1210/en.2014-1152</pub-id><pub-id pub-id-type="pmid">24914944</pub-id></mixed-citation>
</ref>
<ref id="bib89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Moutton</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Schrier Vergano</surname><given-names>S.A.</given-names></name>, <name name-style="western"><surname>Cogne</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>De Saint-Martin</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Hurst</surname><given-names>A.C.E.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Bodamer</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Thevenon</surname><given-names>J.</given-names></name>, <etal></etal></person-group>
<year>2019</year>
<article-title><italic>De novo</italic> loss-of-function <italic>KCNMA1</italic> variants are associated with a new multiple malformation syndrome and a broad spectrum of developmental and neurological phenotypes</article-title>. <source/>Hum. Mol. Genet.
<pub-id pub-id-type="doi">10.1093/hmg/ddz117</pub-id></mixed-citation>
</ref>
<ref id="bib90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Ye</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Zou</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zou</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name>, and <name name-style="western"><surname>Cang</surname><given-names>Y.</given-names></name></person-group>
<year>2014</year>
<article-title>CRL4A(CRBN) E3 ubiquitin ligase restricts BK channel activity and prevents epileptogenesis</article-title>. <source/>Nat. Commun.
<volume>5</volume>:<fpage>3924</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms4924</pub-id><pub-id pub-id-type="pmid">24845235</pub-id></mixed-citation>
</ref>
<ref id="bib91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Hou</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Lang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Yan</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>H.</given-names></name>, <etal></etal></person-group>
<year>2013</year>
<article-title>Human β-defensin 2 is a novel opener of Ca<sup>2+</sup>-activated potassium channels and induces vasodilation and hypotension in monkeys</article-title>. <source/>Hypertension.
<volume>62</volume>:<fpage>415</fpage>–<lpage>425</lpage>. <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.111.01076</pub-id><pub-id pub-id-type="pmid">23734009</pub-id></mixed-citation>
</ref>
<ref id="bib92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Morimoto</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Woda</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Kleyman</surname><given-names>T.R.</given-names></name>, and <name name-style="western"><surname>Satlin</surname><given-names>L.M.</given-names></name></person-group>
<year>2007</year>
<article-title>Ca<sup>2+</sup> dependence of flow-stimulated K secretion in the mammalian cortical collecting duct</article-title>. <source/>Am. J. Physiol. Renal Physiol.
<volume>293</volume>:<fpage>F227</fpage>–<lpage>F235</lpage>. <pub-id pub-id-type="doi">10.1152/ajprenal.00057.2007</pub-id><pub-id pub-id-type="pmid">17389680</pub-id></mixed-citation>
</ref>
<ref id="bib93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ly</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Melman</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Barth</surname><given-names>A.L.</given-names></name>, and <name name-style="western"><surname>Ermentrout</surname><given-names>G.B.</given-names></name></person-group>
<year>2011</year>
<article-title>Phase-resetting curve determines how BK currents affect neuronal firing</article-title>. <source/>J. Comput. Neurosci.
<volume>30</volume>:<fpage>211</fpage>–<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1007/s10827-010-0246-3</pub-id><pub-id pub-id-type="pmid">20517708</pub-id></mixed-citation>
</ref>
<ref id="bib94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maison</surname><given-names>S.F.</given-names></name>, <name name-style="western"><surname>Pyott</surname><given-names>S.J.</given-names></name>, <name name-style="western"><surname>Meredith</surname><given-names>A.L.</given-names></name>, and <name name-style="western"><surname>Liberman</surname><given-names>M.C.</given-names></name></person-group>
<year>2013</year>
<article-title>Olivocochlear suppression of outer hair cells in vivo: evidence for combined action of BK and SK2 channels throughout the cochlea</article-title>. <source/>J. Neurophysiol.
<volume>109</volume>:<fpage>1525</fpage>–<lpage>1534</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00924.2012</pub-id><pub-id pub-id-type="pmid">23282326</pub-id></mixed-citation>
</ref>
<ref id="bib95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manzanares</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Srinivasan</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Salathe</surname><given-names>S.T.</given-names></name>, <name name-style="western"><surname>Ivonnet</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Baumlin</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Dennis</surname><given-names>J.S.</given-names></name>, <name name-style="western"><surname>Conner</surname><given-names>G.E.</given-names></name>, and <name name-style="western"><surname>Salathe</surname><given-names>M.</given-names></name></person-group>
<year>2014</year>
<article-title>IFN-γ-mediated reduction of large-conductance, Ca<sup>2+</sup>-activated, voltage-dependent K<sup>+</sup> (BK) channel activity in airway epithelial cells leads to mucociliary dysfunction</article-title>. <source/>Am. J. Physiol. Lung Cell. Mol. Physiol.
<volume>306</volume>:<fpage>L453</fpage>–<lpage>L462</lpage>. <pub-id pub-id-type="doi">10.1152/ajplung.00247.2013</pub-id><pub-id pub-id-type="pmid">24414257</pub-id></mixed-citation>
</ref>
<ref id="bib96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Puig</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Pietrzykowski</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Zadek</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Emery</surname><given-names>P.</given-names></name>, and <name name-style="western"><surname>Treistman</surname><given-names>S.</given-names></name></person-group>
<year>2004</year>
<article-title>Somatic localization of a specific large-conductance calcium-activated potassium channel subtype controls compartmentalized ethanol sensitivity in the nucleus accumbens</article-title>. <source/>J. Neurosci.
<volume>24</volume>:<fpage>6563</fpage>–<lpage>6572</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0684-04.2004</pub-id><pub-id pub-id-type="pmid">15269268</pub-id></mixed-citation>
</ref>
<ref id="bib97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maruyama</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Gallacher</surname><given-names>D.V.</given-names></name>, and <name name-style="western"><surname>Petersen</surname><given-names>O.H.</given-names></name></person-group>
<year>1983</year>
<article-title>Voltage and Ca<sup>2+</sup>-activated K<sup>+</sup> channel in baso-lateral acinar cell membranes of mammalian salivary glands</article-title>. <source/>Nature.
<volume>302</volume>:<fpage>827</fpage>–<lpage>829</lpage>. <pub-id pub-id-type="doi">10.1038/302827a0</pub-id><pub-id pub-id-type="pmid">6302513</pub-id></mixed-citation>
</ref>
<ref id="bib98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McCobb</surname><given-names>D.P.</given-names></name>, <name name-style="western"><surname>Fowler</surname><given-names>N.L.</given-names></name>, <name name-style="western"><surname>Featherstone</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Lingle</surname><given-names>C.J.</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Krause</surname><given-names>J.E.</given-names></name>, and <name name-style="western"><surname>Salkoff</surname><given-names>L.</given-names></name></person-group>
<year>1995</year>
<article-title>A human calcium-activated potassium channel gene expressed in vascular smooth muscle</article-title>. <source/>Am. J. Physiol.
<volume>269</volume>:<fpage>H767</fpage>–<lpage>H777</lpage>.<pub-id pub-id-type="pmid">7573516</pub-id></mixed-citation>
</ref>
<ref id="bib99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McManus</surname><given-names>O.B.</given-names></name>, and <name name-style="western"><surname>Rothberg</surname><given-names>B.S.</given-names></name></person-group>
<year>2014</year>
<article-title>An old probe sheds new light on BK channel pore structure</article-title>. <source/>J. Gen. Physiol.
<volume>144</volume>:<fpage>499</fpage>–<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.201411306</pub-id><pub-id pub-id-type="pmid">25385785</pub-id></mixed-citation>
</ref>
<ref id="bib100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McManus</surname><given-names>O.B.</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>G.H.</given-names></name>, <name name-style="western"><surname>Giangiacomo</surname><given-names>K.M.</given-names></name>, <name name-style="western"><surname>Feigenbaum</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Reuben</surname><given-names>J.P.</given-names></name>, <name name-style="western"><surname>Addy</surname><given-names>M.E.</given-names></name>, <name name-style="western"><surname>Burka</surname><given-names>J.F.</given-names></name>, <name name-style="western"><surname>Kaczorowski</surname><given-names>G.J.</given-names></name>, and <name name-style="western"><surname>Garcia</surname><given-names>M.L.</given-names></name></person-group>
<year>1993</year>
<article-title>An activator of calcium-dependent potassium channels isolated from a medicinal herb</article-title>. <source/>Biochemistry.
<volume>32</volume>:<fpage>6128</fpage>–<lpage>6133</lpage>. <pub-id pub-id-type="doi">10.1021/bi00075a002</pub-id><pub-id pub-id-type="pmid">7685635</pub-id></mixed-citation>
</ref>
<ref id="bib101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meera</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Wallner</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>M.</given-names></name>, and <name name-style="western"><surname>Toro</surname><given-names>L.</given-names></name></person-group>
<year>1997</year>
<article-title>Large conductance voltage- and calcium-dependent K<sup>+</sup> channel, a distinct member of voltage-dependent ion channels with seven N-terminal transmembrane segments (S0-S6), an extracellular N terminus, and an intracellular (S9-S10) C terminus</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>94</volume>:<fpage>14066</fpage>–<lpage>14071</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.94.25.14066</pub-id><pub-id pub-id-type="pmid">9391153</pub-id></mixed-citation>
</ref>
<ref id="bib102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mehranfard</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Gholamipour-Badie</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Motamedi</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Janahmadi</surname><given-names>M.</given-names></name>, and <name name-style="western"><surname>Naderi</surname><given-names>N.</given-names></name></person-group>
<year>2014</year>
<article-title>The effect of paxilline on early alterations of electrophysiological properties of dentate gyrus granule cells in pilocarpine-treated rats</article-title>. <source/>Iran. J. Pharm. Res.
<volume>13</volume>(<issue>Suppl</issue>):<fpage>125</fpage>–<lpage>132</lpage>.<pub-id pub-id-type="pmid">24711838</pub-id></mixed-citation>
</ref>
<ref id="bib103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mehranfard</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Gholamipour-Badie</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Motamedi</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Janahmadi</surname><given-names>M.</given-names></name>, and <name name-style="western"><surname>Naderi</surname><given-names>N.</given-names></name></person-group>
<year>2015</year>
<article-title>Long-term increases in BK potassium channel underlie increased action potential firing in dentate granule neurons following pilocarpine-induced status epilepticus in rats</article-title>. <source/>Neurosci. Lett.
<volume>585</volume>:<fpage>88</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2014.11.041</pub-id><pub-id pub-id-type="pmid">25434869</pub-id></mixed-citation>
</ref>
<ref id="bib104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Melman</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Bar-Chama</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>McCullough</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Davies</surname><given-names>K.</given-names></name>, and <name name-style="western"><surname>Christ</surname><given-names>G.</given-names></name></person-group>
<year>2007</year>
<article-title>Plasmid-based gene transfer for treatment of erectile dysfunction and overactive bladder: results of a phase I trial</article-title>. <source/>Isr. Med. Assoc. J.
<volume>9</volume>:<fpage>143</fpage>–<lpage>146</lpage>.<pub-id pub-id-type="pmid">17402321</pub-id></mixed-citation>
</ref>
<ref id="bib105">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Meredith</surname><given-names>A.L.</given-names></name></person-group>
<year>2015</year>
<article-title>Genetic Methods for Studying Ion Channel Function in Physiology and Disease</article-title>. In <source/>Handbook of Ion Channels.
<person-group person-group-type="editor"><name name-style="western"><surname>Trudeau</surname><given-names>M.C.</given-names></name>, and <name name-style="western"><surname>Zheng</surname><given-names>J.</given-names></name></person-group>, editors. <publisher-name>CRC Press</publisher-name>
<fpage>545</fpage>–<lpage>556</lpage>.</mixed-citation>
</ref>
<ref id="bib106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meredith</surname><given-names>A.L.</given-names></name>, <name name-style="western"><surname>Thorneloe</surname><given-names>K.S.</given-names></name>, <name name-style="western"><surname>Werner</surname><given-names>M.E.</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>M.T.</given-names></name>, and <name name-style="western"><surname>Aldrich</surname><given-names>R.W.</given-names></name></person-group>
<year>2004</year>
<article-title>Overactive bladder and incontinence in the absence of the BK large conductance Ca<sup>2+</sup>-activated K<sup>+</sup> channel</article-title>. <source/>J. Biol. Chem.
<volume>279</volume>:<fpage>36746</fpage>–<lpage>36752</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M405621200</pub-id><pub-id pub-id-type="pmid">15184377</pub-id></mixed-citation>
</ref>
<ref id="bib107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meredith</surname><given-names>A.L.</given-names></name>, <name name-style="western"><surname>Wiler</surname><given-names>S.W.</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>B.H.</given-names></name>, <name name-style="western"><surname>Takahashi</surname><given-names>J.S.</given-names></name>, <name name-style="western"><surname>Fodor</surname><given-names>A.A.</given-names></name>, <name name-style="western"><surname>Ruby</surname><given-names>N.F.</given-names></name>, and <name name-style="western"><surname>Aldrich</surname><given-names>R.W.</given-names></name></person-group>
<year>2006</year>
<article-title>BK calcium-activated potassium channels regulate circadian behavioral rhythms and pacemaker output</article-title>. <source/>Nat. Neurosci.
<volume>9</volume>:<fpage>1041</fpage>–<lpage>1049</lpage>. <pub-id pub-id-type="doi">10.1038/nn1740</pub-id><pub-id pub-id-type="pmid">16845385</pub-id></mixed-citation>
</ref>
<ref id="bib108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Misonou</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Menegola</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Buchwalder</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>E.W.</given-names></name>, <name name-style="western"><surname>Meredith</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Rhodes</surname><given-names>K.J.</given-names></name>, <name name-style="western"><surname>Aldrich</surname><given-names>R.W.</given-names></name>, and <name name-style="western"><surname>Trimmer</surname><given-names>J.S.</given-names></name></person-group>
<year>2006</year>
<article-title>Immunolocalization of the Ca<sup>2+</sup>-activated K<sup>+</sup> channel Slo1 in axons and nerve terminals of mammalian brain and cultured neurons</article-title>. <source/>J. Comp. Neurol.
<volume>496</volume>:<fpage>289</fpage>–<lpage>302</lpage>. <pub-id pub-id-type="doi">10.1002/cne.20931</pub-id><pub-id pub-id-type="pmid">16566008</pub-id></mixed-citation>
</ref>
<ref id="bib109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montgomery</surname><given-names>J.R.</given-names></name>, and <name name-style="western"><surname>Meredith</surname><given-names>A.L.</given-names></name></person-group>
<year>2012</year>
<article-title>Genetic activation of BK currents in vivo generates bidirectional effects on neuronal excitability</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>109</volume>:<fpage>18997</fpage>–<lpage>19002</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1205573109</pub-id><pub-id pub-id-type="pmid">23112153</pub-id></mixed-citation>
</ref>
<ref id="bib110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montgomery</surname><given-names>J.R.</given-names></name>, <name name-style="western"><surname>Whitt</surname><given-names>J.P.</given-names></name>, <name name-style="western"><surname>Wright</surname><given-names>B.N.</given-names></name>, <name name-style="western"><surname>Lai</surname><given-names>M.H.</given-names></name>, and <name name-style="western"><surname>Meredith</surname><given-names>A.L.</given-names></name></person-group>
<year>2013</year>
<article-title>Mis-expression of the BK K<sup>+</sup> channel disrupts suprachiasmatic nucleus circuit rhythmicity and alters clock-controlled behavior</article-title>. <source/>Am. J. Physiol. Cell Physiol.
<volume>304</volume>:<fpage>C299</fpage>–<lpage>C311</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00302.2012</pub-id><pub-id pub-id-type="pmid">23174562</pub-id></mixed-citation>
</ref>
<ref id="bib111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morrow</surname><given-names>J.P.</given-names></name>, <name name-style="western"><surname>Zakharov</surname><given-names>S.I.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Sok</surname><given-names>A.J.</given-names></name>, and <name name-style="western"><surname>Marx</surname><given-names>S.O.</given-names></name></person-group>
<year>2006</year>
<article-title>Defining the BK channel domains required for beta1-subunit modulation</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>103</volume>:<fpage>5096</fpage>–<lpage>5101</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0600907103</pub-id><pub-id pub-id-type="pmid">16549765</pub-id></mixed-citation>
</ref>
<ref id="bib112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>N’Gouemo</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Faingold</surname><given-names>C.L.</given-names></name>, and <name name-style="western"><surname>Morad</surname><given-names>M.</given-names></name></person-group>
<year>2009</year>
<article-title>Calcium channel dysfunction in inferior colliculus neurons of the genetically epilepsy-prone rat</article-title>. <source/>Neuropharmacology.
<volume>56</volume>:<fpage>665</fpage>–<lpage>675</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2008.11.005</pub-id><pub-id pub-id-type="pmid">19084544</pub-id></mixed-citation>
</ref>
<ref id="bib113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nagaraj</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Nagy</surname><given-names>B.M.</given-names></name>, <name name-style="western"><surname>Papp</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Jain</surname><given-names>P.P.</given-names></name>, <name name-style="western"><surname>Marsh</surname><given-names>L.M.</given-names></name>, <name name-style="western"><surname>Meredith</surname><given-names>A.L.</given-names></name>, <name name-style="western"><surname>Ghanim</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Klepetko</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Kwapiszewska</surname><given-names>G.</given-names></name>, <etal></etal></person-group>
<year>2016</year>
<article-title>Docosahexaenoic acid causes rapid pulmonary arterial relaxation via KCa channel-mediated hyperpolarisation in pulmonary hypertension</article-title>. <source/>Eur. Respir. J.
<volume>48</volume>:<fpage>1127</fpage>–<lpage>1136</lpage>. <pub-id pub-id-type="doi">10.1183/13993003.01814-2015</pub-id><pub-id pub-id-type="pmid">27540020</pub-id></mixed-citation>
</ref>
<ref id="bib114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Narayanan</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Frech</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Walters</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Frigerio</surname><given-names>R.</given-names></name>, and <name name-style="western"><surname>Maraganore</surname><given-names>D.M.</given-names></name></person-group>
<year>2016</year>
<article-title>Low dose verapamil as an adjunct therapy for medically refractory epilepsy - An open label pilot study</article-title>. <source/>Epilepsy Res.
<volume>126</volume>:<fpage>197</fpage>–<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1016/j.eplepsyres.2016.07.004</pub-id><pub-id pub-id-type="pmid">27513375</pub-id></mixed-citation>
</ref>
<ref id="bib115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nardi</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Calderone</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Chericoni</surname><given-names>S.</given-names></name>, and <name name-style="western"><surname>Morelli</surname><given-names>I.</given-names></name></person-group>
<year>2003</year>
<article-title>Natural modulators of large-conductance calcium-activated potassium channels</article-title>. <source/>Planta Med.
<volume>69</volume>:<fpage>885</fpage>–<lpage>892</lpage>. <pub-id pub-id-type="doi">10.1055/s-2003-45095</pub-id><pub-id pub-id-type="pmid">14648389</pub-id></mixed-citation>
</ref>
<ref id="bib116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nelson</surname><given-names>A.B.</given-names></name>, <name name-style="western"><surname>Faulstich</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Moghadam</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Onori</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Meredith</surname><given-names>A.</given-names></name>, and <name name-style="western"><surname>du Lac</surname><given-names>S.</given-names></name></person-group>
<year>2017</year>
<article-title>BK Channels Are Required for Multisensory Plasticity in the Oculomotor System</article-title>. <source/>Neuron.
<volume>93</volume>:<fpage>211</fpage>–<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2016.11.019</pub-id><pub-id pub-id-type="pmid">27989457</pub-id></mixed-citation>
</ref>
<ref id="bib117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neyton</surname><given-names>J.</given-names></name>, and <name name-style="western"><surname>Miller</surname><given-names>C.</given-names></name></person-group>
<year>1988</year>
<article-title>Discrete Ba<sup>2+</sup> block as a probe of ion occupancy and pore structure in the high-conductance Ca<sup>2+</sup> -activated K<sup>+</sup> channel</article-title>. <source/>J. Gen. Physiol.
<volume>92</volume>:<fpage>569</fpage>–<lpage>586</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.92.5.569</pub-id><pub-id pub-id-type="pmid">3235974</pub-id></mixed-citation>
</ref>
<ref id="bib118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olesen</surname><given-names>S.P.</given-names></name>, <name name-style="western"><surname>Munch</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Moldt</surname><given-names>P.</given-names></name>, and <name name-style="western"><surname>Drejer</surname><given-names>J.</given-names></name></person-group>
<year>1994</year><comment>a</comment>
<article-title>Selective activation of Ca<sup>2+</sup>-dependent K<sup>+</sup> channels by novel benzimidazolone</article-title>. <source/>Eur. J. Pharmacol.
<volume>251</volume>:<fpage>53</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/0014-2999(94)90442-1</pub-id><pub-id pub-id-type="pmid">8137869</pub-id></mixed-citation>
</ref>
<ref id="bib119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olesen</surname><given-names>S.P.</given-names></name>, <name name-style="western"><surname>Munch</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Wätjen</surname><given-names>F.</given-names></name>, and <name name-style="western"><surname>Drejer</surname><given-names>J.</given-names></name></person-group>
<year>1994</year><comment>b</comment>
<article-title>NS 004-an activator of Ca<sup>2+</sup>-dependent K<sup>+</sup> channels in cerebellar granule cells</article-title>. <source/>Neuroreport.
<volume>5</volume>:<fpage>1001</fpage>–<lpage>1004</lpage>. <pub-id pub-id-type="doi">10.1097/00001756-199404000-00037</pub-id><pub-id pub-id-type="pmid">7520298</pub-id></mixed-citation>
</ref>
<ref id="bib120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ovsiew</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Meador</surname><given-names>K.J.</given-names></name>, and <name name-style="western"><surname>Sethi</surname><given-names>K.</given-names></name></person-group>
<year>1998</year>
<article-title>Verapamil for severe hyperkinetic movement disorders</article-title>. <source/>Mov. Disord.
<volume>13</volume>:<fpage>341</fpage>–<lpage>344</lpage>. <pub-id pub-id-type="doi">10.1002/mds.870130224</pub-id><pub-id pub-id-type="pmid">9539352</pub-id></mixed-citation>
</ref>
<ref id="bib121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pacheco Otalora</surname><given-names>L.F.</given-names></name>, <name name-style="western"><surname>Hernandez</surname><given-names>E.F.</given-names></name>, <name name-style="western"><surname>Arshadmansab</surname><given-names>M.F.</given-names></name>, <name name-style="western"><surname>Francisco</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Willis</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ermolinsky</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Zarei</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Knaus</surname><given-names>H.G.</given-names></name>, and <name name-style="western"><surname>Garrido-Sanabria</surname><given-names>E.R.</given-names></name></person-group>
<year>2008</year>
<article-title>Down-regulation of BK channel expression in the pilocarpine model of temporal lobe epilepsy</article-title>. <source/>Brain Res.
<volume>1200</volume>:<fpage>116</fpage>–<lpage>131</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2008.01.017</pub-id><pub-id pub-id-type="pmid">18295190</pub-id></mixed-citation>
</ref>
<ref id="bib122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pallanck</surname><given-names>L.</given-names></name>, and <name name-style="western"><surname>Ganetzky</surname><given-names>B.</given-names></name></person-group>
<year>1994</year>
<article-title>Cloning and characterization of human and mouse homologs of the <italic>Drosophila</italic> calcium-activated potassium channel gene, <italic>slowpoke</italic></article-title>
<source/>Hum. Mol. Genet.
<volume>3</volume>:<fpage>1239</fpage>–<lpage>1243</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/3.8.1239</pub-id><pub-id pub-id-type="pmid">7987297</pub-id></mixed-citation>
</ref>
<ref id="bib123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pallotta</surname><given-names>B.S.</given-names></name>, <name name-style="western"><surname>Magleby</surname><given-names>K.L.</given-names></name>, and <name name-style="western"><surname>Barrett</surname><given-names>J.N.</given-names></name></person-group>
<year>1981</year>
<article-title>Single channel recordings of Ca<sup>2+</sup>-activated K<sup>+</sup> currents in rat muscle cell culture</article-title>. <source/>Nature.
<volume>293</volume>:<fpage>471</fpage>–<lpage>474</lpage>. <pub-id pub-id-type="doi">10.1038/293471a0</pub-id><pub-id pub-id-type="pmid">6273730</pub-id></mixed-citation>
</ref>
<ref id="bib124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petrik</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name>, and <name name-style="western"><surname>Brenner</surname><given-names>R.</given-names></name></person-group>
<year>2011</year>
<article-title>Modulation by the BK accessory β4 subunit of phosphorylation-dependent changes in excitability of dentate gyrus granule neurons</article-title>. <source/>Eur. J. Neurosci.
<volume>34</volume>:<fpage>695</fpage>–<lpage>704</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2011.07799.x</pub-id><pub-id pub-id-type="pmid">21848922</pub-id></mixed-citation>
</ref>
<ref id="bib125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pietrzykowski</surname><given-names>A.Z.</given-names></name>, <name name-style="western"><surname>Friesen</surname><given-names>R.M.</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>G.E.</given-names></name>, <name name-style="western"><surname>Puig</surname><given-names>S.I.</given-names></name>, <name name-style="western"><surname>Nowak</surname><given-names>C.L.</given-names></name>, <name name-style="western"><surname>Wynne</surname><given-names>P.M.</given-names></name>, <name name-style="western"><surname>Siegelmann</surname><given-names>H.T.</given-names></name>, and <name name-style="western"><surname>Treistman</surname><given-names>S.N.</given-names></name></person-group>
<year>2008</year>
<article-title>Posttranscriptional regulation of BK channel splice variant stability by miR-9 underlies neuroadaptation to alcohol</article-title>. <source/>Neuron.
<volume>59</volume>:<fpage>274</fpage>–<lpage>287</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2008.05.032</pub-id><pub-id pub-id-type="pmid">18667155</pub-id></mixed-citation>
</ref>
<ref id="bib126">
<mixed-citation publication-type="confproc"><person-group person-group-type="author"><name name-style="western"><surname>Plante</surname><given-names>A.E.</given-names></name>, <name name-style="western"><surname>Moldenhauer</surname><given-names>H.J.</given-names></name>, <name name-style="western"><surname>Harvey</surname><given-names>J.R.M.</given-names></name>, and <name name-style="western"><surname>Meredith</surname><given-names>A.L.</given-names></name></person-group>
<year>2019</year> Gain-of-Function Effects of KCNMA1-N999S Mutation on Human BK Channel Properties, in: <italic>63rd Annual Meeting of the Biophysical Society</italic>.</mixed-citation>
</ref>
<ref id="bib127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pourmasoumi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Vosoughi</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Derakhshandeh-Rishehri</surname><given-names>S.M.</given-names></name>, <name name-style="western"><surname>Assarroudi</surname><given-names>M.</given-names></name>, and <name name-style="western"><surname>Heidari-Beni</surname><given-names>M.</given-names></name></person-group>
<year>2018</year>
<article-title>Association of Omega-3 Fatty Acid and Epileptic Seizure in Epileptic Patients: A Systematic Review</article-title>. <source/>Int. J. Prev. Med.
<volume>9</volume>:<fpage>36</fpage>
<pub-id pub-id-type="doi">10.4103/ijpvm.IJPVM_281_16</pub-id><pub-id pub-id-type="pmid">29721237</pub-id></mixed-citation>
</ref>
<ref id="bib128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pulst</surname><given-names>S.M.</given-names></name></person-group>
<year>1999</year>
<article-title>Genetic linkage analysis</article-title>. <source/>Arch. Neurol.
<volume>56</volume>:<fpage>667</fpage>–<lpage>672</lpage>. <pub-id pub-id-type="doi">10.1001/archneur.56.6.667</pub-id><pub-id pub-id-type="pmid">10369304</pub-id></mixed-citation>
</ref>
<ref id="bib129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pyott</surname><given-names>S.J.</given-names></name>, and <name name-style="western"><surname>Duncan</surname><given-names>R.K.</given-names></name></person-group>
<year>2016</year>
<article-title>BK Channels in the Vertebrate Inner Ear</article-title>. <source/>Int. Rev. Neurobiol.
<volume>128</volume>:<fpage>369</fpage>–<lpage>399</lpage>. <pub-id pub-id-type="doi">10.1016/bs.irn.2016.03.016</pub-id><pub-id pub-id-type="pmid">27238269</pub-id></mixed-citation>
</ref>
<ref id="bib130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pyott</surname><given-names>S.J.</given-names></name>, <name name-style="western"><surname>Meredith</surname><given-names>A.L.</given-names></name>, <name name-style="western"><surname>Fodor</surname><given-names>A.A.</given-names></name>, <name name-style="western"><surname>Vázquez</surname><given-names>A.E.</given-names></name>, <name name-style="western"><surname>Yamoah</surname><given-names>E.N.</given-names></name>, and <name name-style="western"><surname>Aldrich</surname><given-names>R.W.</given-names></name></person-group>
<year>2007</year>
<article-title>Cochlear function in mice lacking the BK channel alpha, beta1, or beta4 subunits</article-title>. <source/>J. Biol. Chem.
<volume>282</volume>:<fpage>3312</fpage>–<lpage>3324</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M608726200</pub-id><pub-id pub-id-type="pmid">17135251</pub-id></mixed-citation>
</ref>
<ref id="bib131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raffaelli</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Saviane</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Mohajerani</surname><given-names>M.H.</given-names></name>, <name name-style="western"><surname>Pedarzani</surname><given-names>P.</given-names></name>, and <name name-style="western"><surname>Cherubini</surname><given-names>E.</given-names></name></person-group>
<year>2004</year>
<article-title>BK potassium channels control transmitter release at CA3-CA3 synapses in the rat hippocampus</article-title>. <source/>J. Physiol.
<volume>557</volume>:<fpage>147</fpage>–<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2004.062661</pub-id><pub-id pub-id-type="pmid">15034127</pub-id></mixed-citation>
</ref>
<ref id="bib132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rieg</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Vallon</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Sausbier</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Sausbier</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Kaissling</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Ruth</surname><given-names>P.</given-names></name>, and <name name-style="western"><surname>Osswald</surname><given-names>H.</given-names></name></person-group>
<year>2007</year>
<article-title>The role of the BK channel in potassium homeostasis and flow-induced renal potassium excretion</article-title>. <source/>Kidney Int.
<volume>72</volume>:<fpage>566</fpage>–<lpage>573</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ki.5002369</pub-id><pub-id pub-id-type="pmid">17579662</pub-id></mixed-citation>
</ref>
<ref id="bib133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Robitaille</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Adler</surname><given-names>E.M.</given-names></name>, and <name name-style="western"><surname>Charlton</surname><given-names>M.P.</given-names></name></person-group>
<year>1993</year>
<article-title>Calcium channels and calcium-gated potassium channels at the frog neuromuscular junction</article-title>. <source/>J. Physiol. Paris.
<volume>87</volume>:<fpage>15</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/0928-4257(93)90020-T</pub-id><pub-id pub-id-type="pmid">7508311</pub-id></mixed-citation>
</ref>
<ref id="bib134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rohmann</surname><given-names>K.N.</given-names></name>, <name name-style="western"><surname>Wersinger</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Braude</surname><given-names>J.P.</given-names></name>, <name name-style="western"><surname>Pyott</surname><given-names>S.J.</given-names></name>, and <name name-style="western"><surname>Fuchs</surname><given-names>P.A.</given-names></name></person-group>
<year>2015</year>
<article-title>Activation of BK and SK channels by efferent synapses on outer hair cells in high-frequency regions of the rodent cochlea</article-title>. <source/>J. Neurosci.
<volume>35</volume>:<fpage>1821</fpage>–<lpage>1830</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2790-14.2015</pub-id><pub-id pub-id-type="pmid">25653344</pub-id></mixed-citation>
</ref>
<ref id="bib135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roy</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Morayo Akande</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Large</surname><given-names>R.J.</given-names></name>, <name name-style="western"><surname>Webb</surname><given-names>T.I.</given-names></name>, <name name-style="western"><surname>Camarasu</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Sergeant</surname><given-names>G.P.</given-names></name>, <name name-style="western"><surname>McHale</surname><given-names>N.G.</given-names></name>, <name name-style="western"><surname>Thornbury</surname><given-names>K.D.</given-names></name>, and <name name-style="western"><surname>Hollywood</surname><given-names>M.A.</given-names></name></person-group>
<year>2012</year>
<article-title>Structure-activity relationships of a novel group of large-conductance Ca<sup>2+</sup>-activated K<sup>+</sup> (BK) channel modulators: the GoSlo-SR family</article-title>. <source/>ChemMedChem.
<volume>7</volume>:<fpage>1763</fpage>–<lpage>1769</lpage>. <pub-id pub-id-type="doi">10.1002/cmdc.201200321</pub-id><pub-id pub-id-type="pmid">22930560</pub-id></mixed-citation>
</ref>
<ref id="bib136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sausbier</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Arntz</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Feil</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kamm</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Adelsberger</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Sausbier</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Sailer</surname><given-names>C.A.</given-names></name>, <name name-style="western"><surname>Feil</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Hofmann</surname><given-names>F.</given-names></name>, <etal></etal></person-group>
<year>2004</year>
<article-title>Cerebellar ataxia and Purkinje cell dysfunction caused by Ca<sup>2+</sup>-activated K<sup>+</sup> channel deficiency</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>101</volume>:<fpage>9474</fpage>–<lpage>9478</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0401702101</pub-id><pub-id pub-id-type="pmid">15194823</pub-id></mixed-citation>
</ref>
<ref id="bib137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sausbier</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Arntz</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Bucurenciu</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>X.B.</given-names></name>, <name name-style="western"><surname>Sausbier</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Feil</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kamm</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Essin</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Sailer</surname><given-names>C.A.</given-names></name>, <etal></etal></person-group>
<year>2005</year>
<article-title>Elevated blood pressure linked to primary hyperaldosteronism and impaired vasodilation in BK channel-deficient mice</article-title>. <source/>Circulation.
<volume>112</volume>:<fpage>60</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.0000156448.74296.FE</pub-id><pub-id pub-id-type="pmid">15867178</pub-id></mixed-citation>
</ref>
<ref id="bib138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sausbier</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Matos</surname><given-names>J.E.</given-names></name>, <name name-style="western"><surname>Sausbier</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Beranek</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Arntz</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Neuhuber</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Ruth</surname><given-names>P.</given-names></name>, and <name name-style="western"><surname>Leipziger</surname><given-names>J.</given-names></name></person-group>
<year>2006</year><comment>a</comment>
<article-title>Distal colonic K<sup>+</sup> secretion occurs via BK channels</article-title>. <source/>J. Am. Soc. Nephrol.
<volume>17</volume>:<fpage>1275</fpage>–<lpage>1282</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2005101111</pub-id><pub-id pub-id-type="pmid">16571783</pub-id></mixed-citation>
</ref>
<ref id="bib139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sausbier</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>X.B.</given-names></name>, <name name-style="western"><surname>Beier</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Sausbier</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Wolpers</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Maget</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Dietrich</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Ressmeyer</surname><given-names>A.R.</given-names></name>, <name name-style="western"><surname>Renz</surname><given-names>H.</given-names></name>, <etal></etal></person-group>
<year>2007</year>
<article-title>Reduced rather than enhanced cholinergic airway constriction in mice with ablation of the large conductance Ca<sup>2+</sup>-activated K<sup>+</sup> channel</article-title>. <source/>FASEB J.
<volume>21</volume>:<fpage>812</fpage>–<lpage>822</lpage>. <pub-id pub-id-type="doi">10.1096/fj.06-7167com</pub-id><pub-id pub-id-type="pmid">17197382</pub-id></mixed-citation>
</ref>
<ref id="bib140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sausbier</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Sausbier</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Sailer</surname><given-names>C.A.</given-names></name>, <name name-style="western"><surname>Arntz</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Knaus</surname><given-names>H.G.</given-names></name>, <name name-style="western"><surname>Neuhuber</surname><given-names>W.</given-names></name>, and <name name-style="western"><surname>Ruth</surname><given-names>P.</given-names></name></person-group>
<year>2006</year><comment>b</comment>
<article-title>Ca<sup>2+</sup>-activated K<sup>+</sup> channels of the BK-type in the mouse brain</article-title>. <source/>Histochem. Cell Biol.
<volume>125</volume>:<fpage>725</fpage>–<lpage>741</lpage>. <pub-id pub-id-type="doi">10.1007/s00418-005-0124-7</pub-id><pub-id pub-id-type="pmid">16362320</pub-id></mixed-citation>
</ref>
<ref id="bib141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sausbier</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Dullin</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Missbach-Guentner</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Kabagema</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Flockerzie</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Kuscher</surname><given-names>G.M.</given-names></name>, <name name-style="western"><surname>Stuehmer</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Neuhuber</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Ruth</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Alves</surname><given-names>F.</given-names></name>, and <name name-style="western"><surname>Sausbier</surname><given-names>M.</given-names></name></person-group>
<year>2011</year>
<article-title>Osteopenia due to enhanced cathepsin K release by BK channel ablation in osteoclasts</article-title>. <source/>PLoS One.
<volume>6</volume>:<elocation-id>e21168</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0021168</pub-id><pub-id pub-id-type="pmid">21695131</pub-id></mixed-citation>
</ref>
<ref id="bib142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Savina</surname><given-names>T.A.</given-names></name>, <name name-style="western"><surname>Levin</surname><given-names>S.G.</given-names></name>, <name name-style="western"><surname>Poletaeva</surname><given-names>I.I.</given-names></name>, <name name-style="western"><surname>Fedotova</surname><given-names>I.B.</given-names></name>, and <name name-style="western"><surname>Shchipakina</surname><given-names>T.G.</given-names></name></person-group>
<year>2014</year>
<article-title>Audiogenic kindling changes the subunit composition of BK-channels in dentate gyrus of Krushinskii-Molodkina rats. <italic>Biochemistry (Moscow)</italic></article-title>. <source/>Supplement Series A: Membrane and Cell Biology.
<volume>8</volume>:<fpage>111</fpage>–<lpage>115</lpage>.</mixed-citation>
</ref>
<ref id="bib143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schuckit</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Wilhelmsen</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>T.L.</given-names></name>, <name name-style="western"><surname>Feiler</surname><given-names>H.S.</given-names></name>, <name name-style="western"><surname>Lind</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Lange</surname><given-names>L.A.</given-names></name>, and <name name-style="western"><surname>Kalmijn</surname><given-names>J.</given-names></name></person-group>
<year>2005</year>
<article-title>Autosomal linkage analysis for the level of response to alcohol</article-title>. <source/>Alcohol. Clin. Exp. Res.
<volume>29</volume>:<fpage>1976</fpage>–<lpage>1982</lpage>. <pub-id pub-id-type="doi">10.1097/01.alc.0000187598.82921.27</pub-id><pub-id pub-id-type="pmid">16340454</pub-id></mixed-citation>
</ref>
<ref id="bib144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shao</surname><given-names>L.R.</given-names></name>, <name name-style="western"><surname>Halvorsrud</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Borg-Graham</surname><given-names>L.</given-names></name>, and <name name-style="western"><surname>Storm</surname><given-names>J.F.</given-names></name></person-group>
<year>1999</year>
<article-title>The role of BK-type Ca<sup>2+</sup>-dependent K<sup>+</sup> channels in spike broadening during repetitive firing in rat hippocampal pyramidal cells</article-title>. <source/>J. Physiol.
<volume>521</volume>:<fpage>135</fpage>–<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7793.1999.00135.x</pub-id><pub-id pub-id-type="pmid">10562340</pub-id></mixed-citation>
</ref>
<ref id="bib145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sheehan</surname><given-names>J.J.</given-names></name>, <name name-style="western"><surname>Benedetti</surname><given-names>B.L.</given-names></name>, and <name name-style="western"><surname>Barth</surname><given-names>A.L.</given-names></name></person-group>
<year>2009</year>
<article-title>Anticonvulsant effects of the BK-channel antagonist paxilline</article-title>. <source/>Epilepsia.
<volume>50</volume>:<fpage>711</fpage>–<lpage>720</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2008.01888.x</pub-id><pub-id pub-id-type="pmid">19054419</pub-id></mixed-citation>
</ref>
<ref id="bib146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shruti</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Clem</surname><given-names>R.L.</given-names></name>, and <name name-style="western"><surname>Barth</surname><given-names>A.L.</given-names></name></person-group>
<year>2008</year>
<article-title>A seizure-induced gain-of-function in BK channels is associated with elevated firing activity in neocortical pyramidal neurons</article-title>. <source/>Neurobiol. Dis.
<volume>30</volume>:<fpage>323</fpage>–<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2008.02.002</pub-id><pub-id pub-id-type="pmid">18387812</pub-id></mixed-citation>
</ref>
<ref id="bib147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silveira-Moriyama</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Kovac</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kurian</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Houlden</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Lees</surname><given-names>A.J.</given-names></name>, <name name-style="western"><surname>Walker</surname><given-names>M.C.</given-names></name>, <name name-style="western"><surname>Roze</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Paciorkowski</surname><given-names>A.R.</given-names></name>, <name name-style="western"><surname>Mink</surname><given-names>J.W.</given-names></name>, and <name name-style="western"><surname>Warner</surname><given-names>T.T.</given-names></name></person-group>
<year>2018</year>
<article-title>Phenotypes, genotypes, and the management of paroxysmal movement disorders</article-title>. <source/>Dev. Med. Child Neurol.
<volume>60</volume>:<fpage>559</fpage>–<lpage>565</lpage>. <pub-id pub-id-type="doi">10.1111/dmcn.13744</pub-id><pub-id pub-id-type="pmid">29600549</pub-id></mixed-citation>
</ref>
<ref id="bib148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soder</surname><given-names>R.P.</given-names></name>, and <name name-style="western"><surname>Petkov</surname><given-names>G.V.</given-names></name></person-group>
<year>2011</year>
<article-title>Large conductance Ca<sup>2+</sup>-activated K<sup>+</sup> channel activation with NS1619 decreases myogenic and neurogenic contractions of rat detrusor smooth muscle</article-title>. <source/>Eur. J. Pharmacol.
<volume>670</volume>:<fpage>252</fpage>–<lpage>259</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2011.08.013</pub-id><pub-id pub-id-type="pmid">21914438</pub-id></mixed-citation>
</ref>
<ref id="bib149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Solaro</surname><given-names>C.R.</given-names></name>, <name name-style="western"><surname>Prakriya</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ding</surname><given-names>J.P.</given-names></name>, and <name name-style="western"><surname>Lingle</surname><given-names>C.J.</given-names></name></person-group>
<year>1995</year>
<article-title>Inactivating and noninactivating Ca<sup>2+</sup>- and voltage-dependent K<sup>+</sup> current in rat adrenal chromaffin cells</article-title>. <source/>J. Neurosci.
<volume>15</volume>:<fpage>6110</fpage>–<lpage>6123</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.15-09-06110.1995</pub-id><pub-id pub-id-type="pmid">7545225</pub-id></mixed-citation>
</ref>
<ref id="bib150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sørensen</surname><given-names>M.V.</given-names></name>, <name name-style="western"><surname>Matos</surname><given-names>J.E.</given-names></name>, <name name-style="western"><surname>Sausbier</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Sausbier</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Ruth</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Praetorius</surname><given-names>H.A.</given-names></name>, and <name name-style="western"><surname>Leipziger</surname><given-names>J.</given-names></name></person-group>
<year>2008</year>
<article-title>Aldosterone increases K<sub>Ca</sub>1.1 (BK) channel-mediated colonic K<sup>+</sup> secretion</article-title>. <source/>J. Physiol.
<volume>586</volume>:<fpage>4251</fpage>–<lpage>4264</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2008.156968</pub-id><pub-id pub-id-type="pmid">18617563</pub-id></mixed-citation>
</ref>
<ref id="bib151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spektor</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Rodriguez</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Rosenbaum</surname><given-names>R.S.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>H.Z.</given-names></name>, <name name-style="western"><surname>Melman</surname><given-names>A.</given-names></name>, and <name name-style="western"><surname>Christ</surname><given-names>G.J.</given-names></name></person-group>
<year>2002</year>
<article-title>Potassium channels and human corporeal smooth muscle cell tone: further evidence of the physiological relevance of the Maxi-K channel subtype to the regulation of human corporeal smooth muscle tone in vitro</article-title>. <source/>J. Urol.
<volume>167</volume>:<fpage>2628</fpage>–<lpage>2635</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-5347(05)65049-5</pub-id><pub-id pub-id-type="pmid">11992099</pub-id></mixed-citation>
</ref>
<ref id="bib152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sprossmann</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Pankert</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Sausbier</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Wirth</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>X.B.</given-names></name>, <name name-style="western"><surname>Madlung</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Bucurenciu</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Jakob</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Lamkemeyer</surname><given-names>T.</given-names></name>, <etal></etal></person-group>
<year>2009</year>
<article-title>Inducible knockout mutagenesis reveals compensatory mechanisms elicited by constitutive BK channel deficiency in overactive murine bladder</article-title>. <source/>FEBS J.
<volume>276</volume>:<fpage>1680</fpage>–<lpage>1697</lpage>. <pub-id pub-id-type="doi">10.1111/j.1742-4658.2009.06900.x</pub-id><pub-id pub-id-type="pmid">19220851</pub-id></mixed-citation>
</ref>
<ref id="bib153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Staisch</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Du</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Carvalho-De-Souza</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Kubota</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Bezanilla</surname><given-names>F.</given-names></name>, and <name name-style="western"><surname>Gomez</surname><given-names>C.</given-names></name></person-group>
<year>2016</year>
<article-title>A Mutation Causing Reduced BK Channel Activity Leads to Cognitive Impairment and Progressive Cerebellar Ataxia</article-title>. <source/>Neurology.
<volume>86</volume>:<fpage>P5.394</fpage>.</mixed-citation>
</ref>
<ref id="bib154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stefani</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Ottolia</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Noceti</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Olcese</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Wallner</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Latorre</surname><given-names>R.</given-names></name>, and <name name-style="western"><surname>Toro</surname><given-names>L.</given-names></name></person-group>
<year>1997</year>
<article-title>Voltage-controlled gating in a large conductance Ca<sup>2+</sup>-sensitive K<sup>+</sup>channel (hslo)</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>94</volume>:<fpage>5427</fpage>–<lpage>5431</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.94.10.5427</pub-id><pub-id pub-id-type="pmid">9144254</pub-id></mixed-citation>
</ref>
<ref id="bib155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steinlein</surname><given-names>O.K.</given-names></name></person-group>
<year>2008</year>
<article-title>Genetics and epilepsy</article-title>. <source/>Dialogues Clin. Neurosci.
<volume>10</volume>:<fpage>29</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="pmid">18472482</pub-id></mixed-citation>
</ref>
<ref id="bib156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Storm</surname><given-names>J.F.</given-names></name></person-group>
<year>1987</year>
<article-title>Action potential repolarization and a fast after-hyperpolarization in rat hippocampal pyramidal cells</article-title>. <source/>J. Physiol.
<volume>385</volume>:<fpage>733</fpage>–<lpage>759</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.1987.sp016517</pub-id><pub-id pub-id-type="pmid">2443676</pub-id></mixed-citation>
</ref>
<ref id="bib157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stummann</surname><given-names>T.C.</given-names></name>, <name name-style="western"><surname>Poulsen</surname><given-names>J.H.</given-names></name>, <name name-style="western"><surname>Hay-Schmidt</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Grunnet</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Klaerke</surname><given-names>D.A.</given-names></name>, <name name-style="western"><surname>Rasmussen</surname><given-names>H.B.</given-names></name>, <name name-style="western"><surname>Olesen</surname><given-names>S.P.</given-names></name>, and <name name-style="western"><surname>Jorgensen</surname><given-names>N.K.</given-names></name></person-group>
<year>2003</year>
<article-title>Pharmacological investigation of the role of ion channels in salivary secretion</article-title>. <source/>Pflugers Arch.
<volume>446</volume>:<fpage>78</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1007/s00424-002-0985-8</pub-id><pub-id pub-id-type="pmid">12690466</pub-id></mixed-citation>
</ref>
<ref id="bib158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tabarki</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>AlMajhad</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>AlHashem</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Shaheen</surname><given-names>R.</given-names></name>, and <name name-style="western"><surname>Alkuraya</surname><given-names>F.S.</given-names></name></person-group>
<year>2016</year>
<article-title>Homozygous KCNMA1 mutation as a cause of cerebellar atrophy, developmental delay and seizures</article-title>. <source/>Hum. Genet.
<volume>135</volume>:<fpage>1295</fpage>–<lpage>1298</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-016-1726-y</pub-id><pub-id pub-id-type="pmid">27567911</pub-id></mixed-citation>
</ref>
<ref id="bib159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>X.D.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Reynolds</surname><given-names>M.F.</given-names></name>, <name name-style="western"><surname>Garcia</surname><given-names>M.L.</given-names></name>, <name name-style="western"><surname>Heinemann</surname><given-names>S.H.</given-names></name>, and <name name-style="western"><surname>Hoshi</surname><given-names>T.</given-names></name></person-group>
<year>2003</year>
<article-title>Haem can bind to and inhibit mammalian calcium-dependent Slo1 BK channels</article-title>. <source/>Nature.
<volume>425</volume>:<fpage>531</fpage>–<lpage>535</lpage>. <pub-id pub-id-type="doi">10.1038/nature02003</pub-id><pub-id pub-id-type="pmid">14523450</pub-id></mixed-citation>
</ref>
<ref id="bib160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tanimoto</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Sothilingam</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Euler</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Ruth</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Seeliger</surname><given-names>M.W.</given-names></name>, and <name name-style="western"><surname>Schubert</surname><given-names>T.</given-names></name></person-group>
<year>2012</year>
<article-title>BK channels mediate pathway-specific modulation of visual signals in the in vivo mouse retina</article-title>. <source/>J. Neurosci.
<volume>32</volume>:<fpage>4861</fpage>–<lpage>4866</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4654-11.2012</pub-id><pub-id pub-id-type="pmid">22492042</pub-id></mixed-citation>
</ref>
<ref id="bib161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tanner</surname><given-names>M.R.</given-names></name>, and <name name-style="western"><surname>Beeton</surname><given-names>C.</given-names></name></person-group>
<year>2018</year>
<article-title>Differences in ion channel phenotype and function between humans and animal models</article-title>. <source/>Front. Biosci.
<volume>23</volume>:<fpage>43</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.2741/4581</pub-id></mixed-citation>
</ref>
<ref id="bib162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thieme</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Stumpff</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Ottlecz</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Percicot</surname><given-names>C.L.</given-names></name>, <name name-style="western"><surname>Lambrou</surname><given-names>G.N.</given-names></name>, and <name name-style="western"><surname>Wiederholt</surname><given-names>M.</given-names></name></person-group>
<year>2001</year>
<article-title>Mechanisms of action of unoprostone on trabecular meshwork contractility</article-title>. <source/>Invest. Ophthalmol. Vis. Sci.
<volume>42</volume>:<fpage>3193</fpage>–<lpage>3201</lpage>.<pub-id pub-id-type="pmid">11726622</pub-id></mixed-citation>
</ref>
<ref id="bib163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thorneloe</surname><given-names>K.S.</given-names></name>, <name name-style="western"><surname>Meredith</surname><given-names>A.L.</given-names></name>, <name name-style="western"><surname>Knorn</surname><given-names>A.M.</given-names></name>, <name name-style="western"><surname>Aldrich</surname><given-names>R.W.</given-names></name>, and <name name-style="western"><surname>Nelson</surname><given-names>M.T.</given-names></name></person-group>
<year>2005</year>
<article-title>Urodynamic properties and neurotransmitter dependence of urinary bladder contractility in the BK channel deletion model of overactive bladder</article-title>. <source/>Am. J. Physiol. Renal Physiol.
<volume>289</volume>:<fpage>F604</fpage>–<lpage>F610</lpage>. <pub-id pub-id-type="doi">10.1152/ajprenal.00060.2005</pub-id><pub-id pub-id-type="pmid">15827347</pub-id></mixed-citation>
</ref>
<ref id="bib164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tomás</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Vázquez</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Fernández-Fernández</surname><given-names>J.M.</given-names></name>, <name name-style="western"><surname>Subirana</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Plata</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Heras</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Vila</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Marrugat</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Valverde</surname><given-names>M.A.</given-names></name>, and <name name-style="western"><surname>Sentí</surname><given-names>M.</given-names></name></person-group>
<year>2008</year>
<article-title>Genetic variation in the <italic>KCNMA1</italic> potassium channel alpha subunit as risk factor for severe essential hypertension and myocardial infarction</article-title>. <source/>J. Hypertens.
<volume>26</volume>:<fpage>2147</fpage>–<lpage>2153</lpage>. <pub-id pub-id-type="doi">10.1097/HJH.0b013e32831103d8</pub-id><pub-id pub-id-type="pmid">18854754</pub-id></mixed-citation>
</ref>
<ref id="bib165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trépanier</surname><given-names>M.O.</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Lai</surname><given-names>T.K.</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>H.J.</given-names></name>, <name name-style="western"><surname>Domenichiello</surname><given-names>A.F.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>C.T.</given-names></name>, <name name-style="western"><surname>Taha</surname><given-names>A.Y.</given-names></name>, <name name-style="western"><surname>Bazinet</surname><given-names>R.P.</given-names></name>, and <name name-style="western"><surname>Burnham</surname><given-names>W.M.</given-names></name></person-group>
<year>2014</year>
<article-title>Intraperitoneal administration of docosahexaenoic acid for 14 days increases serum unesterified DHA and seizure latency in the maximal pentylenetetrazol model</article-title>. <source/>Epilepsy Behav.
<volume>33</volume>:<fpage>138</fpage>–<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1016/j.yebeh.2014.02.020</pub-id><pub-id pub-id-type="pmid">24662925</pub-id></mixed-citation>
</ref>
<ref id="bib166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tricarico</surname><given-names>D.</given-names></name>, and <name name-style="western"><surname>Mele</surname><given-names>A.</given-names></name></person-group>
<year>2017</year>
<article-title>Commentary: A BK (Slo1) channel journey from molecule to physiology</article-title>. <source/>Front. Pharmacol.
<volume>8</volume>:<fpage>188</fpage>
<pub-id pub-id-type="doi">10.3389/fphar.2017.00188</pub-id><pub-id pub-id-type="pmid">28424624</pub-id></mixed-citation>
</ref>
<ref id="bib167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tricarico</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Barbieri</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Mele</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Carbonara</surname><given-names>G.</given-names></name>, and <name name-style="western"><surname>Camerino</surname><given-names>D.C.</given-names></name></person-group>
<year>2004</year>
<article-title>Carbonic anhydrase inhibitors are specific openers of skeletal muscle BK channel of K<sup>+</sup>-deficient rats</article-title>. <source/>FASEB J.
<volume>18</volume>:<fpage>760</fpage>–<lpage>761</lpage>. <pub-id pub-id-type="doi">10.1096/fj.03-0722fje</pub-id><pub-id pub-id-type="pmid">14766795</pub-id></mixed-citation>
</ref>
<ref id="bib168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Typlt</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Mirkowski</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Azzopardi</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Ruettiger</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Ruth</surname><given-names>P.</given-names></name>, and <name name-style="western"><surname>Schmid</surname><given-names>S.</given-names></name></person-group>
<year>2013</year><comment>a</comment>
<article-title>Mice with deficient BK channel function show impaired prepulse inhibition and spatial learning, but normal working and spatial reference memory</article-title>. <source/>PLoS One.
<volume>8</volume>:<elocation-id>e81270</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0081270</pub-id><pub-id pub-id-type="pmid">24303038</pub-id></mixed-citation>
</ref>
<ref id="bib169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Typlt</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Mirkowski</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Azzopardi</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Ruth</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Pilz</surname><given-names>P.K.</given-names></name>, and <name name-style="western"><surname>Schmid</surname><given-names>S.</given-names></name></person-group>
<year>2013</year><comment>b</comment>
<article-title>Habituation of reflexive and motivated behavior in mice with deficient BK channel function</article-title>. <source/>Front. Integr. Nuerosci.
<volume>7</volume>:<fpage>79</fpage>
<pub-id pub-id-type="doi">10.3389/fnint.2013.00079</pub-id></mixed-citation>
</ref>
<ref id="bib170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uhlén</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Fagerberg</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Hallström</surname><given-names>B.M.</given-names></name>, <name name-style="western"><surname>Lindskog</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Oksvold</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Mardinoglu</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Sivertsson</surname><given-names>Å.</given-names></name>, <name name-style="western"><surname>Kampf</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Sjöstedt</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Asplund</surname><given-names>A.</given-names></name>, <etal></etal></person-group>
<year>2015</year>
<article-title>Proteomics. Tissue-based map of the human proteome</article-title>. <source/>Science.
<volume>347</volume>:<elocation-id>1260419</elocation-id>
<pub-id pub-id-type="doi">10.1126/science.1260419</pub-id><pub-id pub-id-type="pmid">25613900</pub-id></mixed-citation>
</ref>
<ref id="bib171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Unterberger</surname><given-names>I.</given-names></name>, and <name name-style="western"><surname>Trinka</surname><given-names>E.</given-names></name></person-group>
<year>2008</year>
<article-title>Diagnosis and treatment of paroxysmal dyskinesias revisited</article-title>. <source/>Ther. Adv. Neurol. Disorder.
<volume>1</volume>:<fpage>4</fpage>–<lpage>11</lpage>.</mixed-citation>
</ref>
<ref id="bib172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Valverde</surname><given-names>M.A.</given-names></name>, <name name-style="western"><surname>Rojas</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Amigo</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Cosmelli</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Orio</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Bahamonde</surname><given-names>M.I.</given-names></name>, <name name-style="western"><surname>Mann</surname><given-names>G.E.</given-names></name>, <name name-style="western"><surname>Vergara</surname><given-names>C.</given-names></name>, and <name name-style="western"><surname>Latorre</surname><given-names>R.</given-names></name></person-group>
<year>1999</year>
<article-title>Acute activation of Maxi-K channels (hSlo) by estradiol binding to the beta subunit</article-title>. <source/>Science.
<volume>285</volume>:<fpage>1929</fpage>–<lpage>1931</lpage>. <pub-id pub-id-type="doi">10.1126/science.285.5435.1929</pub-id><pub-id pub-id-type="pmid">10489376</pub-id></mixed-citation>
</ref>
<ref id="bib173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vang</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Mazer</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Casserly</surname><given-names>B.</given-names></name>, and <name name-style="western"><surname>Choudhary</surname><given-names>G.</given-names></name></person-group>
<year>2010</year>
<article-title>Activation of endothelial BK<sub>Ca</sub> channels causes pulmonary vasodilation</article-title>. <source/>Vascul. Pharmacol.
<volume>53</volume>:<fpage>122</fpage>–<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1016/j.vph.2010.05.001</pub-id><pub-id pub-id-type="pmid">20470901</pub-id></mixed-citation>
</ref>
<ref id="bib174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van Goor</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y.X.</given-names></name>, and <name name-style="western"><surname>Stojilkovic</surname><given-names>S.S.</given-names></name></person-group>
<year>2001</year>
<article-title>Paradoxical role of large-conductance calcium-activated K<sup>+</sup> (BK) channels in controlling action potential-driven Ca<sup>2+</sup> entry in anterior pituitary cells</article-title>. <source/>J. Neurosci.
<volume>21</volume>:<fpage>5902</fpage>–<lpage>5915</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-16-05902.2001</pub-id><pub-id pub-id-type="pmid">11487613</pub-id></mixed-citation>
</ref>
<ref id="bib175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wallner</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Meera</surname><given-names>P.</given-names></name>, and <name name-style="western"><surname>Toro</surname><given-names>L.</given-names></name></person-group>
<year>1996</year>
<article-title>Determinant for beta-subunit regulation in high-conductance voltage-activated and Ca<sup>2+</sup>-sensitive K<sup>+</sup> channels: an additional transmembrane region at the N terminus</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>93</volume>:<fpage>14922</fpage>–<lpage>14927</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.93.25.14922</pub-id><pub-id pub-id-type="pmid">8962157</pub-id></mixed-citation>
</ref>
<ref id="bib176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name>, and <name name-style="western"><surname>Sigworth</surname><given-names>F.J.</given-names></name></person-group>
<year>2009</year>
<article-title>Structure of the BK potassium channel in a lipid membrane from electron cryomicroscopy</article-title>. <source/>Nature.
<volume>461</volume>:<fpage>292</fpage>–<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1038/nature08291</pub-id><pub-id pub-id-type="pmid">19718020</pub-id></mixed-citation>
</ref>
<ref id="bib177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Rothberg</surname><given-names>B.S.</given-names></name>, and <name name-style="western"><surname>Brenner</surname><given-names>R.</given-names></name></person-group>
<year>2009</year>
<article-title>Mechanism of increased BK channel activation from a channel mutation that causes epilepsy</article-title>. <source/>J. Gen. Physiol.
<volume>133</volume>:<fpage>283</fpage>–<lpage>294</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.200810141</pub-id><pub-id pub-id-type="pmid">19204188</pub-id></mixed-citation>
</ref>
<ref id="bib178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Jaffe</surname><given-names>D.B.</given-names></name>, and <name name-style="western"><surname>Brenner</surname><given-names>R.</given-names></name></person-group>
<year>2014</year>
<article-title>Current understanding of iberiotoxin-resistant BK channels in the nervous system</article-title>. <source/>Front. Physiol.
<volume>5</volume>:<fpage>382</fpage>
<pub-id pub-id-type="doi">10.3389/fphys.2014.00382</pub-id><pub-id pub-id-type="pmid">25346692</pub-id></mixed-citation>
</ref>
<ref id="bib179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Bugay</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Ling</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Chuang</surname><given-names>H.H.</given-names></name>, <name name-style="western"><surname>Jaffe</surname><given-names>D.B.</given-names></name>, and <name name-style="western"><surname>Brenner</surname><given-names>R.</given-names></name></person-group>
<year>2016</year>
<article-title>Knockout of the BK β4-subunit promotes a functional coupling of BK channels and ryanodine receptors that mediate a fAHP-induced increase in excitability</article-title>. <source/>J. Neurophysiol.
<volume>116</volume>:<fpage>456</fpage>–<lpage>465</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00857.2015</pub-id><pub-id pub-id-type="pmid">27146987</pub-id></mixed-citation>
</ref>
<ref id="bib180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Bao</surname><given-names>X.</given-names></name>, and <name name-style="western"><surname>Wu</surname><given-names>X.</given-names></name></person-group>
<year>2017</year>
<article-title><italic>KCNMA1</italic> mutation in children with paroxysmal dyskinesia and epilepsy: Case report and literature review</article-title>. <source/>Transl. Sci. Rare Dis.
<volume>2</volume>:<fpage>8</fpage>.</mixed-citation>
</ref>
<ref id="bib181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y.J.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>M.W.</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>A.A.</given-names></name>, and <name name-style="western"><surname>Wu</surname><given-names>S.N.</given-names></name></person-group>
<year>2008</year>
<article-title>Riluzole-induced block of voltage-gated Na<sup>+</sup> current and activation of BK<sub>Ca</sub> channels in cultured differentiated human skeletal muscle cells</article-title>. <source/>Life Sci.
<volume>82</volume>:<fpage>11</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2007.10.015</pub-id><pub-id pub-id-type="pmid">18068197</pub-id></mixed-citation>
</ref>
<ref id="bib182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wanner</surname><given-names>S.G.</given-names></name>, <name name-style="western"><surname>Koch</surname><given-names>R.O.</given-names></name>, <name name-style="western"><surname>Koschak</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Trieb</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Garcia</surname><given-names>M.L.</given-names></name>, <name name-style="western"><surname>Kaczorowski</surname><given-names>G.J.</given-names></name>, and <name name-style="western"><surname>Knaus</surname><given-names>H.G.</given-names></name></person-group>
<year>1999</year>
<article-title>High-conductance calcium-activated potassium channels in rat brain: pharmacology, distribution, and subunit composition</article-title>. <source/>Biochemistry.
<volume>38</volume>:<fpage>5392</fpage>–<lpage>5400</lpage>. <pub-id pub-id-type="doi">10.1021/bi983040c</pub-id><pub-id pub-id-type="pmid">10220326</pub-id></mixed-citation>
</ref>
<ref id="bib183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Werner</surname><given-names>M.E.</given-names></name>, <name name-style="western"><surname>Zvara</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Meredith</surname><given-names>A.L.</given-names></name>, <name name-style="western"><surname>Aldrich</surname><given-names>R.W.</given-names></name>, and <name name-style="western"><surname>Nelson</surname><given-names>M.T.</given-names></name></person-group>
<year>2005</year>
<article-title>Erectile dysfunction in mice lacking the large-conductance calcium-activated potassium (BK) channel</article-title>. <source/>J. Physiol.
<volume>567</volume>:<fpage>545</fpage>–<lpage>556</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2005.093823</pub-id><pub-id pub-id-type="pmid">16020453</pub-id></mixed-citation>
</ref>
<ref id="bib184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Werner</surname><given-names>M.E.</given-names></name>, <name name-style="western"><surname>Meredith</surname><given-names>A.L.</given-names></name>, <name name-style="western"><surname>Aldrich</surname><given-names>R.W.</given-names></name>, and <name name-style="western"><surname>Nelson</surname><given-names>M.T.</given-names></name></person-group>
<year>2008</year>
<article-title>Hypercontractility and impaired sildenafil relaxations in the BK<sub>Ca</sub> channel deletion model of erectile dysfunction</article-title>. <source/>Am. J. Physiol. Regul. Integr. Comp. Physiol.
<volume>295</volume>:<fpage>R181</fpage>–<lpage>R188</lpage>. <pub-id pub-id-type="doi">10.1152/ajpregu.00173.2008</pub-id><pub-id pub-id-type="pmid">18480246</pub-id></mixed-citation>
</ref>
<ref id="bib185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>White</surname><given-names>R.S.</given-names></name>, <name name-style="western"><surname>Zemen</surname><given-names>B.G.</given-names></name>, <name name-style="western"><surname>Khan</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Montgomery</surname><given-names>J.R.</given-names></name>, <name name-style="western"><surname>Herrera</surname><given-names>G.M.</given-names></name>, and <name name-style="western"><surname>Meredith</surname><given-names>A.L.</given-names></name></person-group>
<year>2015</year>
<article-title>Evaluation of mouse urinary bladder smooth muscle for diurnal differences in contractile properties</article-title>. <source/>Front. Pharmacol.
<volume>5</volume>:<fpage>293</fpage>
<pub-id pub-id-type="doi">10.3389/fphar.2014.00293</pub-id><pub-id pub-id-type="pmid">25620932</pub-id></mixed-citation>
</ref>
<ref id="bib186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whitmire</surname><given-names>L.E.</given-names></name>, <name name-style="western"><surname>Ling</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Bugay</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Carver</surname><given-names>C.M.</given-names></name>, <name name-style="western"><surname>Timilsina</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Chuang</surname><given-names>H.H.</given-names></name>, <name name-style="western"><surname>Jaffe</surname><given-names>D.B.</given-names></name>, <name name-style="western"><surname>Shapiro</surname><given-names>M.S.</given-names></name>, <name name-style="western"><surname>Cavazos</surname><given-names>J.E.</given-names></name>, and <name name-style="western"><surname>Brenner</surname><given-names>R.</given-names></name></person-group>
<year>2017</year>
<article-title>Downregulation of <italic>KCNMB4</italic> expression and changes in BK channel subtype in hippocampal granule neurons following seizure activity</article-title>. <source/>PLoS One.
<volume>12</volume>:<elocation-id>e0188064</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0188064</pub-id><pub-id pub-id-type="pmid">29145442</pub-id></mixed-citation>
</ref>
<ref id="bib187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whitt</surname><given-names>J.P.</given-names></name>, <name name-style="western"><surname>Montgomery</surname><given-names>J.R.</given-names></name>, and <name name-style="western"><surname>Meredith</surname><given-names>A.L.</given-names></name></person-group>
<year>2016</year>
<article-title>BK channel inactivation gates daytime excitability in the circadian clock</article-title>. <source/>Nat. Commun.
<volume>7</volume>:<fpage>10837</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms10837</pub-id><pub-id pub-id-type="pmid">26940770</pub-id></mixed-citation>
</ref>
<ref id="bib188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whitt</surname><given-names>J.P.</given-names></name>, <name name-style="western"><surname>McNally</surname><given-names>B.A.</given-names></name>, and <name name-style="western"><surname>Meredith</surname><given-names>A.L.</given-names></name></person-group>
<year>2018</year>
<article-title>Differential contribution of Ca<sup>2+</sup> sources to day and night BK current activation in the circadian clock</article-title>. <source/>J. Gen. Physiol.
<volume>150</volume>:<fpage>259</fpage>–<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.201711945</pub-id><pub-id pub-id-type="pmid">29237755</pub-id></mixed-citation>
</ref>
<ref id="bib189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Womack</surname><given-names>M.D.</given-names></name>, <name name-style="western"><surname>Hoang</surname><given-names>C.</given-names></name>, and <name name-style="western"><surname>Khodakhah</surname><given-names>K.</given-names></name></person-group>
<year>2009</year>
<article-title>Large conductance calcium-activated potassium channels affect both spontaneous firing and intracellular calcium concentration in cerebellar Purkinje neurons</article-title>. <source/>Neuroscience.
<volume>162</volume>:<fpage>989</fpage>–<lpage>1000</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.05.016</pub-id><pub-id pub-id-type="pmid">19446607</pub-id></mixed-citation>
</ref>
<ref id="bib190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wykes</surname><given-names>R.C.</given-names></name>, and <name name-style="western"><surname>Lignani</surname><given-names>G.</given-names></name></person-group>
<year>2018</year>
<article-title>Gene therapy and editing: Novel potential treatments for neuronal channelopathies</article-title>. <source/>Neuropharmacology.
<volume>132</volume>:<fpage>108</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2017.05.029</pub-id><pub-id pub-id-type="pmid">28564577</pub-id></mixed-citation>
</ref>
<ref id="bib191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xia</surname><given-names>X.M.</given-names></name>, <name name-style="western"><surname>Zeng</surname><given-names>X.</given-names></name>, and <name name-style="western"><surname>Lingle</surname><given-names>C.J.</given-names></name></person-group>
<year>2002</year>
<article-title>Multiple regulatory sites in large-conductance calcium-activated potassium channels</article-title>. <source/>Nature.
<volume>418</volume>:<fpage>880</fpage>–<lpage>884</lpage>. <pub-id pub-id-type="doi">10.1038/nature00956</pub-id><pub-id pub-id-type="pmid">12192411</pub-id></mixed-citation>
</ref>
<ref id="bib192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>J.</given-names></name>, and <name name-style="western"><surname>Aldrich</surname><given-names>R.W.</given-names></name></person-group>
<year>2010</year>
<article-title>LRRC26 auxiliary protein allows BK channel activation at resting voltage without calcium</article-title>. <source/>Nature.
<volume>466</volume>:<fpage>513</fpage>–<lpage>516</lpage>. <pub-id pub-id-type="doi">10.1038/nature09162</pub-id><pub-id pub-id-type="pmid">20613726</pub-id></mixed-citation>
</ref>
<ref id="bib193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>J.</given-names></name>, and <name name-style="western"><surname>Aldrich</surname><given-names>R.W.</given-names></name></person-group>
<year>2012</year>
<article-title>BK potassium channel modulation by leucine-rich repeat-containing proteins</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>109</volume>:<fpage>7917</fpage>–<lpage>7922</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1205435109</pub-id><pub-id pub-id-type="pmid">22547800</pub-id></mixed-citation>
</ref>
<ref id="bib194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>G.</given-names></name>, and <name name-style="western"><surname>Cui</surname><given-names>J.</given-names></name></person-group>
<year>2015</year>
<article-title>BK channels: multiple sensors, one activation gate</article-title>. <source/>Front. Physiol.
<volume>6</volume>:<fpage>29</fpage>
<pub-id pub-id-type="doi">10.3389/fphys.2015.00029</pub-id><pub-id pub-id-type="pmid">25705194</pub-id></mixed-citation>
</ref>
<ref id="bib195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Krishnamoorthy</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Saxena</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Delaloye</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Sept</surname><given-names>D.</given-names></name>, and <name name-style="western"><surname>Cui</surname><given-names>J.</given-names></name></person-group>
<year>2010</year>
<article-title>An epilepsy/dyskinesia-associated mutation enhances BK channel activation by potentiating Ca<sup>2+</sup> sensing</article-title>. <source/>Neuron.
<volume>66</volume>:<fpage>871</fpage>–<lpage>883</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.05.009</pub-id><pub-id pub-id-type="pmid">20620873</pub-id></mixed-citation>
</ref>
<ref id="bib196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>P.Y.</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Mao</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Wen</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>X.Q.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Z.F.</given-names></name>, and <name name-style="western"><surname>Zeng</surname><given-names>X.R.</given-names></name></person-group>
<year>2013</year>
<article-title>Function of BK<sub>Ca</sub> channels is reduced in human vascular smooth muscle cells from Han Chinese patients with hypertension</article-title>. <source/>Hypertension.
<volume>61</volume>:<fpage>519</fpage>–<lpage>525</lpage>. <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.111.00211</pub-id><pub-id pub-id-type="pmid">23232643</pub-id></mixed-citation>
</ref>
<ref id="bib197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yeşil</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Aralaşmak</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Akyüz</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>İçağasıoğlu</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Uygur Şahin</surname><given-names>T.</given-names></name>, and <name name-style="western"><surname>Bayram</surname><given-names>Y.</given-names></name></person-group>
<year>2018</year>
<article-title>Expanding the Phenotype of Homozygous <italic>KCNMA1</italic> Mutations; Dyskinesia, Epilepsy, Intellectual Disability, Cerebellar and Corticospinal Tract Atrophy</article-title>. <source/>Balkan Med. J.
<volume>35</volume>:<fpage>336</fpage>–<lpage>339</lpage>. <pub-id pub-id-type="doi">10.4274/balkanmedj.2017.0986</pub-id><pub-id pub-id-type="pmid">29545233</pub-id></mixed-citation>
</ref>
<ref id="bib198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yuan</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Leonetti</surname><given-names>M.D.</given-names></name>, <name name-style="western"><surname>Pico</surname><given-names>A.R.</given-names></name>, <name name-style="western"><surname>Hsiung</surname><given-names>Y.</given-names></name>, and <name name-style="western"><surname>MacKinnon</surname><given-names>R.</given-names></name></person-group>
<year>2010</year>
<article-title>Structure of the human BK channel Ca<sup>2+</sup>-activation apparatus at 3.0 A resolution</article-title>. <source/>Science.
<volume>329</volume>:<fpage>182</fpage>–<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1126/science.1190414</pub-id><pub-id pub-id-type="pmid">20508092</pub-id></mixed-citation>
</ref>
<ref id="bib199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yuan</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Leonetti</surname><given-names>M.D.</given-names></name>, <name name-style="western"><surname>Hsiung</surname><given-names>Y.</given-names></name>, and <name name-style="western"><surname>MacKinnon</surname><given-names>R.</given-names></name></person-group>
<year>2011</year>
<article-title>Open structure of the Ca<sup>2+</sup> gating ring in the high-conductance Ca<sup>2+</sup>-activated K<sup>+</sup> channel</article-title>. <source/>Nature.
<volume>481</volume>:<fpage>94</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1038/nature10670</pub-id><pub-id pub-id-type="pmid">22139424</pub-id></mixed-citation>
</ref>
<ref id="bib200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yue</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Breschi</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Vierstra</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Ryba</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Sandstrom</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Pope</surname><given-names>B.D.</given-names></name>, <etal></etal>. <collab>Mouse ENCODE Consortium</collab></person-group>
<year>2014</year>
<article-title>A comparative encyclopedia of DNA elements in the mouse genome</article-title>. <source/>Nature.
<volume>515</volume>:<fpage>355</fpage>–<lpage>364</lpage>. <pub-id pub-id-type="doi">10.1038/nature13992</pub-id><pub-id pub-id-type="pmid">25409824</pub-id></mixed-citation>
</ref>
<ref id="bib201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>X.L.</given-names></name>, and <name name-style="western"><surname>Gold</surname><given-names>M.S.</given-names></name></person-group>
<year>2009</year>
<article-title>Dihydropyridine block of voltage-dependent K<sup>+</sup> currents in rat dorsal root ganglion neurons</article-title>. <source/>Neuroscience.
<volume>161</volume>:<fpage>184</fpage>–<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.03.012</pub-id><pub-id pub-id-type="pmid">19289157</pub-id></mixed-citation>
</ref>
<ref id="bib202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>S.Y.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Moller</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Zou</surname><given-names>X.</given-names></name>, and <name name-style="western"><surname>Cui</surname><given-names>J.</given-names></name></person-group>
<year>2010</year>
<article-title>Ion sensing in the RCK1 domain of BK channels</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>107</volume>:<fpage>18700</fpage>–<lpage>18705</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1010124107</pub-id><pub-id pub-id-type="pmid">20937866</pub-id></mixed-citation>
</ref>
<ref id="bib203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Z.B.</given-names></name>, <name name-style="western"><surname>Tian</surname><given-names>M.Q.</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>Y.W.</given-names></name>, and <name name-style="western"><surname>Wu</surname><given-names>Y.</given-names></name></person-group>
<year>2015</year>
<article-title><italic>De novo KCNMA1</italic> mutations in children with early-onset paroxysmal dyskinesia and developmental delay</article-title>. <source/>Mov. Disord.
<volume>30</volume>:<fpage>1290</fpage>–<lpage>1292</lpage>. <pub-id pub-id-type="doi">10.1002/mds.26216</pub-id><pub-id pub-id-type="pmid">26195193</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>